2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web:
www.eosmedchem.comEmail: info@eosmedchem.com ; eosmedchem@gmail.com
| Drug_Names: N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,4-diamine, CAS: 150784-74-0, stock 347.3g, assay 98.5%, MWt 263.30, Formula C15H13N5, Purity >98%, SMILES NC1=CC=C(NC2=NC=CC(C3=CC=CN=C3)=N2)C=C1, MDL NA |
| Drug_Names: 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide, CAS: 1675248-19-7, stock 697.6g, assay 98.1%, MWt 330.38, Formula C16H22N6O2, Purity >98%, SMILES O=C(CC(N)=O)N1C[C@H](N(C2=C3C(NC=C3)=NC=N2)C)[C@H](C)CC1, MDL NA |
| Drug_Names: (R)-1-(5-Bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indol-1-yl)ethanone, CAS: 205369-12-6, stock 627.7g, assay 99%, MWt 335.24, Formula C16H19BrN2O, Purity >98%, SMILES O=C(C)N(C(C=C1)=C2C=C1Br)C=C2C[C@@H]3N(C)CCC3, MDL MFCD13180643 |
| Drug_Names: 4-(2-Carboxy-1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid, CAS: 146464-92-8, stock 747.4g, assay 98.5%, MWt 392.37, Formula C19H16N6O4, Purity >98%, SMILES O=C(O)C1=CC=C(C(CC#C)(C(O)=O)CC2=NC3=C(N)N=C(N)N=C3N=C2)C=C1, MDL MFCD09833978 |
| Drug_Names: (3aR,6aS)-1-(tert-Butoxycarbonyl)octahydrocyclopenta[c]pyrrol-2-ium carboxyformate, CAS: 907606-68-2, stock 328.4g, assay 98.9%, MWt 301.34, Formula C14H23NO6, Purity >98%, SMILES O=C(OC(C)(C)C)[C@H]1NC[C@]2([H])CCC[C@]12[H].OC(C(O)=O)=O, MDL MFCD22124391 |
| Drug_Names: (S)-2-aminopentan-1-ol hydrochloride, CAS: 2025376-01-4, stock 795.2g, assay 98.6%, MWt 139.62, Formula C5H14ClNO, Purity >98%, SMILES N[C@@H](CCC)CO.Cl, MDL NA |
| Drug_Names: (S)-2-(((benzyloxy)carbonyl)amino)-2-cyclohexylacetic acid, CAS: 69901-75-3, stock 674.8g, assay 98.9%, MWt 291.34, Formula C16H21NO4, Purity >98%, SMILES OC([C@H](C1CCCCC1)NC(OCC2=CC=CC=C2)=O)=O, MDL NA |
| Drug_Names: (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid, CAS: 402958-98-9, stock 443.5g, assay 98.9%, MWt 513.63, Formula C27H39N5O5, Purity >98%, SMILES [H][C@@]12[C@@](CN(C([C@H](C(C)(C)C)NC([C@H](C3CCCCC3)NC(C4=CN=CC=N4)=O)=O)=O)[C@@H]2C(O)=O)([H])CCC1, MDL NA |
| Drug_Names: 5-(Piperazin-1-yl)benzofuran-2-carboxamide hydrochloride, CAS: 913730-87-7, stock 456.2g, assay 98.4%, MWt 281.74, Formula C13H16ClN3O2, Purity >98%, SMILES O=C(N)C1=CC2=CC(N3CCNCC3)=CC=C2O1.[H]Cl, MDL NA |
| Drug_Names: 2-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoic acid, CAS: 1289942-66-0, stock 69.6g, assay 98%, MWt 254.26, Formula C12H15FN2O3, Purity >98%, SMILES FC1=C(C(NC)=O)C=CC(NC(C(O)=O)(C)C)=C1, MDL MFCD22581651 |
| Drug_Names: Methyl 2-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoate, CAS: 1332524-01-2, stock 302.9g, assay 98.5%, MWt 268.28, Formula C13H17FN2O3, Purity >98%, SMILES FC1=C(C(NC)=O)C=CC(NC(C(OC)=O)(C)C)=C1, MDL MFCD22581652 |
| Drug_Names: (S)-2-(Boc-amino)-1-pentanol, CAS: 116611-55-3, stock 671.4g, assay 98.1%, MWt 203.28, Formula C10H21NO3, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H](CO)CCC, MDL NA |
| Drug_Names: tert-Butyl ((2S,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl)carbamate, CAS: 944716-71-6, stock 792.9g, assay 98.3%, MWt 286.37, Formula C14H26N2O4, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H]([C@H](O)C(NC1CC1)=O)CCC, MDL NA |
| Drug_Names: 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid, CAS: 13721-01-2, stock 881g, assay 98.4%, MWt 189.17, Formula C10H7NO3, Purity >98%, SMILES O=C1C(C(O)=O)=CNC2=CC=CC=C21, MDL MFCD00498984 |
| Drug_Names: 2,4-Di-tert-butyl-5-nitrophenyl methyl carbonate, CAS: 873055-55-1, stock 87.3g, assay 98.7%, MWt 309.36, Formula C16H23NO5, Purity >98%, SMILES CC(C)(C)C1=C([N+]([O-])=O)C=C(OC(OC)=O)C(C(C)(C)C)=C1, MDL MFCD11113067 |
| Drug_Names: 5-Amino-2,4-di-tert-butylphenyl methyl carbonate, CAS: 1182822-31-6, stock 853.6g, assay 98.6%, MWt 279.37, Formula C16H25NO3, Purity >98%, SMILES CC(C)(C)C1=C(N)C=C(OC(OC)=O)C(C(C)(C)C)=C1, MDL MFCD21606649 |
| Drug_Names: (R)-2-(Boc-amino)-1-pentanol, CAS: 116611-57-5, stock 96.4g, assay 98.7%, MWt 203.28, Formula C10H21NO3, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@@H](CO)CCC, MDL NA |
| Drug_Names: (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone, CAS: 915095-87-3, stock 231.8g, assay 98.3%, MWt 428.65, Formula C17H14ClIO3, Purity >98%, SMILES ClC1=C(C(C2=CC=C(O[C@@H]3COCC3)C=C2)=O)C=C(I)C=C1, MDL NA |
| Drug_Names: (3R,4S,5R,6R)-3,4,5-Tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one, CAS: 32384-65-9, stock 553.6g, assay 98.4%, MWt 466.86, Formula C18H42O6Si4, Purity >98%, SMILES O=C1[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](CO[Si](C)(C)C)O1, MDL MFCD22665922 |
| Drug_Names: (1S,3aR,6aS)-Ethyl octahydrocyclopenta[c]pyrrole-1-carboxylate hydrochloride, CAS: 1147103-42-1, stock 561.9g, assay 98.2%, MWt 219.71, Formula C10H18ClNO2, Purity >98%, SMILES O=C(OCC)[C@H]1NC[C@@]2([H])[C@]1([H])CCC2.[H]Cl, MDL NA |
| Drug_Names: (1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamine hydrochloride, CAS: 1402222-66-5, stock 364.7g, assay 98.5%, MWt 205.63, Formula C9H10ClF2N, Purity >98%, SMILES FC1=CC([C@H]2[C@H](N)C2)=CC=C1F.[H]Cl, MDL NA |
| Drug_Names: (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(2-(trifluoromethyl)phenyl)propan-1-amine, CAS: 1431699-53-4, stock 81.9g, assay 98.3%, MWt 357.41, Formula C22H22F3N, Purity >98%, SMILES C[C@@H](NCCCC1=C(C(F)(F)F)C=CC=C1)C2=C(C=CC=C3)C3=CC=C2, MDL NA |
| Drug_Names: (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(m-tolyl)propan-1-amine, CAS: 253337-60-9, stock 586.7g, assay 98%, MWt 303.44, Formula C22H25N, Purity >98%, SMILES C[C@@H](NCCCC1=CC(C)=CC=C1)C2=CC=CC3=C2C=CC=C3, MDL NA |
| Drug_Names: (R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoromethyl)phenyl)propan-1-amine, CAS: 1428185-71-0, stock 833.7g, assay 98%, MWt 357.41, Formula C22H22F3N, Purity >98%, SMILES C[C@@H](NCCCC1=CC=C(C(F)(F)F)C=C1)C2=CC=CC3=C2C=CC=C3, MDL NA |
| Drug_Names: Cinacalcet N-Oxide, CAS: 1229224-94-5, stock 76.9g, assay 98%, MWt 373.41, Formula C22H22F3NO, Purity >98%, SMILES C[C@@H](N(O)CCCC1=CC(C(F)(F)F)=CC=C1)C2=CC=CC3=C2C=CC=C3, MDL NA |
| Drug_Names: (E)-2-(1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile, CAS: 196597-79-2, stock 698.4g, assay 98.7%, MWt 197.23, Formula C13H11NO, Purity >98%, SMILES N#C/C=C1CCC2=CC=C3OCCC3=C\12, MDL NA |
| Drug_Names: 3,3-Dichloro-1-(4-iodophenyl)piperidin-2-one, CAS: 545445-10-1, stock 837.1g, assay 98%, MWt 370.01, Formula C11H10Cl2INO, Purity >98%, SMILES IC1=CC=C(C=C1)N(CCCC2(Cl)Cl)C2=O, MDL NA |
| Drug_Names: Dibenzo[b,f][1,4]thiazepin-11(10H)-one, CAS: 3159-07-7, stock 816.6g, assay 98.9%, MWt 227.28, Formula C13H9NOS, Purity >98%, SMILES O=C1NC2=CC=CC=C2SC3=CC=CC=C13, MDL NA |
| Drug_Names: 1-[2-(2-Hydroxyethoxyl)-ethyl] piperazine, CAS: 13349-82-1, stock 245.5g, assay 98.3%, MWt 174.24, Formula C8H18N2O2, Purity >98%, SMILES OCCOCCN1CCNCC1, MDL MFCD00074931 |
| Drug_Names: Methyl 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucopyranoside, CAS: 1030825-21-8, stock 792.9g, assay 99%, MWt 474.54, Formula C25H27FO6S, Purity >98%, SMILES O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)C1(C2=CC=C(C)C(CC3=CC=C(C4=CC=C(F)C=C4)S3)=C2)OC, MDL NA |
| Drug_Names: 1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone, CAS: 477600-76-3, stock 318.8g, assay 98.5%, MWt 287.36, Formula C15H21N5O, Purity >98%, SMILES CC(N1C[C@H](N(C)C2=C3C(NC=C3)=NC=N2)[C@H](C)CC1)=O, MDL NA |
| Drug_Names: Lithium 4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoate, CAS: 1445586-53-7, stock 201.2g, assay 98.8%, MWt 354.29, Formula C18H15LiN6O2, Purity >98%, SMILES [O-]C(C1=CC=C(C=C1)C(CC#C)CC2=NC3=C(N)N=C(N)N=C3N=C2)=O.[Li+], MDL NA |
| Drug_Names: Methyl 4-(4-(methoxycarbonyl)hepta-1,6-diyn-4-yl)benzoate, CAS: 1026380-17-5, stock 644.1g, assay 98.4%, MWt 284.31, Formula C17H16O4, Purity >98%, SMILES O=C(OC)C1=CC=C(C(CC#C)(C(OC)=O)CC#C)C=C1, MDL NA |
| Drug_Names: (S)-5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine (S)-2-hydroxy-2-phenylacetate, CAS: 439133-67-2, stock 744.2g, assay 98.7%, MWt 329.39, Formula C19H23NO4, Purity >98%, SMILES O[C@H](C(O)=O)C1=CC=CC=C1.N[C@@H]2CC3=C(C(OC)=CC=C3)CC2, MDL NA |
| Drug_Names: (S)-methyl 2-((tert-butoxycarbonyl)amino)pentanoate, CAS: 64896-37-3, stock 741.2g, assay 98.8%, MWt 231.29, Formula C11H21NO4, Purity >98%, SMILES CCC[C@@H](C(OC)=O)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (3S)-3-((tert-butoxycarbonyl)amino)-1-(cyclopropylamino)-1-oxohexan-2-yl acetate, CAS: 856707-38-5, stock 734.5g, assay 98%, MWt 328.40, Formula C16H28N2O5, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H](C(OC(C)=O)C(NC1CC1)=O)CCC, MDL NA |
| Drug_Names: H-Chg-OMe.HCl, CAS: 14328-63-3, stock 590.8g, assay 98.7%, MWt 207.70, Formula C9H18ClNO2, Purity >98%, SMILES N[C@H](C(OC)=O)C1CCCCC1.Cl, MDL MFCD00797545 |
| Drug_Names: (3R,4S,5R,6R)-6-(acetoxymethyl)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triyl, CAS: 1222075-02-6, stock 639.8g, assay 98.7%, MWt 642.69, Formula C33H35FO10S, Purity >98%, SMILES CC1=CC=C(C2([C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O2)OC)C=C1CC3=CC=C(C4=CC=C(F)C=C4)S3, MDL NA |
| Drug_Names: 2-((6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)methyl)benzonitrile, CAS: 865758-95-8, stock 178.1g, assay 98.6%, MWt 261.66, Formula C12H8ClN3O2, Purity >98%, SMILES O=C(C=C(Cl)N1CC2=CC=CC=C2C#N)NC1=O, MDL MFCD09907853 |
| Drug_Names: (R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, CAS: 1268836-55-0, stock 691.2g, assay 98.3%, MWt 578.62, Formula C31H30N8O4, Purity >98%, SMILES N#CC1=CC=CC=C1CN(C(N2C)=O)C(N3C[C@H](NC(N(CC4=CC=CC=C4C#N)C5=O)=CC(N5C)=O)CCC3)=CC2=O, MDL NA |
| Drug_Names: 2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, CAS: 865758-96-9, stock 571.1g, assay 98.2%, MWt 275.69, Formula C13H10ClN3O2, Purity >98%, SMILES N#CC1=CC=CC=C1CN(C(N2C)=O)C(Cl)=CC2=O, MDL MFCD11558902 |
| Drug_Names: 2,2'-((6-Chloro-2,4-dioxopyrimidine-1,3(2H,4H)-diyl)bis(methylene))dibenzonitrile, CAS: 1618644-29-3, stock 404g, assay 98.2%, MWt 376.80, Formula C20H13ClN4O2, Purity >98%, SMILES O=C(C=C(Cl)N1CC2=CC=CC=C2C#N)N(CC3=CC=CC=C3C#N)C1=O, MDL NA |
| Drug_Names: 6-(Hydroxymethyl)uracil, CAS: 22126-44-9, stock 175.9g, assay 98.5%, MWt 142.11, Formula C5H6N2O3, Purity >98%, SMILES O=C1NC(C=C(CO)N1)=O, MDL NA |
| Drug_Names: Methyl 2,3,4-trimethoxyphenyl ketone, CAS: 13909-73-4, stock 878.6g, assay 98.1%, MWt 210.23, Formula C11H14O4, Purity >98%, SMILES O=C(C)C(C(OC)=C1OC)=CC=C1OC, MDL MFCD00008726 |
| Drug_Names: (6-Bromo-4-((4-methyl-3-nitrophenyl)amino)quinolin-3-yl)methanol, CAS: 1431510-25-6, stock 146g, assay 98.3%, MWt 388.22, Formula C17H14BrN3O3, Purity >98%, SMILES OCC1=C(NC2=CC=C(C)C([N+]([O-])=O)=C2)C3=CC(Br)=CC=C3N=C1, MDL NA |
| Drug_Names: 6-Bromo-4-((4-methyl-3-nitrophenyl)amino)quinoline-3-carbaldehyde, CAS: 1431510-26-7, stock 29.1g, assay 98.5%, MWt 386.20, Formula C17H12BrN3O3, Purity >98%, SMILES O=CC1=C(NC2=CC=C(C)C([N+]([O-])=O)=C2)C3=CC(Br)=CC=C3N=C1, MDL NA |
| Drug_Names: N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanesulfonamide, CAS: 616880-14-9, stock 795.7g, assay 98.9%, MWt 297.18, Formula C13H20BNO4S, Purity >98%, SMILES CS(=O)(NC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1)=O, MDL MFCD05663876 |
| Drug_Names: N-(4-Bromophenyl)methanesulfonamide, CAS: 4284-50-8, stock 330.7g, assay 98.6%, MWt 250.11, Formula C7H8BrNO2S, Purity >98%, SMILES CS(=O)(NC1=CC=C(Br)C=C1)=O, MDL MFCD00031385 |
| Drug_Names: N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 2227197-38-6, stock 549.1g, assay 98.8%, MWt 259.35, Formula C14H21N5, Purity >98%, SMILES CN1C[C@H](N(C2=C3C(NC=C3)=NC=N2)C)[C@H](C)CC1, MDL NA |
| Drug_Names: 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile, CAS: 1616761-00-2, stock 660.1g, assay 98.5%, MWt 346.81, Formula C16H19ClN6O, Purity >98%, SMILES O=C(CC#N)N1C[C@H](N(C2=C3C(NC=C3)=NC(Cl)=N2)C)[C@H](C)CC1, MDL NA |
| Drug_Names: 1-(7-Chloro-1H-indol-3-yl)-N,N-dimethylmethanamine, CAS: 159503-76-1, stock 117.3g, assay 98.9%, MWt 208.69, Formula C11H13ClN2, Purity >98%, SMILES ClC1=C2C(C(CN(C)C)=CN2)=CC=C1, MDL NA |
| Drug_Names: 2-Amino-3-(7-chloro-1H-indol-3-yl)propanoic acid (hydrochloride), CAS: 2070014-72-9, stock 717.3g, assay 99%, MWt 275.13, Formula C11H12Cl2N2O2, Purity >98%, SMILES NC(CC1=CNC2=C(Cl)C=CC=C12)C(O)=O.Cl, MDL NA |
| Drug_Names: Methyl 2-amino-3-(7-chloro-1H-indol-3-yl)propanoate, CAS: 862377-53-5, stock 822.9g, assay 98.5%, MWt 252.70, Formula C12H13ClN2O2, Purity >98%, SMILES ClC1=C2C(C(CC(N)C(OC)=O)=CN2)=CC=C1, MDL NA |
| Drug_Names: 2-Amino-3-(7-chloro-1H-indol-3-yl)-N-methylpropanamide, CAS: 2070014-71-8, stock 679.6g, assay 98.2%, MWt 251.71, Formula C12H14ClN3O, Purity >98%, SMILES ClC1=C2C(C(CC(N)C(NC)=O)=CN2)=CC=C1, MDL NA |
| Drug_Names: 2-Acetamido-3-(7-chloro-1H-indol-3-yl)propanoic acid, CAS: 77290-47-2, stock 614.6g, assay 98.9%, MWt 280.71, Formula C13H13ClN2O3, Purity >98%, SMILES O=C(O)C(CC1=CNC2=C(Cl)C=CC=C12)NC(C)=O, MDL NA |
| Drug_Names: 4,4'-Dimethyl[1,1'-biphenyl]-2,2'-dicarboxylic acid, CAS: 2941-79-9, stock 254.6g, assay 98.3%, MWt 270.28, Formula C16H14O4, Purity >98%, SMILES O=C(O)C1=C(C2=C(C(O)=O)C=C(C)C=C2)C=CC(C)=C1, MDL NA |
| Drug_Names: 2-Chloro-4-(2,5-difluoro-4-nitrophenoxy)pyridine, CAS: 1225278-64-7, stock 848.4g, assay 98.9%, MWt 286.62, Formula C11H5ClF2N2O3, Purity >98%, SMILES O=[N+](C1=C(F)C=C(OC2=CC(Cl)=NC=C2)C(F)=C1)[O-], MDL NA |
| Drug_Names: 4-[(2-Chloropyridin-4-yl)oxy]-2,5-difluorobenzenamine, CAS: 1225278-65-8, stock 244.6g, assay 98.6%, MWt 256.64, Formula C11H7ClF2N2O, Purity >98%, SMILES NC1=CC(F)=C(OC2=CC(Cl)=NC=C2)C=C1F, MDL NA |
| Drug_Names: 2,5-Difluoro-4-((2-(1-methyl-1H-pyrazol-4-yl)pyridin-4-yl)oxy)aniline, CAS: 1225278-35-2, stock 717.3g, assay 98%, MWt 302.28, Formula C15H12F2N4O, Purity >98%, SMILES NC1=CC(F)=C(OC2=CC(C3=CN(C)N=C3)=NC=C2)C=C1F, MDL NA |
| Drug_Names: 1-(phenylcarbamoyl)cyclopropanecarboxylic acid, CAS: 145591-80-6, stock 783.3g, assay 98.6%, MWt 205.21, Formula C11H11NO3, Purity >98%, SMILES O=C(O)C1(CC1)C(NC2=CC=CC=C2)=O, MDL NA |
| Drug_Names: 3-(4-Aminobutyl)-1H-Indole-5-carbonitrile, CAS: 143612-85-5, stock 598g, assay 98.5%, MWt 213.28, Formula C13H15N3, Purity >98%, SMILES N#CC1=CC2=C(NC=C2CCCCN)C=C1, MDL NA |
| Drug_Names: Ethyl 5-(bis(2-chloroethyl)amino)benzofuran-2-carboxylate, CAS: 294174-66-6, stock 322.3g, assay 98.2%, MWt 330.21, Formula C15H17Cl2NO3, Purity >98%, SMILES ClCCN(CCCl)C1=CC=C2C(C=C(C(OCC)=O)O2)=C1, MDL NA |
| Drug_Names: (S)-6-(Propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide, CAS: 165950-84-5, stock 248.3g, assay 98.6%, MWt 286.21, Formula C13H20BrNO, Purity >98%, SMILES OC1=CC=CC2=C1CC[C@H](NCCC)C2.Br, MDL MFCD20485837 |
| Drug_Names: (S)-2,2-diphenyl-2-(pyrrolidin-3-yl)acetic acid (hydrobromide), CAS: 1415566-36-7, stock 231.9g, assay 98%, MWt 362.26, Formula C18H20BrNO2, Purity >98%, SMILES O=C(O)C(C1=CC=CC=C1)([C@H]2CNCC2)C3=CC=CC=C3.Br, MDL NA |
| Drug_Names: 5-Methyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(4-pyridyl)-4-pyrimidinyl]-2-pyridinesulfonamide, CAS: 290815-30-4, stock 544.4g, assay 98.2%, MWt 483.93, Formula C22H18ClN5O4S, Purity >98%, SMILES O=S(NC1=C(OC(C=CC=C2)=C2OC)C(Cl)=NC(C3=CC=NC=C3)=N1)(C4=NC=C(C)C=C4)=O, MDL NA |
| Drug_Names: N-(2-oxo-1-((6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl)-1,2-dihydropyrimidin-4-yl)benzamide, CAS: 119411-03-9, stock 285.1g, assay 98.6%, MWt 587.81, Formula C28H41N3O7Si2, Purity >98%, SMILES O=C([C@H](N1C(N=C(C=C1)NC(C2=CC=CC=C2)=O)=O)O3)[C@H](O4)[C@H]3CO[Si](C(C)C)(C(C)C)O[Si]4(C(C)C)C(C)C, MDL NA |
| Drug_Names: N-(1-((6aR,8R,9S,9aR)-9-hydroxy-2,2,4,4-tetraisopropyl-9-methyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, CAS: 817204-34-5, stock 677g, assay 98.7%, MWt 603.85, Formula C29H45N3O7Si2, Purity >98%, SMILES O[C@@]([C@H](N1C(N=C(C=C1)NC(C2=CC=CC=C2)=O)=O)O3)(C)[C@H](O4)[C@H]3CO[Si](C(C)C)(C(C)C)O[Si]4(C(C)C)C(C)C, MDL NA |
| Drug_Names: (2R,3R,4S,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-hydroxy-4-methyltetrahydrofuran-3-yl benzoate, CAS: 863329-62-8, stock 217.5g, assay 98.7%, MWt 569.56, Formula C31H27N3O8, Purity >98%, SMILES O[C@@]([C@H](N1C(N=C(C=C1)NC(C2=CC=CC=C2)=O)=O)O3)(C)[C@H](OC(C4=CC=CC=C4)=O)[C@H]3COC(C5=CC=CC=C5)=O, MDL NA |
| Drug_Names: (2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-hydroxy-4-methyltetrahydrofuran-3-yl benzoate, CAS: 863329-64-0, stock 18.8g, assay 99%, MWt 569.56, Formula C31H27N3O8, Purity >98%, SMILES O=C(N=C(C=C1)NC(C2=CC=CC=C2)=O)N1[C@H](O3)[C@](C)(O)[C@H](OC(C4=CC=CC=C4)=O)[C@H]3COC(C5=CC=CC=C5)=O, MDL NA |
| Drug_Names: Sofosbuvir Impurity 4, CAS: 863329-63-9, stock 326.1g, assay 98.8%, MWt 551.55, Formula C31H25N3O7, Purity >98%, SMILES O=C(N=C(C=C1)NC(C2=CC=CC=C2)=O)N1[C@H](O3)C([C@H](OC(C4=CC=CC=C4)=O)[C@H]3COC(C5=CC=CC=C5)=O)=C, MDL NA |
| Drug_Names: N-(5-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-nitro-6-(4-nitrophenethoxy)pyridin-2-yl)acetamide, CAS: 1843217-56-0, stock 897.3g, assay 98.9%, MWt 462.41, Formula C20H22N4O9, Purity >98%, SMILES CC(NC1=NC(OCCC2=CC=C([N+]([O-])=O)C=C2)=C([C@@H]3O[C@H](CO)[C@@H](O)C3)C=C1[N+]([O-])=O)=O, MDL NA |
| Drug_Names: Methyl 1-(4-bromophenyl)-3-hydroxycyclobutanecarboxylate, CAS: 1432059-59-0, stock 659.2g, assay 99%, MWt 285.13, Formula C12H13BrO3, Purity >98%, SMILES O=C(OC)C1(CC(O)C1)C(C=C2)=CC=C2Br, MDL NA |
| Drug_Names: rel-(1R,2R)-2-(pent-4-en-1-yl)cyclopropan-1-ol, CAS: 1384277-05-7, stock 174.8g, assay 98.1%, MWt 126.20, Formula C8H14O, Purity >98%, SMILES O[C@@H]1C[C@H]1CCCC=C, MDL NA |
| Drug_Names: (1S,2S)-2-(pent-4-en-1-yl)cyclopropyl acetate, CAS: 1535210-30-0, stock 752.1g, assay 98.8%, MWt 168.23, Formula C10H16O2, Purity >98%, SMILES C=CCCC[C@H]1C[C@@H]1OC(C)=O, MDL NA |
| Drug_Names: 2,3-Dichloro-6-methoxyquinoxaline, CAS: 39267-04-4, stock 501.5g, assay 98.9%, MWt 229.06, Formula C9H6Cl2N2O, Purity >98%, SMILES ClC1=NC2=CC(OC)=CC=C2N=C1Cl, MDL MFCD00461063 |
| Drug_Names: 1-(tert-Butyl) 2-methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate, CAS: 1206524-79-9, stock 51.9g, assay 98.5%, MWt 437.87, Formula C20H24ClN3O6, Purity >98%, SMILES COC1=CC=C(N=C(Cl)C(O[C@@H](CN2C(OC(C)(C)C)=O)C[C@H]2C(OC)=O)=N3)C3=C1, MDL NA |
| Drug_Names: Methyl (2S)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-2-carboxylate hydrochloride, CAS: 1361028-94-5, stock 326.5g, assay 98.3%, MWt 374.22, Formula C15H17Cl2N3O4, Purity >98%, SMILES O=C(OC)[C@H]1NC[C@H](OC2=NC3=CC(OC)=CC=C3N=C2Cl)C1.Cl, MDL NA |
| Drug_Names: (2S,4R)-methyl 4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)-1-((S)-3,3-dimethyl-2-((((1R,2R)-2-(pent-4-en-1-yl)cyclopropoxy)carbonyl)amino)butanoyl)pyrrolidine-2-carboxylate, CAS: 1206524-81-3, stock 879.8g, assay 98%, MWt 603.11, Formula C30H39ClN4O7, Purity >98%, SMILES O=C(OC)[C@H]1N(C([C@H](C(C)(C)C)NC(O[C@H]2[C@H](CCCC=C)C2)=O)=O)C[C@H](OC3=NC4=CC(OC)=CC=C4N=C3Cl)C1, MDL NA |
| Drug_Names: Methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphan-13-ene-35-carboxylate, CAS: 1206524-83-5, stock 525.4g, assay 98.9%, MWt 566.65, Formula C30H38N4O7, Purity >98%, SMILES COC1=CC=C(N=C(/C=C/CCC[C@@H]2C[C@H]2OC(N[C@@H](C(C)(C)C)C3=O)=O)C(O[C@H]4CN3[C@H](C(OC)=O)C4)=N5)C5=C1, MDL NA |
| Drug_Names: MK-5172, CAS: 1206524-85-7, stock 704.9g, assay 98.1%, MWt 554.63, Formula C29H38N4O7, Purity >98%, SMILES COC1=CC=C(N=C(CCCCC[C@@H]2C[C@H]2OC(N[C@@H](C(C)(C)C)C3=O)=O)C(O[C@H]4CN3[C@H](C(O)=O)C4)=N5)C5=C1, MDL NA |
| Drug_Names: (1R,2S)-1-Amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide 4-methylbenzenesulfonate (1:1), CAS: 1028252-16-5, stock 555.1g, assay 98.7%, MWt 402.49, Formula C16H22N2O6S2, Purity >98%, SMILES O=C([C@]1(N)[C@H](C=C)C1)NS(=O)(C2CC2)=O.O=S(C3=CC=C(C)C=C3)(O)=O, MDL NA |
| Drug_Names: Diethyl 2-acetamido-2-((7-chloro-1H-indol-3-yl)methyl)malonate, CAS: 582319-05-9, stock 132.3g, assay 98.6%, MWt 380.82, Formula C18H21ClN2O5, Purity >98%, SMILES O=C(OCC)C(NC(C)=O)(CC1=CNC2=C1C=CC=C2Cl)C(OCC)=O, MDL NA |
| Drug_Names: 5-Chloro-N-(4-nitrophenyl)pentanamide, CAS: 1039914-85-6, stock 484.7g, assay 98.9%, MWt 256.69, Formula C11H13ClN2O3, Purity >98%, SMILES O=C(NC1=CC=C([N+]([O-])=O)C=C1)CCCCCl, MDL NA |
| Drug_Names: N-Methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 1260614-73-0, stock 187.5g, assay 98.5%, MWt 245.32, Formula C13H19N5, Purity >98%, SMILES CN([C@H]1[C@@H](C)CCNC1)C2=C3C(NC=C3)=NC=N2, MDL NA |
| Drug_Names: Methyl 6-bromo-1-(pentan-3-yl)-1H-indole-4-carboxylate, CAS: 2070014-80-9, stock 239g, assay 98.8%, MWt 324.21, Formula C15H18BrNO2, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=C1C=CN2C(CC)CC)OC, MDL NA |
| Drug_Names: 6-Cyano-1-(pentan-3-yl)-1H-indole-4-carboxylic acid, CAS: 2070015-43-7, stock 335.3g, assay 98.7%, MWt 256.30, Formula C15H16N2O2, Purity >98%, SMILES O=C(C1=CC(C#N)=CC2=C1C=CN2C(CC)CC)O, MDL NA |
| Drug_Names: (3S,5S,8R,9S,10S,13S,14S,E)-17-hydrazono-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-ol, CAS: 10481-80-8, stock 77.3g, assay 98.5%, MWt 304.47, Formula C19H32N2O, Purity >98%, SMILES C[C@]1([C@](CC/2)([H])[C@]3([H])CC[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC1)C2=N/N, MDL NA |
| Drug_Names: (3S,5S,8R,9S,10S,13S,14S)-17-iodo-10,13-dimethyl-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol, CAS: 95043-81-5, stock 848.6g, assay 99%, MWt 400.34, Formula C19H29IO, Purity >98%, SMILES C[C@@]12C(I)=CC[C@@]1([H])[C@]3([H])CC[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC2, MDL NA |
| Drug_Names: (8R,9S,10S,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, CAS: 219843-76-2, stock 185.7g, assay 98.9%, MWt 393.56, Formula C26H35NO2, Purity >98%, SMILES C[C@@]12C(C3=CN=CC=C3)=CC[C@@]1([H])[C@]4([H])CC[C@@]5([H])C[C@@H](OC(C)=O)CC[C@]5(C)[C@@]4([H])CC2, MDL NA |
| Drug_Names: 4-(2-Oxo-3H-benzimidazol-1-yl)butanoic acid, CAS: 3273-68-5, stock 531.2g, assay 98.7%, MWt 220.22, Formula C11H12N2O3, Purity >98%, SMILES O=C1NC2=CC=CC=C2N1CCCC(O)=O, MDL MFCD06656423 |
| Drug_Names: 3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one, CAS: 881386-01-2, stock 443.5g, assay 98.6%, MWt 289.11, Formula C11H10Cl2N2O3, Purity >98%, SMILES O=C1C(Cl)(Cl)CCCN1C2=CC=C([N+]([O-])=O)C=C2, MDL MFCD23142941 |
| Drug_Names: Methyl 6-bromo-2-cyclopentyl-2H-indazole-4-carboxylate, CAS: 2070014-74-1, stock 29.1g, assay 98.8%, MWt 323.19, Formula C14H15BrN2O2, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=NN(C3CCCC3)C=C21)OC, MDL NA |
| Drug_Names: (S)-4-amino-1-(2-hydroxy-3-(trityloxy)propyl)pyrimidin-2(1H)-one, CAS: 132336-30-2, stock 415.6g, assay 98.2%, MWt 427.50, Formula C26H25N3O3, Purity >98%, SMILES O=C1N=C(N)C=CN1C[C@H](O)COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4, MDL NA |
| Drug_Names: ((3-(Hexadecyloxy)propoxy)(hydroxy)phosphoryl)methyl 4-methylbenzenesulfonate, CAS: 864068-45-1, stock 243.1g, assay 98.7%, MWt 548.71, Formula C27H49O7PS, Purity >98%, SMILES O=S(OCP(OCCCOCCCCCCCCCCCCCCCC)(O)=O)(C1=CC=C(C)C=C1)=O, MDL NA |
| Drug_Names: (S)-1-(2-hydroxy-3-(trityloxy)propyl)-4-(((4-methoxyphenyl)diphenylmethyl)amino)pyrimidin-2(1H)-one, CAS: 864068-43-9, stock 109.2g, assay 98.4%, MWt 699.84, Formula C46H41N3O4, Purity >98%, SMILES O=C1N=C(NC(C2=CC=CC=C2)(C3=CC=C(OC)C=C3)C4=CC=CC=C4)C=CN1C[C@H](O)COC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7, MDL NA |
| Drug_Names: 2,3-dichloro-N-(pyridin-3-ylmethyl)benzamide, CAS: 425685-04-7, stock 5.5g, assay 98.9%, MWt 281.14, Formula C13H10Cl2N2O, Purity >98%, SMILES ClC1=CC=CC(C(NCC2=CC=CN=C2)=O)=C1Cl, MDL NA |
| Drug_Names: 2-Chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 1616760-97-4, stock 824.8g, assay 98.5%, MWt 279.77, Formula C13H18ClN5, Purity >98%, SMILES CN([C@@H]1[C@H](C)CCNC1)C2=C3C(NC=C3)=NC(Cl)=N2, MDL NA |
| Drug_Names: NSC 92421, CAS: 7057-46-7, stock 406.7g, assay 98.3%, MWt 532.47, Formula C26H23F3N2O7, Purity >98%, SMILES O=C1C(C(F)(F)F)=CN([C@H]2C[C@H](OC(C3=CC=C(C)C=C3)=O)[C@@H](COC(C4=CC=C(C)C=C4)=O)O2)C(N1)=O, MDL NA |
| Drug_Names: (R)-6-(propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide, CAS: 167016-87-7, stock 84.4g, assay 98.5%, MWt 286.21, Formula C13H20BrNO, Purity >98%, SMILES OC1=CC=CC2=C1CC[C@@H](NCCC)C2.Br, MDL NA |
| Drug_Names: (2R,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, CAS: 1589590-87-3, stock 101.8g, assay 98%, MWt 444.52, Formula C24H25FO5S, Purity >98%, SMILES CC1=CC=C([C@@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C=C1CC3=CC=C(C4=CC=C(F)C=C4)S3, MDL NA |
| Drug_Names: Methanesulfonic acid 2-(5-methyl-2-phenyloxazol-4-yl)ethyl ester, CAS: 227029-27-8, stock 784.5g, assay 98.9%, MWt 281.33, Formula C13H15NO4S, Purity >98%, SMILES CC1=C(CCOS(C)(=O)=O)N=C(C2=CC=CC=C2)O1, MDL MFCD17014833 |
| Drug_Names: 6,7-Dihydrobenzo[b]thiophen-4(5H)-one, CAS: 13414-95-4, stock 690.6g, assay 99%, MWt 152.21, Formula C8H8OS, Purity >98%, SMILES O=C1CCCC2=C1C=CS2, MDL MFCD00005861 |
| Drug_Names: 2-Acetyl-6,7-dihydrobenzo[b]thiophen-4(5H)-one, CAS: 74458-89-2, stock 204.5g, assay 98.4%, MWt 194.25, Formula C10H10O2S, Purity >98%, SMILES O=C1CCCC2=C1C=C(C(C)=O)S2, MDL NA |
| Drug_Names: (S)-4-benzyl-3-(2-methoxyacetyl)oxazolidin-2-one, CAS: 129952-14-3, stock 376.7g, assay 98.2%, MWt 249.26, Formula C13H15NO4, Purity >98%, SMILES O=C1OC[C@H](CC2=CC=CC=C2)N1C(COC)=O, MDL NA |
| Drug_Names: 3-Bromo-N-methylaniline hydrochloride, CAS: 152814-26-1, stock 871.1g, assay 98.5%, MWt 222.51, Formula C7H9BrClN, Purity >98%, SMILES BrC1=CC(NC)=CC=C1.Cl, MDL NA |
| Drug_Names: tert-Butyl (4-(prop-2-yn-1-yloxy)benzyl)carbamate, CAS: 1380401-33-1, stock 839.2g, assay 98.9%, MWt 261.32, Formula C15H19NO3, Purity >98%, SMILES C#CCOC1=CC=C(CNC(OC(C)(C)C)=O)C=C1, MDL NA |
| Drug_Names: 4,6-Dichloro-2-(propylsulfinyl)pyrimidin-5-amine, CAS: 1823431-32-8, stock 806.1g, assay 98.5%, MWt 254.14, Formula C7H9Cl2N3OS, Purity >98%, SMILES ClC1=NC(S(CCC)=O)=NC(Cl)=C1N, MDL NA |
| Drug_Names: 4,6-Dichloro-2-(propylsulfonyl)pyrimidin-5-amine, CAS: 1482484-62-7, stock 583.2g, assay 98.6%, MWt 270.14, Formula C7H9Cl2N3O2S, Purity >98%, SMILES ClC1=NC(S(CCC)(=O)=O)=NC(Cl)=C1N, MDL NA |
| Drug_Names: 4,6-Dichloro-2-(propylthio)pyrimidine, CAS: 1401318-10-2, stock 143.9g, assay 98.2%, MWt 223.12, Formula C7H8Cl2N2S, Purity >98%, SMILES ClC1=NC(SCCC)=NC(Cl)=C1, MDL NA |
| Drug_Names: (3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 155899-66-4, stock 435.3g, assay 98.2%, MWt 173.21, Formula C8H15NO3, Purity >98%, SMILES O[C@H]1C[C@@H](N)[C@H]2[C@@H]1OC(C)(C)O2, MDL MFCD22690255 |
| Drug_Names: 3-Ethoxy-4-nitrobenzoic acid, CAS: 367501-32-4, stock 267.2g, assay 98%, MWt 211.17, Formula C9H9NO5, Purity >98%, SMILES OC(C(C=C1)=CC(OCC)=C1[N+]([O-])=O)=O, MDL NA |
| Drug_Names: (4-Amino-3-ethoxyphenyl)(4-(4-methylpiperazin-1-yl)piperidin-1-yl)methanone, CAS: 1521197-86-3, stock 885.6g, assay 98.7%, MWt 346.47, Formula C19H30N4O2, Purity >98%, SMILES NC1=C(OCC)C=C(C(N2CCC(N3CCN(C)CC3)CC2)=O)C=C1, MDL NA |
| Drug_Names: 2-Chloro-11-cyclopentyl-5-methyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one, CAS: 1521197-46-5, stock 421.1g, assay 98.3%, MWt 328.80, Formula C17H17ClN4O, Purity >98%, SMILES ClC1=NC=C2C(N(C3CCCC3)C(C=CC=C4)=C4C(N2C)=O)=N1, MDL NA |
| Drug_Names: (S)-tert-Butyl (2,6-dimethyl-3-oxohept-1-en-4-yl)carbamate, CAS: 247068-81-1, stock 163.5g, assay 98.2%, MWt 255.35, Formula C14H25NO3, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@@H](CC(C)C)C(C(C)=C)=O, MDL MFCD26227261 |
| Drug_Names: 3-Morpholino-1-phenyl-5,6-dihydropyridin-2(1H)-one, CAS: 1197377-73-3, stock 170.5g, assay 98.3%, MWt 258.32, Formula C15H18N2O2, Purity >98%, SMILES O=C1C(N2CCOCC2)=CCCN1C3=CC=CC=C3, MDL NA |
| Drug_Names: (S)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide, CAS: 1770812-37-7, stock 52.2g, assay 98.4%, MWt 470.33, Formula C19H17Cl2N3O5S, Purity >98%, SMILES O=C(C1=CC(Cl)=C(Cl)S1)NC[C@H](OC2=O)CN2C(C=C3)=CC=C3N4CCOCC4=O, MDL NA |
| Drug_Names: (R)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide, CAS: 1770812-38-8, stock 752g, assay 98.9%, MWt 470.33, Formula C19H17Cl2N3O5S, Purity >98%, SMILES O=C(C1=CC(Cl)=C(Cl)S1)NC[C@@H](OC2=O)CN2C(C=C3)=CC=C3N4CCOCC4=O, MDL NA |
| Drug_Names: 1,3-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)urea, CAS: 1365267-35-1, stock 736.2g, assay 98.8%, MWt 608.60, Formula C29H32N6O9, Purity >98%, SMILES O=C1N(C2=CC=C(N3C[C@@H](OC3=O)CNC(NC[C@H]4CN(C5=CC=C(N6CCOCC6=O)C=C5)C(O4)=O)=O)C=C2)CCOC1, MDL NA |
| Drug_Names: (S)-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)acetamide, CAS: 1429334-00-8, stock 20.5g, assay 98.6%, MWt 333.34, Formula C16H19N3O5, Purity >98%, SMILES O=C1N(C2=CC=C(N3C[C@@H](OC3=O)CNC(C)=O)C=C2)CCOC1, MDL NA |
| Drug_Names: Fesoterodine, CAS: 286930-02-7, stock 161.1g, assay 98.2%, MWt 411.58, Formula C26H37NO3, Purity >98%, SMILES O=C(C(C)C)OC1=CC=C(CO)C=C1[C@@H](C2=CC=CC=C2)CCN(C(C)C)C(C)C, MDL NA |
| Drug_Names: 1-(5-Bromo-4-chloro-3-hydroxy-1H-indol-1-yl)ethanone, CAS: 125328-76-9, stock 889.1g, assay 98.4%, MWt 288.53, Formula C10H7BrClNO2, Purity >98%, SMILES O=C(C)N1C2=CC=C(Br)C(Cl)=C2C(O)=C1, MDL MFCD04972041 |
| Drug_Names: 4-Amino-3-fluorophenol hydrochloride, CAS: 18266-53-0, stock 683g, assay 98.1%, MWt 163.58, Formula C6H7ClFNO, Purity >98%, SMILES OC1=CC=C(N)C(F)=C1.Cl, MDL MFCD01632189 |
| Drug_Names: Ethyl 3-((S)-1-((1S,3aS,7aS,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)ethoxy)propanoate, CAS: 413571-27-4, stock 469.4g, assay 98.5%, MWt 661.11, Formula C38H68O5Si2, Purity >98%, SMILES C[C@H](OCCC(OCC)=O)[C@H]1CC[C@@]2([H])/C(CCC[C@@]21C)=C/C=C3C[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C/3=C, MDL NA |
| Drug_Names: 5-Bromo-2-methyl-3-nitrobenzoic acid, CAS: 107650-20-4, stock 885.5g, assay 98.6%, MWt 260.04, Formula C8H6BrNO4, Purity >98%, SMILES OC(C1=CC(Br)=CC([N+]([O-])=O)=C1C)=O, MDL MFCD07357316 |
| Drug_Names: Methyl 6-bromo-1-(sec-butyl)-1H-indole-4-carboxylate, CAS: 1346576-37-1, stock 176.2g, assay 98.1%, MWt 310.19, Formula C14H16BrNO2, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=C1C=CN2C(C)CC)OC, MDL NA |
| Drug_Names: Methyl 6-bromo-1-(sec-butyl)-3-formyl-1H-indole-4-carboxylate, CAS: 1346576-38-2, stock 421g, assay 98.6%, MWt 338.20, Formula C15H16BrNO3, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=C1C(C=O)=CN2C(C)CC)OC, MDL NA |
| Drug_Names: Methyl 6-bromo-1-(sec-butyl)-3-methyl-1H-indole-4-carboxylate, CAS: 1346576-39-3, stock 777g, assay 98.5%, MWt 324.21, Formula C15H18BrNO2, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=C1C(C)=CN2C(C)CC)OC, MDL NA |
| Drug_Names: 6-Bromo-1-(sec-butyl)-3-methyl-1H-indole-4-carboxylic acid, CAS: 1346575-54-9, stock 776.6g, assay 98.9%, MWt 310.19, Formula C14H16BrNO2, Purity >98%, SMILES OC(C1=CC(Br)=CC2=C1C(C)=CN2C(C)CC)=O, MDL NA |
| Drug_Names: 6-Bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, CAS: 1346574-53-5, stock 84.2g, assay 98.6%, MWt 444.36, Formula C22H26BrN3O2, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=C1C(C)=CN2C(C)CC)NCC3=C(C)C=C(C)NC3=O, MDL NA |
| Drug_Names: (S)-6-Bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, CAS: 1346574-54-6, stock 242.3g, assay 98.1%, MWt 444.36, Formula C22H26BrN3O2, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=C1C(C)=CN2[C@@H](C)CC)NCC3=C(C)C=C(C)NC3=O, MDL NA |
| Drug_Names: (R)-6-bromo-1-(sec-butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-1H-indole-4-carboxamide, CAS: 1346574-55-7, stock 178.2g, assay 98.7%, MWt 444.36, Formula C22H26BrN3O2, Purity >98%, SMILES O=C(C1=CC(Br)=CC2=C1C(C)=CN2[C@H](C)CC)NCC3=C(C)C=C(C)NC3=O, MDL NA |
| Drug_Names: tert-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine-1-carboxylate, CAS: 496786-98-2, stock 745g, assay 98.5%, MWt 389.30, Formula C20H32BN3O4, Purity >98%, SMILES CC1(C)C(C)(C)OB(C2=CN=C(N3CCN(C(OC(C)(C)C)=O)CC3)C=C2)O1, MDL MFCD04039875 |
| Drug_Names: 4-Boc-1-(5-bromo-2-pyridyl)piperazine, CAS: 153747-97-8, stock 645.5g, assay 98.7%, MWt 342.23, Formula C14H20BrN3O2, Purity >98%, SMILES BrC1=CN=C(N2CCN(C(OC(C)(C)C)=O)CC2)C=C1, MDL MFCD07369772 |
| Drug_Names: 2-Methoxy-5-(trifluoromethyl)aniline hydrochloride, CAS: 254435-23-9, stock 76.7g, assay 98.6%, MWt 227.61, Formula C8H9ClF3NO, Purity >98%, SMILES COC1=CC=C(C(F)(F)F)C=C1N.Cl, MDL NA |
| Drug_Names: 2-Isocyanato-1-methoxy-4-(trifluoromethyl)benzene, CAS: 16588-75-3, stock 674.7g, assay 98.4%, MWt 217.14, Formula C9H6F3NO2, Purity >98%, SMILES COC1=CC=C(C(F)(F)F)C=C1N=C=O, MDL NA |
| Drug_Names: 1-(2-Bromo-6-fluorophenyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)urea, CAS: 917389-23-2, stock 82.8g, assay 98.8%, MWt 407.16, Formula C15H11BrF4N2O2, Purity >98%, SMILES O=C(NC1=C(OC)C=CC(C(F)(F)F)=C1)NC2=C(F)C=CC=C2Br, MDL NA |
| Drug_Names: Methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-oxo-1,2,3,4-tetrahydroquinazolin-4-yl)acetate, CAS: 917389-21-0, stock 784.7g, assay 98.5%, MWt 412.34, Formula C19H16F4N2O4, Purity >98%, SMILES O=C(OC)CC1N(C2=CC(C(F)(F)F)=CC=C2OC)C(NC3=C1C=CC=C3F)=O, MDL NA |
| Drug_Names: Methyl 2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate, CAS: 791117-40-3, stock 524.9g, assay 99%, MWt 586.58, Formula C30H30F4N4O4, Purity >98%, SMILES O=C(OC)CC1N(C2=CC(C(F)(F)F)=CC=C2OC)C(N3CCN(C4=CC=CC(OC)=C4)CC3)=NC5=C1C=CC=C5F, MDL NA |
| Drug_Names: Methyl 5-bromo-2-methyl-3-((tetrahydro-2H-pyran-4-yl)amino)benzoate, CAS: 1403257-49-7, stock 881.7g, assay 98.8%, MWt 328.20, Formula C14H18BrNO3, Purity >98%, SMILES O=C(OC)C1=CC(Br)=CC(NC2CCOCC2)=C1C, MDL NA |
| Drug_Names: Methyl 5-bromo-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzoate, CAS: 1403257-79-3, stock 869.4g, assay 98.8%, MWt 356.25, Formula C16H22BrNO3, Purity >98%, SMILES O=C(OC)C1=CC(Br)=CC(N(CC)C2CCOCC2)=C1C, MDL NA |
| Drug_Names: 5-Bromo-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzoic acid, CAS: 1403257-81-7, stock 257.5g, assay 98.1%, MWt 342.23, Formula C15H20BrNO3, Purity >98%, SMILES OC(C1=CC(Br)=CC(N(CC)C2CCOCC2)=C1C)=O, MDL NA |
| Drug_Names: 5-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-2-methylbenzamide, CAS: 1403257-80-6, stock 182.3g, assay 98.7%, MWt 476.41, Formula C23H30BrN3O3, Purity >98%, SMILES O=C(C1=CC(Br)=CC(N(CC)C2CCOCC2)=C1C)NCC3=C(C)C=C(C)NC3=O, MDL NA |
| Drug_Names: (R)-JQ-1 (carboxylic acid), CAS: 202592-24-3, stock 261.2g, assay 98%, MWt 400.88, Formula C19H17ClN4O2S, Purity >98%, SMILES ClC1=CC=C(C(C2=C(N3C4=NN=C3C)SC(C)=C2C)=N[C@@H]4CC(O)=O)C=C1, MDL NA |
| Drug_Names: 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, CAS: 330786-24-8, stock 813g, assay 98.3%, MWt 303.32, Formula C17H13N5O, Purity >98%, SMILES NC1=C2C(NN=C2C3=CC=C(OC4=CC=CC=C4)C=C3)=NC=N1, MDL NA |
| Drug_Names: (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, CAS: 866607-35-4, stock 645.1g, assay 98.4%, MWt 612.66, Formula C32H33FO9S, Purity >98%, SMILES CC1=CC=C([C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O2)C=C1CC3=CC=C(C4=CC=C(F)C=C4)S3, MDL NA |
| Drug_Names: 5-Chloro-N-(4-(3-morpholino-2-oxo-5,6-dihydropyridin-1(2H)-yl)phenyl)pentanamide, CAS: 1643330-62-4, stock 575.7g, assay 98.8%, MWt 391.89, Formula C20H26ClN3O3, Purity >98%, SMILES O=C1C(N2CCOCC2)=CCCN1C3=CC=C(NC(CCCCCl)=O)C=C3, MDL NA |
| Drug_Names: tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate, CAS: 247068-82-2, stock 674.2g, assay 98.6%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H](C([C@]1(C)OC1)=O)CC(C)C, MDL NA |
| Drug_Names: (1S,2S,5R)-methyl 3-((S)-2-amino-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate (hydrochloride), CAS: 847644-96-6, stock 443.9g, assay 98.2%, MWt 318.84, Formula C15H27ClN2O3, Purity >98%, SMILES CC1(C)[C@H]2[C@@H]1CN(C([C@@H](N)C(C)(C)C)=O)[C@@H]2C(OC)=O.Cl, MDL NA |
| Drug_Names: (1R,2S,5S)-methyl 3-((R)-2-(3-(tert-butyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate, CAS: 2170811-36-4, stock 561.8g, assay 98.1%, MWt 381.51, Formula C20H35N3O4, Purity >98%, SMILES CC1(C)[C@H]2[C@@H]1CN(C([C@H](NC(NC(C)(C)C)=O)C(C)(C)C)=O)[C@@H]2C(OC)=O, MDL NA |
| Drug_Names: 2-(4-Fluorophenyl)-5-(2-methylbenzyl)thiophene, CAS: 2005454-69-1, stock 614.5g, assay 98.4%, MWt 282.38, Formula C18H15FS, Purity >98%, SMILES CC1=C(CC2=CC=C(C3=CC=C(F)C=C3)S2)C=CC=C1, MDL NA |
| Drug_Names: (1R,2R)-Cyclohexane-1,2-diamine, CAS: 20439-47-8, stock 797.5g, assay 98.5%, MWt 114.19, Formula C6H14N2, Purity >98%, SMILES N[C@H]1[C@H](N)CCCC1, MDL MFCD00062985 |
| Drug_Names: Ethyl 2-(((3aR,4S,6R,6aS)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)acetate, CAS: 866551-95-3, stock 342.2g, assay 98.8%, MWt 393.43, Formula C20H27NO7, Purity >98%, SMILES CC(O1)(C)O[C@H]2[C@@H]1[C@H](NC(OCC3=CC=CC=C3)=O)C[C@@H]2OCC(OCC)=O, MDL NA |
| Drug_Names: Benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate, CAS: 274693-54-8, stock 827.3g, assay 98.3%, MWt 351.39, Formula C18H25NO6, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)N[C@@H]2C[C@H](OCCO)[C@]3([H])[C@@]2([H])OC(C)(C)O3, MDL NA |
| Drug_Names: (S)-2-Amino-4-methyl-1-((R)-2-methyloxiran-2-yl)pentan-1-one 2,2,2-trifluoroacetate, CAS: 247068-85-5, stock 589.6g, assay 98.6%, MWt 285.26, Formula C11H18F3NO4, Purity >98%, SMILES FC(F)(C(O)=O)F.CC(C)C[C@H](N)C([C@]1(C)OC1)=O, MDL NA |
| Drug_Names: 1-(2-Nitrophenyl)piperidin-2-one, CAS: 203509-92-6, stock 729.8g, assay 98.6%, MWt 220.22, Formula C11H12N2O3, Purity >98%, SMILES O=C1CCCCN1C2=CC=CC=C2[N+]([O-])=O, MDL NA |
| Drug_Names: N-[(1S)-1-(1-Naphthalenyl)ethyl]-3-(trifluoromethyl)benzenepropanamide, CAS: 955371-05-8, stock 125g, assay 98.8%, MWt 371.40, Formula C22H20F3NO, Purity >98%, SMILES [H][C@@](C)(NC(CCC1=CC=CC(C(F)(F)F)=C1)=O)C2=CC=CC3=C2C=CC=C3, MDL NA |
| Drug_Names: N-Acetylneuraminic acid methyl ester, CAS: 32766-94-2, stock 785.3g, assay 98.5%, MWt 323.30, Formula C12H21NO9, Purity >98%, SMILES O=C(C1(O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1)OC, MDL NA |
| Drug_Names: (1S,2R)-1-((2R,3R,4S)-3-acetamido-4,6-diacetoxy-6-(methoxycarbonyl)tetrahydro-2H-pyran-2-yl)propane-1,2,3-triyl triacetate, CAS: 73208-82-9, stock 270.5g, assay 98.9%, MWt 533.48, Formula C22H31NO14, Purity >98%, SMILES O=C(C(O[C@@]1([H])[C@H](OC(C)=O)[C@H](OC(C)=O)COC(C)=O)(C[C@H](OC(C)=O)[C@H]1NC(C)=O)OC(C)=O)OC, MDL NA |
| Drug_Names: (1S,2R)-1-((2R,3R,4S)-3-acetamido-4-acetoxy-6-chloro-6-(methoxycarbonyl)tetrahydro-2H-pyran-2-yl)propane-1,2,3-triyl triacetate, CAS: 132883-18-2, stock 858.2g, assay 98.4%, MWt 509.89, Formula C20H28ClNO12, Purity >98%, SMILES O=C(C1(Cl)C[C@H](OC(C)=O)[C@@H](NC(C)=O)[C@H]([C@H](OC(C)=O)[C@H](OC(C)=O)COC(C)=O)O1)OC, MDL NA |
| Drug_Names: 4-Amino-2,6-dihydroxypyrimidine, CAS: 873-83-6, stock 115.7g, assay 98.8%, MWt 127.10, Formula C4H5N3O2, Purity >98%, SMILES OC1=CC(N)=NC(O)=N1, MDL MFCD00006071 |
| Drug_Names: ethyl (S)-Piperidine-3-carboxylate (2R,3R)-2,3-dihydroxysuccinate, CAS: 83602-38-4, stock 791.2g, assay 98.4%, MWt 307.30, Formula C12H21NO8, Purity >98%, SMILES O=C(OCC)[C@@H]1CNCCC1.O[C@H]([C@@H](O)C(O)=O)C(O)=O, MDL NA |
| Drug_Names: 2-(1-(Ethylsulfonyl)azetidin-3-ylidene)acetonitrile, CAS: 1187595-85-2, stock 250.7g, assay 98.6%, MWt 186.23, Formula C7H10N2O2S, Purity >98%, SMILES O=S(N1C/C(C1)=C\C#N)(CC)=O, MDL NA |
| Drug_Names: tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate, CAS: 129888-60-4, stock 28.3g, assay 98.1%, MWt 279.35, Formula C11H21NO5S, Purity >98%, SMILES O=C(N1CC(OS(=O)(C)=O)CCC1)OC(C)(C)C, MDL MFCD07787193 |
| Drug_Names: (S)-tert-Butyl 3-(methylsulfonyloxy)piperidine-1-carboxylate, CAS: 940890-90-4, stock 305.5g, assay 98.2%, MWt 279.35, Formula C11H21NO5S, Purity >98%, SMILES O=C(N1C[C@@H](OS(=O)(C)=O)CCC1)OC(C)(C)C, MDL MFCD09953027 |
| Drug_Names: Ethyl 6-(4-aminophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate, CAS: 503615-07-4, stock 21.4g, assay 98.7%, MWt 406.43, Formula C22H22N4O4, Purity >98%, SMILES O=C(N(C(C=C1)=CC=C1N)CC2)C3=C2C(C(OCC)=O)=NN3C4=CC=C(OC)C=C4, MDL MFCD18251628 |
| Drug_Names: Ethyl 5-aminobenzofuran-2-carboxylate hydrochloride, CAS: 183288-42-8, stock 484.9g, assay 98.2%, MWt 241.67, Formula C11H12ClNO3, Purity >98%, SMILES O=C(C1=CC2=CC(N)=CC=C2O1)OCC.Cl, MDL MFCD22574189 |
| Drug_Names: (R)-tert-butyl 3-(7-(2-(cyclopropylmethoxy)-6-((4-methoxybenzyl)oxy)phenyl)-2-oxo-2,4-dihydro-1H-pyrido[2,3-d][1,3]oxazin-5-yl)piperidine-1-carboxylate, CAS: 600734-05-2, stock 670.8g, assay 98.5%, MWt 615.72, Formula C35H41N3O7, Purity >98%, SMILES O=C(N1C[C@@H](C2=C3C(NC(OC3)=O)=NC(C4=C(OCC5=CC=C(OC)C=C5)C=CC=C4OCC6CC6)=C2)CCC1)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl 3-(tosyloxy)piperidine-1-carboxylate, CAS: 85275-46-3, stock 188.9g, assay 99%, MWt 355.45, Formula C17H25NO5S, Purity >98%, SMILES O=C(N1CC(OS(=O)(C2=CC=C(C)C=C2)=O)CCC1)OC(C)(C)C, MDL MFCD07787194 |
| Drug_Names: N-2-Pyridinyl-beta-alanine ethyl ester, CAS: 103041-38-9, stock 479.4g, assay 98.7%, MWt 194.23, Formula C10H14N2O2, Purity >98%, SMILES CCOC(CCNC1=NC=CC=C1)=O, MDL MFCD09833621 |
| Drug_Names: Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate, CAS: 429659-01-8, stock 742.1g, assay 98.4%, MWt 372.38, Formula C18H20N4O5, Purity >98%, SMILES O=C(OCC)CCN(C(C1=CC=C(NC)C([N+]([O-])=O)=C1)=O)C2=NC=CC=C2, MDL MFCD09833623 |
| Drug_Names: Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate, CAS: 211915-84-3, stock 834.8g, assay 98.7%, MWt 482.53, Formula C27H26N6O3, Purity >98%, SMILES O=C(OCC)CCN(C(C1=CC=C2C(N=C(CNC3=CC=C(C#N)C=C3)N2C)=C1)=O)C4=NC=CC=C4, MDL NA |
| Drug_Names: 2-(4-Methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetic acid, CAS: 676491-47-7, stock 265.5g, assay 98.6%, MWt 301.26, Formula C13H11N5O4, Purity >98%, SMILES COC1=C2C(C(C(O)=O)=O)=CNC2=C(N3C=NC(C)=N3)N=C1, MDL NA |
| Drug_Names: (R)-1-[5-Amino-2-(2-benzyloxy-1,1-dimethyl-ethyl)-6-fluoro-indol-1-yl]-3-benzyloxy-propan-2-ol, CAS: 1294504-67-8, stock 677.2g, assay 98.5%, MWt 476.58, Formula C29H33FN2O3, Purity >98%, SMILES FC1=C(N)C=C(C=C2C(C)(C)COCC3=CC=CC=C3)C(N2C[C@@H](O)COCC4=CC=CC=C4)=C1, MDL NA |
| Drug_Names: (R)-N-(1-(3-(benzyloxy)-2-hydroxypropyl)-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-5-yl)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamide, CAS: 1294504-68-9, stock 170.8g, assay 98.9%, MWt 700.74, Formula C40H39F3N2O6, Purity >98%, SMILES FC1=C(NC(C2(CC2)C3=CC4=C(OC(F)(F)O4)C=C3)=O)C=C(C=C5C(C)(C)COCC6=CC=CC=C6)C(N5C[C@@H](O)COCC7=CC=CC=C7)=C1, MDL NA |
| Drug_Names: 2-(2-fluorophenyl)thiophene, CAS: 209592-45-0, stock 670.5g, assay 98.8%, MWt 178.23, Formula C10H7FS, Purity >98%, SMILES FC(C=CC=C1)=C1C2=CC=CS2, MDL NA |
| Drug_Names: 2-(3-Fluorophenyl)thiophene, CAS: 58861-49-7, stock 833.7g, assay 98.4%, MWt 178.23, Formula C10H7FS, Purity >98%, SMILES FC1=CC=CC(C2=CC=CS2)=C1, MDL NA |
| Drug_Names: Phenyl (4-methylthiazol-2-yl)carbamate, CAS: 813445-31-7, stock 894.3g, assay 98.7%, MWt 234.27, Formula C11H10N2O2S, Purity >98%, SMILES O=C(OC1=CC=CC=C1)NC2=NC(C)=CS2, MDL NA |
| Drug_Names: (S)-N1-(4-Methylthiazol-2-yl)pyrrolidine-1,2-dicarboxamide, CAS: 1217486-98-0, stock 644.5g, assay 98.9%, MWt 254.31, Formula C10H14N4O2S, Purity >98%, SMILES O=C(NC1=NC(C)=CS1)N(CCC2)[C@@H]2C(N)=O, MDL NA |
| Drug_Names: 1-(N-Pivaloyl)-4-(4-Bromophenyl)piperazine, CAS: 352437-09-3, stock 491.2g, assay 98.2%, MWt 341.24, Formula C15H21BrN2O2, Purity >98%, SMILES O=C(OC(C)(C)C)N1CCN(C2=CC=C(Br)C=C2)CC1, MDL MFCD07371649 |
| Drug_Names: tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate, CAS: 470478-90-1, stock 289.5g, assay 98.2%, MWt 388.31, Formula C21H33BN2O4, Purity >98%, SMILES O=C(OC(C)(C)C)N(CC1)CCN1C2=CC=C(C=C2)B(OC(C)3C)OC3(C)C, MDL MFCD06411544 |
| Drug_Names: 6-Bromopyrazolo[1,5-a]pyrimidine, CAS: 705263-10-1, stock 181.4g, assay 98.1%, MWt 198.02, Formula C6H4BrN3, Purity >98%, SMILES BrC1=CN2C(N=C1)=CC=N2, MDL MFCD09832894 |
| Drug_Names: ethyl (2S,3R)-3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate, CAS: 93635-76-8, stock 182.4g, assay 98.1%, MWt 248.27, Formula C11H20O6, Purity >98%, SMILES O=C(OCC)[C@](O)(C)[C@H](O)[C@@H]1OC(OC1)(C)C, MDL MFCD11112138 |
| Drug_Names: ((2R,3R,4R)-3-(Benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate, CAS: 874638-80-9, stock 654.6g, assay 98.8%, MWt 372.34, Formula C20H17FO6, Purity >98%, SMILES O=C(O1)[C@@](F)(C)[C@H](OC(C2=CC=CC=C2)=O)[C@H]1COC(C3=CC=CC=C3)=O, MDL NA |
| Drug_Names: 2-Amino-4,5-diphenylfuran-3-carbonitrile, CAS: 5503-73-1, stock 722.9g, assay 98.6%, MWt 260.29, Formula C17H12N2O, Purity >98%, SMILES N#CC1=C(N)OC(C2=CC=CC=C2)=C1C3=CC=CC=C3, MDL MFCD00274265 |
| Drug_Names: 5,6-Diphenylfuro[2,3-d]pyrimidin-4-ol, CAS: 106561-29-9, stock 42.8g, assay 98.2%, MWt 288.30, Formula C18H12N2O2, Purity >98%, SMILES OC1=C2C(C3=CC=CC=C3)=C(C4=CC=CC=C4)OC2=NC=N1, MDL NA |
| Drug_Names: 4-Chloro-5,6-diphenylfuro[2,3-d]pyrimidine, CAS: 65148-07-4, stock 604.2g, assay 98%, MWt 306.75, Formula C18H11ClN2O, Purity >98%, SMILES ClC1=C2C(C3=CC=CC=C3)=C(C4=CC=CC=C4)OC2=NC=N1, MDL NA |
| Drug_Names: (1S,4R)-methyl 4-(tritylamino)cyclopent-2-enecarboxylate, CAS: 1113025-16-3, stock 290.5g, assay 98.6%, MWt 383.48, Formula C26H25NO2, Purity >98%, SMILES O=C(OC)[C@H]1C[C@@H](NC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=C1, MDL NA |
| Drug_Names: 2-(4,6-Dichloropyrimidin-5-yl)acetaldehyde, CAS: 16019-33-3, stock 699.2g, assay 98.4%, MWt 191.01, Formula C6H4Cl2N2O, Purity >98%, SMILES O=CCC1=C(Cl)N=CN=C1Cl, MDL MFCD09991563 |
| Drug_Names: tert-Butyl 3-oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate, CAS: 162427-15-8, stock 377.9g, assay 98.9%, MWt 209.24, Formula C11H15NO3, Purity >98%, SMILES O=C(N(C1=O)C2C=CC1C2)OC(C)(C)C, MDL NA |
| Drug_Names: (1R,4S)-tert-Butyl 3-oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate, CAS: 151792-53-9, stock 214.2g, assay 98.2%, MWt 209.24, Formula C11H15NO3, Purity >98%, SMILES O=C(N(C1=O)[C@H]2C=C[C@@H]1C2)OC(C)(C)C, MDL NA |
| Drug_Names: methyl (1S,4R)-4-aminocyclopent-2-ene-1-carboxylate hydrochloride, CAS: 229613-83-6, stock 274.2g, assay 98.8%, MWt 177.63, Formula C7H12ClNO2, Purity >98%, SMILES O=C(OC)[C@@H]1C=C[C@H](N)C1.Cl, MDL NA |
| Drug_Names: 2-((1S,4S)-4-phenylcyclohexyl)acetic acid, CAS: 148962-93-0, stock 381.1g, assay 98.4%, MWt 218.29, Formula C14H18O2, Purity >98%, SMILES O=C(O)C[C@H]1CC[C@@H](C2=CC=CC=C2)CC1, MDL NA |
| Drug_Names: tert-Butyl 3-amino-6,6-dimethyl-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate, CAS: 718632-44-1, stock 819.5g, assay 98.4%, MWt 252.31, Formula C12H20N4O2, Purity >98%, SMILES CC(C)(C)OC(N1C(C)(C)C2=NNC(N)=C2C1)=O, MDL MFCD12031273 |
| Drug_Names: 5-tert-Butyl 1-ethyl 3-amino-6,6-dimethylpyrrolo[3,4-c]pyrazole-1,5(4H,6H)-dicarboxylate, CAS: 718632-47-4, stock 738.8g, assay 98.1%, MWt 324.38, Formula C15H24N4O4, Purity >98%, SMILES O=C(OC(C)(C)C)N1C(C)(C)C2=C(C1)C(N)=NN2C(OCC)=O, MDL NA |
| Drug_Names: N-Methyl-2-nitrobenzenesulfonamide, CAS: 23530-40-7, stock 778.6g, assay 98.9%, MWt 216.21, Formula C7H8N2O4S, Purity >98%, SMILES O=S(C1=C([N+]([O-])=O)C=CC=C1)(NC)=O, MDL MFCD01115621 |
| Drug_Names: 2-Amino-N-methylbenzenesulfonamide, CAS: 16288-77-0, stock 502.4g, assay 98.5%, MWt 186.23, Formula C7H10N2O2S, Purity >98%, SMILES O=S(C(C=CC=C1)=C1N)(NC)=O, MDL MFCD04035388 |
| Drug_Names: 2-Methoxy-4-(4-methylpiperazin-1-yl)aniline, CAS: 122833-04-9, stock 282.5g, assay 98.1%, MWt 221.30, Formula C12H19N3O, Purity >98%, SMILES NC1=C(OC)C=C(C=C1)N2CCN(C)CC2, MDL MFCD11848954 |
| Drug_Names: 2-(5-Bromo-2-chloro-pyrimidin-4-ylamino)-N-methyl-benzenesulfonamide, CAS: 761440-01-1, stock 863.2g, assay 98.2%, MWt 377.64, Formula C11H10BrClN4O2S, Purity >98%, SMILES O=S(C(C=CC=C1)=C1NC2=C(Br)C=NC(Cl)=N2)(NC)=O, MDL NA |
| Drug_Names: 2-((2,5-Dichloropyrimidin-4-yl)amino)-N-methylbenzenesulfonamide, CAS: 761440-11-3, stock 0.1g, assay 98.2%, MWt 333.19, Formula C11H10Cl2N4O2S, Purity >98%, SMILES O=S(C(C=CC=C1)=C1NC2=C(Cl)C=NC(Cl)=N2)(NC)=O, MDL NA |
| Drug_Names: 2-(3-Methoxyphenyl)quinazolin-4(3H)-one, CAS: 56071-04-6, stock 57g, assay 98.6%, MWt 252.27, Formula C15H12N2O2, Purity >98%, SMILES O=C1NC(C2=CC=CC(OC)=C2)=NC3=C1C=CC=C3, MDL NA |
| Drug_Names: 2-(3-Hydroxyphenyl)quinazolin-4(3H)-one, CAS: 911417-23-7, stock 718.3g, assay 98.2%, MWt 238.24, Formula C14H10N2O2, Purity >98%, SMILES O=C1NC(C2=CC=CC(O)=C2)=NC3=C1C=CC=C3, MDL NA |
| Drug_Names: 2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetic acid, CAS: 911417-62-4, stock 105.9g, assay 98.1%, MWt 411.41, Formula C23H17N5O3, Purity >98%, SMILES O=C(O)COC1=CC(C2=NC3=CC=CC=C3C(NC4=CC5=C(C=C4)NN=C5)=N2)=CC=C1, MDL NA |
| Drug_Names: 3-(4-Chloroquinazolin-2-yl)phenyl acetate, CAS: 911417-24-8, stock 117.1g, assay 98.3%, MWt 298.72, Formula C16H11ClN2O2, Purity >98%, SMILES O=C(C)OC1=CC(C2=NC3=C(C=CC=C3)C(Cl)=N2)=CC=C1, MDL NA |
| Drug_Names: tert-Butyl 5-((2-(3-hydroxyphenyl)quinazolin-4-yl)amino)-1H-indazole-1-carboxylate, CAS: 911417-26-0, stock 230.8g, assay 99%, MWt 453.49, Formula C26H23N5O3, Purity >98%, SMILES O=C(OC(C)(C)C)N1N=CC2=C1C=CC(NC3=NC(C4=CC=CC(O)=C4)=NC5=CC=CC=C35)=C2, MDL NA |
| Drug_Names: (S)-3-amino-N-(2-(dimethylamino)-1-phenylethyl)-6,6-dimethyl-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxamide, CAS: 898044-54-7, stock 660.5g, assay 98.1%, MWt 342.44, Formula C18H26N6O, Purity >98%, SMILES O=C(N[C@@H](C1=CC=CC=C1)CN(C)C)N2CC3=C(N)NN=C3C(C)2C, MDL NA |
| Drug_Names: 1-Piperidinepropanol, CAS: 104-58-5, stock 96.1g, assay 98.6%, MWt 143.23, Formula C8H17NO, Purity >98%, SMILES OCCCN1CCCCC1, MDL MFCD00023781 |
| Drug_Names: Ethyl 3-(4-chlorophenyl)propanoate, CAS: 7116-36-1, stock 159.2g, assay 98.9%, MWt 212.67, Formula C11H13ClO2, Purity >98%, SMILES O=C(OCC)CCC1=CC=C(C=C1)Cl, MDL MFCD07772956 |
| Drug_Names: tert-Butyl 4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazine-1-carboxylate, CAS: 1032756-20-9, stock 136.2g, assay 98.3%, MWt 526.65, Formula C25H34N8O3S, Purity >98%, SMILES O=C(OC(C)(C)C)N(CC1)CCN1CC2=C(C)C3=C(S2)C(N4CCOCC4)=NC(C5=CN=C(N)N=C5)=N3, MDL NA |
| Drug_Names: 2-Chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde, CAS: 955979-02-9, stock 142.6g, assay 98.6%, MWt 297.76, Formula C12H12ClN3O2S, Purity >98%, SMILES ClC1=NC2=C(SC(C=O)=C2C)C(N3CCOCC3)=N1, MDL NA |
| Drug_Names: (2-Chloro-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methanol, CAS: 1032758-44-3, stock 376.7g, assay 98.3%, MWt 299.78, Formula C12H14ClN3O2S, Purity >98%, SMILES ClC1=NC2=C(SC(CO)=C2C)C(N3CCOCC3)=N1, MDL NA |
| Drug_Names: 4-(6-(Bromomethyl)-2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)morpholine, CAS: 1032758-45-4, stock 779.1g, assay 98.5%, MWt 362.67, Formula C12H13BrClN3OS, Purity >98%, SMILES ClC1=NC2=C(SC(CBr)=C2C)C(N3CCOCC3)=N1, MDL NA |
| Drug_Names: N-(5-Bromopyrimidin-2-yl)acetamide, CAS: 180530-15-8, stock 487.4g, assay 98.6%, MWt 216.04, Formula C6H6BrN3O, Purity >98%, SMILES O=C(C)NC(N=C1)=NC=C1Br, MDL NA |
| Drug_Names: N-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)acetamide, CAS: 1218791-37-7, stock 188.5g, assay 98.9%, MWt 263.10, Formula C12H18BN3O3, Purity >98%, SMILES O=C(C)NC(N=C1)=NC=C1B(OC(C)2C)OC2(C)C, MDL MFCD12546523 |
| Drug_Names: 7-Methylthieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, CAS: 35265-81-7, stock 582.9g, assay 98.8%, MWt 182.20, Formula C7H6N2O2S, Purity >98%, SMILES O=C(C(SC=C1C)=C1N2)NC2=O, MDL MFCD20617523 |
| Drug_Names: 2,4-dichloro-7-methylthieno[3,2-d]pyrimidine, CAS: 35265-83-9, stock 216.8g, assay 98.1%, MWt 219.09, Formula C7H4Cl2N2S, Purity >98%, SMILES ClC1=NC(Cl)=NC2=C1SC=C2C, MDL MFCD08061253 |
| Drug_Names: 4-(2-Chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)morpholine, CAS: 35265-88-4, stock 207.6g, assay 98.6%, MWt 269.75, Formula C11H12ClN3OS, Purity >98%, SMILES ClC1=NC2=C(SC=C2C)C(N3CCOCC3)=N1, MDL MFCD21648615 |
| Drug_Names: (S)-2-(1-(3-ethyl-7-((pyridin-3-ylmethyl)amino)pyrazolo[1,5-a]pyrimidin-5-yl)piperidin-2-yl)ethanol, CAS: 779353-02-5, stock 283.3g, assay 98.3%, MWt 380.49, Formula C21H28N6O, Purity >98%, SMILES CCC1=C2N(N=C1)C(NCC3=CN=CC=C3)=CC(N(CCCC4)[C@@H]4CCO)=N2, MDL NA |
| Drug_Names: (R)-methyl 2-(3,5-difluorophenyl)-2-hydroxyacetate, CAS: 1584127-72-9, stock 837.5g, assay 98.1%, MWt 202.15, Formula C9H8F2O3, Purity >98%, SMILES O=C(OC)[C@H](O)C1=CC(F)=CC(F)=C1, MDL NA |
| Drug_Names: 2-(2-Formylphenyl)acetic acid, CAS: 1723-55-3, stock 189.5g, assay 98.9%, MWt 164.16, Formula C9H8O3, Purity >98%, SMILES O=C(O)CC1=CC=CC=C1C=O, MDL NA |
| Drug_Names: 3-methyl-3H-benzo[d][1,2]diazepin-4(5H)-one, CAS: 400819-99-0, stock 58.8g, assay 98.8%, MWt 174.20, Formula C10H10N2O, Purity >98%, SMILES O=C1N(C)N=CC2=CC=CC=C2C1, MDL NA |
| Drug_Names: 4-Methoxy-2,3-dimethylbenzoic acid, CAS: 5628-61-5, stock 78.2g, assay 98.8%, MWt 180.20, Formula C10H12O3, Purity >98%, SMILES O=C(O)C1=CC=C(OC)C(C)=C1C, MDL MFCD06203271 |
| Drug_Names: 2-Ethyl-4-methoxy-3-methylbenzoic acid, CAS: 1181770-76-2, stock 675.6g, assay 98.8%, MWt 194.23, Formula C11H14O3, Purity >98%, SMILES O=C(O)C1=CC=C(OC)C(C)=C1CC, MDL NA |
| Drug_Names: 2-Chloro-N-(4-methoxybenzyl)-9H-purin-6-amine, CAS: 203436-09-3, stock 456.3g, assay 98.1%, MWt 289.72, Formula C13H12ClN5O, Purity >98%, SMILES ClC1=NC(NCC(C=C2)=CC=C2OC)=C(N=CN3)C3=N1, MDL NA |
| Drug_Names: 2-Chloro-9-isopropyl-N-(4-methoxybenzyl)-9H-purin-6-amine, CAS: 203436-13-9, stock 210.1g, assay 98.9%, MWt 331.80, Formula C16H18ClN5O, Purity >98%, SMILES ClC1=NC(NCC2=CC=C(OC)C=C2)=C3C(N(C(C)C)C=N3)=N1, MDL NA |
| Drug_Names: 2-(3-(Piperidin-4-ylidenemethyl)phenoxy)-5-(trifluoromethyl)pyridine, CAS: 1020336-04-2, stock 392g, assay 98.8%, MWt 334.34, Formula C18H17F3N2O, Purity >98%, SMILES FC(F)(F)C(C=C1)=CN=C1OC2=CC=CC(/C=C3CCNCC/3)=C2, MDL NA |
| Drug_Names: (3-((5-(Trifluoromethyl)pyridin-2-yl)oxy)phenyl)methanol, CAS: 1020325-22-7, stock 815.1g, assay 98.3%, MWt 269.22, Formula C13H10F3NO2, Purity >98%, SMILES FC(F)(F)C1=CN=C(OC2=CC(CO)=CC=C2)C=C1, MDL NA |
| Drug_Names: 2-(3-(Chloromethyl)phenoxy)-5-(trifluoromethyl)pyridine, CAS: 1020325-30-7, stock 448.1g, assay 98.3%, MWt 287.66, Formula C13H9ClF3NO, Purity >98%, SMILES FC(F)(F)C1=CN=C(OC2=CC(CCl)=CC=C2)C=C1, MDL NA |
| Drug_Names: tert-Butyl 4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxylate, CAS: 1020325-45-4, stock 133.7g, assay 98.9%, MWt 434.45, Formula C23H25F3N2O3, Purity >98%, SMILES O=C(OC(C)(C)C)N(CC/1)CCC1=C\C2=CC=CC(OC3=NC=C(C=C3)C(F)(F)F)=C2, MDL NA |
| Drug_Names: Methyl 4-amino-1H-pyrazole-3-carboxylate, CAS: 360056-45-7, stock 163.4g, assay 98.4%, MWt 141.13, Formula C5H7N3O2, Purity >98%, SMILES O=C(OC)C1=NNC=C1N, MDL MFCD02646737 |
| Drug_Names: 4-(2,6-Dichlorobenzamido)-1H-pyrazole-3-carboxylic acid, CAS: 825619-04-3, stock 879.7g, assay 98.6%, MWt 300.10, Formula C11H7Cl2N3O3, Purity >98%, SMILES O=C(C(C(Cl)=CC=C1)=C1Cl)NC2=CNN=C2C(O)=O, MDL NA |
| Drug_Names: Monoethyl 1,1-cyclobutanedicarboxylate, CAS: 54450-84-9, stock 361.2g, assay 98.2%, MWt 172.18, Formula C8H12O4, Purity >98%, SMILES O=C(O)C1(CCC1)C(OCC)=O, MDL MFCD10699115 |
| Drug_Names: Ethyl 1-((tert-butoxycarbonyl)amino)cyclobutane-1-carboxylate, CAS: 163554-54-9, stock 252.4g, assay 98.5%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES O=C(OC(C)(C)C)NC1(CCC1)C(OCC)=O, MDL NA |
| Drug_Names: Ethyl 1-aminocyclobutanecarboxylate hydrochloride, CAS: 145143-60-8, stock 848.3g, assay 98.3%, MWt 179.64, Formula C7H14ClNO2, Purity >98%, SMILES O=C(OCC)C1(CCC1)N.Cl, MDL MFCD05664344 |
| Drug_Names: 1-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid, CAS: 120728-10-1, stock 572.3g, assay 98.2%, MWt 215.25, Formula C10H17NO4, Purity >98%, SMILES O=C(OC(C)(C)C)NC1(CCC1)C(O)=O, MDL MFCD02682623 |
| Drug_Names: 1-Methoxy-2,3-dimethylbenzene, CAS: 2944-49-2, stock 358.8g, assay 98.6%, MWt 136.19, Formula C9H12O, Purity >98%, SMILES CC1=C(C)C=CC=C1OC, MDL MFCD00008376 |
| Drug_Names: 4-((2-(4-Nitro-1H-pyrazol-3-yl)-1H-benzo[d]imidazol-5-yl)methyl)morpholine, CAS: 825619-29-2, stock 356.7g, assay 98.1%, MWt 328.33, Formula C15H16N6O3, Purity >98%, SMILES [O-][N+](C1=CNN=C1C2=NC3=CC(CN4CCOCC4)=CC=C3N2)=O, MDL NA |
| Drug_Names: (3,4-Dinitrophenyl)(morpholino)methanone, CAS: 65003-28-3, stock 513.4g, assay 98.6%, MWt 281.22, Formula C11H11N3O6, Purity >98%, SMILES [O-][N+](C1=CC(C(N2CCOCC2)=O)=CC=C1[N+]([O-])=O)=O, MDL NA |
| Drug_Names: 4-(3,4-Dinitrobenzyl)morpholine, CAS: 825619-03-2, stock 835.5g, assay 98.2%, MWt 267.24, Formula C11H13N3O5, Purity >98%, SMILES [O-][N+](C1=CC(CN2CCOCC2)=CC=C1[N+]([O-])=O)=O, MDL NA |
| Drug_Names: 4-(Morpholinomethyl)benzene-1,2-diamine, CAS: 825619-02-1, stock 14.3g, assay 98.8%, MWt 207.27, Formula C11H17N3O, Purity >98%, SMILES NC1=CC(CN2CCOCC2)=CC=C1N, MDL MFCD11046432 |
| Drug_Names: tert-Butyl 3-Bromobenzoate, CAS: 69038-74-0, stock 476.8g, assay 98.3%, MWt 257.12, Formula C11H13BrO2, Purity >98%, SMILES O=C(C1=CC(Br)=CC=C1)OC(C)(C)C, MDL MFCD06657802 |
| Drug_Names: 3-(tert-Butoxycarbonyl)benzeneboronic acid, CAS: 220210-56-0, stock 857.9g, assay 98.3%, MWt 222.05, Formula C11H15BO4, Purity >98%, SMILES O=C(OC(C)(C)C)C1=CC(B(O)O)=CC=C1, MDL MFCD01630855 |
| Drug_Names: tert-Butyl 3-(3-methylpyridin-2-yl)benzoate, CAS: 1083057-12-8, stock 7.9g, assay 98.3%, MWt 269.34, Formula C17H19NO2, Purity >98%, SMILES O=C(OC(C)(C)C)C1=CC=CC(C2=NC=CC=C2C)=C1, MDL NA |
| Drug_Names: tert-Butyl 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoate, CAS: 1160221-25-9, stock 449.8g, assay 98.3%, MWt 508.51, Formula C28H26F2N2O5, Purity >98%, SMILES O=C(NC(N=C1C2=CC(C(OC(C)(C)C)=O)=CC=C2)=CC=C1C)C3(C4=CC=C5OC(F)(F)OC5=C4)CC3, MDL NA |
| Drug_Names: tert-Butyl 3-(6-amino-3-methylpyridin-2-yl)benzoate, CAS: 1083057-14-0, stock 64.2g, assay 98.3%, MWt 284.35, Formula C17H20N2O2, Purity >98%, SMILES O=C(OC(C)(C)C)C1=CC=CC(C2=NC(N)=CC=C2C)=C1, MDL MFCD16659611 |
| Drug_Names: 1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarbonitrile, CAS: 862574-87-6, stock 39.7g, assay 98.1%, MWt 223.18, Formula C11H7F2NO2, Purity >98%, SMILES N#CC1(CC1)C2=CC=C3OC(F)(F)OC3=C2, MDL MFCD14155913 |
| Drug_Names: (2,2-Difluorobenzo[d][1,3]dioxol-5-yl)methanol, CAS: 72768-97-9, stock 646.9g, assay 98.3%, MWt 188.13, Formula C8H6F2O3, Purity >98%, SMILES FC1(F)OC2=CC(CO)=CC=C2O1, MDL MFCD06202699 |
| Drug_Names: 2,2-Difluoro-1,3-benzodioxole-5-acetonitrile, CAS: 68119-31-3, stock 616g, assay 98.9%, MWt 197.14, Formula C9H5F2NO2, Purity >98%, SMILES N#CCC1=CC=C2OC(F)(F)OC2=C1, MDL MFCD09923942 |
| Drug_Names: 3-Ethoxy-4-methoxybenzaldehyde, CAS: 1131-52-8, stock 538.6g, assay 98.1%, MWt 180.20, Formula C10H12O3, Purity >98%, SMILES O=CC1=CC=C(OC)C(OCC)=C1, MDL MFCD00010128 |
| Drug_Names: Benzyl N-[1-(hydroxymethyl)cyclopropyl]carbamate, CAS: 103500-22-7, stock 418.5g, assay 98.9%, MWt 221.25, Formula C12H15NO3, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)NC2(CO)CC2, MDL NA |
| Drug_Names: 6-Hydroxy-N-methyl-1-naphthamide, CAS: 847802-91-9, stock 537.4g, assay 98.4%, MWt 201.22, Formula C12H11NO2, Purity >98%, SMILES O=C(NC)C1=CC=CC2=C1C=CC(O)=C2, MDL MFCD19441202 |
| Drug_Names: 1-(2-Amino-4-(benzyloxy)-5-methoxyphenyl)ethanone, CAS: 75665-73-5, stock 710.5g, assay 98.3%, MWt 271.31, Formula C16H17NO3, Purity >98%, SMILES O=C(C)C1=C(N)C=C(OCC2=CC=CC=C2)C(OC)=C1, MDL MFCD21606560 |
| Drug_Names: 7-(Benzyloxy)-6-methoxyquinolin-4-ol, CAS: 849217-23-8, stock 22g, assay 98.5%, MWt 281.31, Formula C17H15NO3, Purity >98%, SMILES OC1=CC=NC2=CC(OCC3=CC=CC=C3)=C(OC)C=C21, MDL MFCD16877538 |
| Drug_Names: (3S,4S)-tert-Butyl 3-hydroxy-4-(methylamino)pyrrolidine-1-carboxylate (S)-2-hydroxysuccinate, CAS: 1233960-11-6, stock 437.3g, assay 98.1%, MWt 350.36, Formula C14H26N2O8, Purity >98%, SMILES CN[C@H]1CN(C(OC(C)(C)C)=O)C[C@@H]1O.O[C@H](C(O)=O)CC(O)=O, MDL MFCD06616818 |
| Drug_Names: (3S,4S)-4-Methoxy-N-methylpyrrolidin-3-amine bis(4-methylbenzenesulfonate), CAS: 372482-03-6, stock 845.1g, assay 98.5%, MWt 474.59, Formula C20H30N2O7S2, Purity >98%, SMILES CN[C@H]1CNC[C@@H]1OC.O=S(C2=CC=C(C)C=C2)(O)=O.O=S(C3=CC=C(C)C=C3)(O)=O, MDL NA |
| Drug_Names: Ethyl 3-(2,6-dichloropyridin-3-yl)-3-oxopropanoate, CAS: 174727-36-7, stock 164.9g, assay 98.5%, MWt 262.09, Formula C10H9Cl2NO3, Purity >98%, SMILES O=C(CC(OCC)=O)C(C(Cl)=N1)=CC=C1Cl, MDL MFCD08275023 |
| Drug_Names: Ethyl 7-chloro-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate, CAS: 174726-87-5, stock 337.8g, assay 98.9%, MWt 335.77, Formula C14H10ClN3O3S, Purity >98%, SMILES O=C1C(C(OCC)=O)=CN(C2=NC=CS2)C3=NC(Cl)=CC=C31, MDL NA |
| Drug_Names: 1,3-Dibromo-2-(3-bromopropoxy)benzene, CAS: 206347-33-3, stock 233.7g, assay 98.8%, MWt 372.88, Formula C9H9Br3O, Purity >98%, SMILES BrC1=CC=CC(Br)=C1OCCCBr, MDL NA |
| Drug_Names: (R)-N-(1-(4-Bromophenyl)ethyl)-2-methoxyacetamide, CAS: 960238-03-3, stock 247.9g, assay 98.5%, MWt 272.14, Formula C11H14BrNO2, Purity >98%, SMILES BrC1=CC=C([C@H](NC(COC)=O)C)C=C1, MDL NA |
| Drug_Names: Acetone acetylhydrazone, CAS: 3742-63-0, stock 399.3g, assay 98.9%, MWt 114.15, Formula C5H10N2O, Purity >98%, SMILES CC(N/N=C(C)/C)=O, MDL NA |
| Drug_Names: 1-Acetyl-2-isopropylhydrazine, CAS: 4466-50-6, stock 100.2g, assay 98.7%, MWt 116.16, Formula C5H12N2O, Purity >98%, SMILES CC(NNC(C)C)=O, MDL MFCD01672496 |
| Drug_Names: Ethyl 1-isopropyl-3-methyl-1H-1,2,4-triazole-5-carboxylate, CAS: 1282517-47-8, stock 393.6g, assay 98.6%, MWt 197.23, Formula C9H15N3O2, Purity >98%, SMILES O=C(C1=NC(C)=NN1C(C)C)OCC, MDL NA |
| Drug_Names: 2-Bromo-1-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)ethanone, CAS: 1282517-46-7, stock 24g, assay 98.3%, MWt 246.10, Formula C8H12BrN3O, Purity >98%, SMILES CC1=NN(C(C)C)C(C(CBr)=O)=N1, MDL NA |
| Drug_Names: 4-Bromo-2-fluorobenzimidamide hydrochloride, CAS: 1187927-25-8, stock 851.3g, assay 98.9%, MWt 253.50, Formula C7H7BrClFN2, Purity >98%, SMILES N=C(N)C1=CC=C(Br)C=C1F.Cl, MDL MFCD04114441 |
| Drug_Names: 5-(2-(4-Bromo-2-fluorophenyl)-1H-imidazol-4-yl)-1-isopropyl-3-methyl-1H-1,2,4-triazole, CAS: 1282516-76-0, stock 856.2g, assay 98.4%, MWt 364.22, Formula C15H15BrFN5, Purity >98%, SMILES CC1=NN(C(C)C)C(C2=CNC(C3=CC=C(Br)C=C3F)=N2)=N1, MDL NA |
| Drug_Names: 2-(2-(4-Bromo-2-fluorophenyl)-4-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-1H-imidazol-1-yl)ethanol, CAS: 1282516-77-1, stock 97.7g, assay 98.2%, MWt 408.27, Formula C17H19BrFN5O, Purity >98%, SMILES FC1=CC(Br)=CC=C1C2=NC(C3=NC(C)=NN3C(C)C)=CN2CCO, MDL NA |
| Drug_Names: 9-Bromo-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine, CAS: 1282514-63-9, stock 766.1g, assay 98%, MWt 388.26, Formula C17H18BrN5O, Purity >98%, SMILES BrC1=CC=C2C3=NC(C4=NC(C)=NN4C(C)C)=CN3CCOC2=C1, MDL NA |
| Drug_Names: Ethyl 2-methyl-2-(4-(4,4,5,5-tetramEthyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate, CAS: 1201657-32-0, stock 85.6g, assay 98.5%, MWt 308.18, Formula C15H25BN2O4, Purity >98%, SMILES CC1(C)C(C)(C)OB(C2=CN(C(C)(C(OCC)=O)C)N=C2)O1, MDL NA |
| Drug_Names: Ethyl 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoate, CAS: 1282514-64-0, stock 373.3g, assay 98.1%, MWt 489.57, Formula C26H31N7O3, Purity >98%, SMILES CC(C)(N1N=CC(C2=CC=C3C4=NC(C5=NC(C)=NN5C(C)C)=CN4CCOC3=C2)=C1)C(OCC)=O, MDL NA |
| Drug_Names: 2-(4-(2-(1-Isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid, CAS: 1282513-03-4, stock 808.8g, assay 98.5%, MWt 461.52, Formula C24H27N7O3, Purity >98%, SMILES CC(C)(N1N=CC(C2=CC=C3C4=NC(C5=NC(C)=NN5C(C)C)=CN4CCOC3=C2)=C1)C(O)=O, MDL NA |
| Drug_Names: Ethyl 2-(4-bromo-1H-pyrazol-1-yl)-2-methylpropanoate, CAS: 1040377-17-0, stock 333.8g, assay 98.3%, MWt 261.12, Formula C9H13BrN2O2, Purity >98%, SMILES BrC1=CN(C(C)(C(OCC)=O)C)N=C1, MDL NA |
| Drug_Names: (6S)-5-[(tert-butoxy)carbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid, CAS: 1129634-44-1, stock 397.7g, assay 98.8%, MWt 241.28, Formula C12H19NO4, Purity >98%, SMILES O=C([C@H](C1)N(C(OC(C)(C)C)=O)CC21CC2)O, MDL NA |
| Drug_Names: 2'-Bromospiro[[1,3]dithiolane-2,9'-fluorene], CAS: 113425-37-9, stock 474.5g, assay 98.1%, MWt 335.28, Formula C15H11BrS2, Purity >98%, SMILES BrC1=CC2=C(C=C1)C3=C(C=CC=C3)C24SCCS4, MDL NA |
| Drug_Names: 2-Bromo-9,9-difluoro-9H-fluorene, CAS: 1823405-12-4, stock 457.6g, assay 98.5%, MWt 281.10, Formula C13H7BrF2, Purity >98%, SMILES FC1(F)C2=C(C3=C1C=C(Br)C=C3)C=CC=C2, MDL NA |
| Drug_Names: 1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)ethanone, CAS: 1698910-38-1, stock 391.4g, assay 98.7%, MWt 323.13, Formula C15H9BrF2O, Purity >98%, SMILES FC1(F)C2=C(C3=C1C=C(Br)C=C3)C=CC(C(C)=O)=C2, MDL NA |
| Drug_Names: 2-Bromo-1-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)ethanone, CAS: 1446138-83-5, stock 3g, assay 98.7%, MWt 402.03, Formula C15H8Br2F2O, Purity >98%, SMILES BrC1=CC2=C(C=C1)C3=C(C=C(C(CBr)=O)C=C3)C2(F)F, MDL NA |
| Drug_Names: (S)-6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptane hydrochloride, CAS: 2004675-25-4, stock 781.1g, assay 98.8%, MWt 478.76, Formula C22H19BrClF2N3, Purity >98%, SMILES FC1(F)C2=C(C3=C1C=C(Br)C=C3)C=CC(C4=CN=C([C@H](C5)NCC65CC6)N4)=C2.Cl, MDL NA |
| Drug_Names: Methyl ((S)-1-((S)-6-(5-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptan-5-yl)-3-methyl-1-oxobutan-2-yl)carbamate, CAS: 1256388-50-7, stock 158.6g, assay 98.3%, MWt 599.47, Formula C29H29BrF2N4O3, Purity >98%, SMILES O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(Br)=C3)=C4C=C2)N1)C5)CC65CC6)=O)C(C)C, MDL NA |
| Drug_Names: (1R,3S,4S)-Ethyl 2-azabicyclo[2.2.1]heptane-3-carboxylate hydrochloride, CAS: 188057-41-2, stock 782.1g, assay 98.2%, MWt 205.68, Formula C9H16ClNO2, Purity >98%, SMILES O=C(OCC)[C@H]1N[C@]2([H])CC[C@@]1([H])C2.Cl, MDL NA |
| Drug_Names: (1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid, CAS: 291775-59-2, stock 80.2g, assay 98.9%, MWt 241.28, Formula C12H19NO4, Purity >98%, SMILES O=C([C@H]1N(C(OC(C)(C)C)=O)[C@]2([H])CC[C@@]1([H])C2)O, MDL NA |
| Drug_Names: Ledipasvir Intermediate, CAS: 1256393-27-7, stock 282.1g, assay 98.5%, MWt 831.95, Formula C47H51F2N7O5, Purity >98%, SMILES O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N(C(OC(C)(C)C)=O)[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C, MDL NA |
| Drug_Names: methyl ((S)-1-((S)-6-(5-(7-(2-((1R,3S,4S)-2-azabicyclo[2.2.1]heptan-3-yl)-1H-benzo[d]imidazol-6-yl)-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptan-5-yl)-3-methyl-1-oxobutan-2-yl)carbamate (hydrochloride), CAS: 2004675-26-5, stock 440.7g, assay 99%, MWt 768.29, Formula C42H44ClF2N7O3, Purity >98%, SMILES O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C.Cl, MDL NA |
| Drug_Names: 2-(Azetidin-3-ylidene)acetonitrile hydrochloride, CAS: 1314910-43-4, stock 151.6g, assay 98%, MWt 130.58, Formula C5H7ClN2, Purity >98%, SMILES N#C/C=C1CNC\1.Cl, MDL NA |
| Drug_Names: 5-Bromoacetyl-2-hydroxybenzaldehyde, CAS: 115787-50-3, stock 830.3g, assay 98.3%, MWt 243.05, Formula C9H7BrO3, Purity >98%, SMILES O=CC1=CC(C(CBr)=O)=CC=C1O, MDL MFCD09833486 |
| Drug_Names: 2-Bromo-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethan-1-one, CAS: 62932-94-9, stock 359.7g, assay 98.3%, MWt 245.07, Formula C9H9BrO3, Purity >98%, SMILES OC1=CC=C(C(CBr)=O)C=C1CO, MDL NA |
| Drug_Names: 2-Bromo-1-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)ethanone, CAS: 102293-80-1, stock 402.9g, assay 98.3%, MWt 285.13, Formula C12H13BrO3, Purity >98%, SMILES O=C(CBr)C1=CC=C2C(COC(C)(C)O2)=C1, MDL NA |
| Drug_Names: Di-(tert-butyl) 2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxoethyliminodicarbonate, CAS: 452339-70-7, stock 620.3g, assay 98.7%, MWt 421.48, Formula C22H31NO7, Purity >98%, SMILES O=C(CN(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)C1=CC=C2C(COC(C)(C)O2)=C1, MDL NA |
| Drug_Names: tert-Butyl (2-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)-2-oxoethyl)carbamate, CAS: 452339-71-8, stock 585.1g, assay 98.5%, MWt 321.37, Formula C17H23NO5, Purity >98%, SMILES O=C(CNC(OC(C)(C)C)=O)C1=CC=C2C(COC(C)(C)O2)=C1, MDL NA |
| Drug_Names: tert-Butyl (2R)-2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethylcarbamate, CAS: 452339-72-9, stock 337.2g, assay 98.9%, MWt 323.38, Formula C17H25NO5, Purity >98%, SMILES CC1(C)OC2=CC=C([C@@H](O)CNC(OC(C)(C)C)=O)C=C2CO1, MDL NA |
| Drug_Names: (5R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one, CAS: 452339-73-0, stock 301.5g, assay 98.1%, MWt 249.26, Formula C13H15NO4, Purity >98%, SMILES CC1(C)OC2=CC=C([C@@H](O3)CNC3=O)C=C2CO1, MDL NA |
| Drug_Names: (R)-3-(6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)-5-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one, CAS: 503068-36-8, stock 616g, assay 98.4%, MWt 552.49, Formula C28H35Cl2NO6, Purity >98%, SMILES ClC1=CC=CC(Cl)=C1COCCOCCCCCCN2C[C@H](OC2=O)C3=CC=C4OC(C)(C)OCC4=C3, MDL NA |
| Drug_Names: 2-((2,6-Dichlorobenzyl)oxy)ethanol, CAS: 85309-91-7, stock 618.3g, assay 98.8%, MWt 221.08, Formula C9H10Cl2O2, Purity >98%, SMILES ClC1=C(COCCO)C(Cl)=CC=C1, MDL NA |
| Drug_Names: 2-[2-(6-Bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene, CAS: 503070-57-3, stock 800.7g, assay 98.1%, MWt 384.14, Formula C15H21BrCl2O2, Purity >98%, SMILES BrCCCCCCOCCOCC1=C(Cl)C=CC=C1Cl, MDL NA |
| Drug_Names: (S)-2-phenyl-1-(thiazol-2-yl)ethanamine, CAS: 130199-65-4, stock 549.4g, assay 98.5%, MWt 204.29, Formula C11H12N2S, Purity >98%, SMILES N[C@H](C1=NC=CS1)CC2=CC=CC=C2, MDL NA |
| Drug_Names: 2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile, CAS: 330792-68-2, stock 109.3g, assay 98.1%, MWt 262.26, Formula C16H10N2O2, Purity >98%, SMILES N#C/C(C#N)=C(O)/C1=CC=C(OC2=CC=CC=C2)C=C1, MDL NA |
| Drug_Names: 2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile, CAS: 330792-69-3, stock 661.7g, assay 98.4%, MWt 276.29, Formula C17H12N2O2, Purity >98%, SMILES N#C/C(C#N)=C(OC)\C1=CC=C(OC2=CC=CC=C2)C=C1, MDL NA |
| Drug_Names: 5-Amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile, CAS: 330792-70-6, stock 279.7g, assay 98.4%, MWt 276.29, Formula C16H12N4O, Purity >98%, SMILES N#CC1=C(C2=CC=C(OC3=CC=CC=C3)C=C2)NN=C1N, MDL NA |
| Drug_Names: tert-Butyl 3-(((4-bromophenyl)sulfonyl)oxy)piperidine-1-carboxylate, CAS: 2070015-39-1, stock 602.2g, assay 98.7%, MWt 420.32, Formula C16H22BrNO5S, Purity >98%, SMILES O=C(N1CC(OS(=O)(C2=CC=C(Br)C=C2)=O)CCC1)OC(C)(C)C, MDL NA |
| Drug_Names: (S)-tert-butyl 3-(((4-bromophenyl)sulfonyl)oxy)piperidine-1-carboxylate, CAS: 2070009-69-5, stock 607.5g, assay 98.3%, MWt 420.32, Formula C16H22BrNO5S, Purity >98%, SMILES O=C(N1C[C@@H](OS(=O)(C2=CC=C(Br)C=C2)=O)CCC1)OC(C)(C)C, MDL NA |
| Drug_Names: (R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate, CAS: 1022150-11-3, stock 797.6g, assay 98.9%, MWt 486.57, Formula C27H30N6O3, Purity >98%, SMILES O=C(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate, CAS: 936563-86-9, stock 713.2g, assay 98.1%, MWt 486.57, Formula C27H30N6O3, Purity >98%, SMILES O=C(N1CC(N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)OC(C)(C)C, MDL NA |
| Drug_Names: Methyl 4-amino-2-methoxybenzoate, CAS: 27492-84-8, stock 546.3g, assay 98.2%, MWt 181.19, Formula C9H11NO3, Purity >98%, SMILES O=C(OC)C1=CC=C(N)C=C1OC, MDL MFCD00017202 |
| Drug_Names: 1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine acetate, CAS: 906093-30-9, stock 487.7g, assay 98.8%, MWt 302.37, Formula C16H22N4O2, Purity >98%, SMILES CC(O)=O.CC1=NN(C2=CC=CC=C2)C(N3CCNCC3)=C1, MDL NA |
| Drug_Names: H-D-Tle-OMe.HCl, CAS: 167223-43-0, stock 52.3g, assay 98.1%, MWt 181.66, Formula C7H16ClNO2, Purity >98%, SMILES O=C(OC)[C@H](N)C(C)(C)C.Cl, MDL MFCD11113177 |
| Drug_Names: 1-(4-Iodophenyl)-2-piperidinone, CAS: 385425-15-0, stock 400.8g, assay 98.5%, MWt 301.12, Formula C11H12INO, Purity >98%, SMILES O=C1N(CCCC1)C(C=C2)=CC=C2I, MDL MFCD04037128 |
| Drug_Names: (5-(2-Fluorophenyl)thiophen-2-yl)(5-iodo-2-methylphenyl)methanone, CAS: 2070015-36-8, stock 176.2g, assay 98.5%, MWt 422.26, Formula C18H12FIOS, Purity >98%, SMILES CC1=C(C(C2=CC=C(C3=C(F)C=CC=C3)S2)=O)C=C(I)C=C1, MDL NA |
| Drug_Names: (5-(3-Fluorophenyl)thiophen-2-yl)(5-iodo-2-methylphenyl)methanone, CAS: 2070015-41-5, stock 154.1g, assay 98.2%, MWt 422.26, Formula C18H12FIOS, Purity >98%, SMILES CC1=C(C(C2=CC=C(C3=CC(F)=CC=C3)S2)=O)C=C(I)C=C1, MDL NA |
| Drug_Names: tert-Butyl ((3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl)carbamate, CAS: 856707-39-6, stock 249.6g, assay 98.5%, MWt 286.37, Formula C14H26N2O4, Purity >98%, SMILES CCC[C@@H](C(O)C(NC1CC1)=O)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: Ethyl 1-(4-methoxyphenyl)-7a-morpholino-6-(4-nitrophenyl)-7-oxo-3a,4,5,6,7,7a-hexahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate, CAS: 1620386-62-0, stock 768.1g, assay 98.7%, MWt 523.54, Formula C26H29N5O7, Purity >98%, SMILES O=C(N(C1=CC=C([N+]([O-])=O)C=C1)CC2)C3(N4CCOCC4)C2C(C(OCC)=O)=NN3C5=CC=C(OC)C=C5, MDL NA |
| Drug_Names: (2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-D-valine, CAS: 1033882-31-3, stock 27.2g, assay 98.3%, MWt 376.45, Formula C19H28N4O4, Purity >98%, SMILES O=C([C@H](C1CCCCC1)NC(C2=NC=CN=C2)=O)N[C@H](C(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: (S)-2-((R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoic acid, CAS: 1585973-07-4, stock 43.1g, assay 98.1%, MWt 376.45, Formula C19H28N4O4, Purity >98%, SMILES O=C([C@@H](C1CCCCC1)NC(C2=NC=CN=C2)=O)N[C@@H](C(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: (R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetic acid, CAS: 1359843-82-5, stock 295.6g, assay 98.2%, MWt 263.29, Formula C13H17N3O3, Purity >98%, SMILES O=C(C1=NC=CN=C1)N[C@H](C2CCCCC2)C(O)=O, MDL NA |
| Drug_Names: 3-(4-Bromobutyl)-1H-indole-5-carbonitrile, CAS: 2167751-62-2, stock 509.7g, assay 98.1%, MWt 277.16, Formula C13H13BrN2, Purity >98%, SMILES BrCCCCC1=CNC2=CC=C(C#N)C=C12, MDL NA |
| Drug_Names: (1S,3aR,6aS)-2-((R)-2-((R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid, CAS: 1616728-82-5, stock 393.3g, assay 98.5%, MWt 513.63, Formula C27H39N5O5, Purity >98%, SMILES O=C([C@@H](C(C)(C)C)NC([C@@H](C1CCCCC1)NC(C2=CN=CC=N2)=O)=O)N3[C@H](C(O)=O)[C@@]4([H])CCC[C@]([H])4C3, MDL NA |
| Drug_Names: (R)-2-((R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoic acid, CAS: 1616728-80-3, stock 735.5g, assay 98.8%, MWt 376.45, Formula C19H28N4O4, Purity >98%, SMILES O=C([C@@H](C1CCCCC1)NC(C2=CN=CC=N2)=O)N[C@H](C(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: (1S,3aR,6aS)-2-((S)-2-((R)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid, CAS: 1616728-85-8, stock 682.4g, assay 98.7%, MWt 513.63, Formula C27H39N5O5, Purity >98%, SMILES O=C([C@H](C(C)(C)C)NC([C@@H](C1CCCCC1)NC(C2=CN=CC=N2)=O)=O)N3[C@H](C(O)=O)[C@@]4([H])CCC[C@]([H])4C3, MDL NA |
| Drug_Names: 8-Aminonaphthalen-2-ol, CAS: 118-46-7, stock 628.7g, assay 98.4%, MWt 159.18, Formula C10H9NO, Purity >98%, SMILES NC1=C(C(C=C2)=CC=C1)C=C2O, MDL MFCD00004031 |
| Drug_Names: Ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate, CAS: 52980-28-6, stock 828.7g, assay 98.9%, MWt 217.22, Formula C12H11NO3, Purity >98%, SMILES O=C1C(C(OCC)=O)=CNC2=CC=CC=C12, MDL MFCD01314279 |
| Drug_Names: 2,4-Bis(1,1-dimethylethyl)phenyl methyl ester, CAS: 873055-54-0, stock 699.8g, assay 98.4%, MWt 264.36, Formula C16H24O3, Purity >98%, SMILES O=C(OC)OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C, MDL NA |
| Drug_Names: (2R)-2-{[(tert-butoxy)carbonyl]amino}non-8-enoic acid, CAS: 881683-84-7, stock 684.9g, assay 98.2%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES C=CCCCCC[C@@H](NC(OC(C)(C)C)=O)C(O)=O, MDL NA |
| Drug_Names: Indoline-2-carboxylic acid, CAS: 78348-24-0, stock 390.1g, assay 98.3%, MWt 163.17, Formula C9H9NO2, Purity >98%, SMILES O=C(O)C1NC2=C(C1)C=CC=C2, MDL MFCD00010635 |
| Drug_Names: Methyl 2-indolecarboxylate, CAS: 1202-04-6, stock 749.5g, assay 98.4%, MWt 175.18, Formula C10H9NO2, Purity >98%, SMILES O=C(OC)C(N1)=CC2=C1C=CC=C2, MDL MFCD00460779 |
| Drug_Names: 1,4,7-Tri(p-tolylsulfonyl)-1,4,7-triazacyclononane, CAS: 52667-89-7, stock 415.4g, assay 98.4%, MWt 591.76, Formula C27H33N3O6S3, Purity >98%, SMILES CC1=CC=C(S(N2CCN(S(C3=CC=C(C)C=C3)(=O)=O)CCN(S(C4=CC=C(C)C=C4)(=O)=O)CC2)(=O)=O)C=C1, MDL NA |
| Drug_Names: NSC 134465, CAS: 143300-67-8, stock 548.4g, assay 98.5%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES CCOC(CC(NCCC(OCC)=O)=O)=O, MDL NA |
| Drug_Names: 1-(3-Nitrophenyl)piperidin-2-one, CAS: 132573-13-8, stock 808.1g, assay 98.7%, MWt 220.22, Formula C11H12N2O3, Purity >98%, SMILES O=C1N(C2=CC=CC([N+]([O-])=O)=C2)CCCC1, MDL NA |
| Drug_Names: 1-phenylpiperidin-2-one, CAS: 4789-09-7, stock 894.4g, assay 98.1%, MWt 175.23, Formula C11H13NO, Purity >98%, SMILES O=C1CCCCN1C2=CC=CC=C2, MDL NA |
| Drug_Names: (R)-N-(1-(naphthalen-2-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine, CAS: 2074615-22-6, stock 557.6g, assay 98.1%, MWt 357.41, Formula C22H22F3N, Purity >98%, SMILES C[C@@]([H])(NCCCC1=CC=CC(C(F)(F)F)=C1)C2=CC=C3C(C=CC=C3)=C2, MDL NA |
| Drug_Names: (S)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine, CAS: 694495-47-1, stock 790.3g, assay 98.7%, MWt 357.41, Formula C22H22F3N, Purity >98%, SMILES FC(C1=CC(CCCN[C@H](C2=C3C=CC=CC3=CC=C2)C)=CC=C1)(F)F, MDL NA |
| Drug_Names: (S)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine (hydrochloride), CAS: 1217809-88-5, stock 56.1g, assay 98.2%, MWt 393.87, Formula C22H23ClF3N, Purity >98%, SMILES C[C@H](NCCCC1=CC=CC(C(F)(F)F)=C1)C2=CC=CC3=C2C=CC=C3.Cl, MDL NA |
| Drug_Names: Methyl 5-amino-1-benzofuran-2-carboxylate hydrochloride, CAS: 383677-67-6, stock 359.2g, assay 98.5%, MWt 227.64, Formula C10H10ClNO3, Purity >98%, SMILES NC1=CC=C2C(C=C(C(OC)=O)O2)=C1.Cl, MDL MFCD11857868 |
| Drug_Names: 2,5-Dichloropyrimidine, CAS: 22536-67-0, stock 222.3g, assay 98.7%, MWt 148.98, Formula C4H2Cl2N2, Purity >98%, SMILES ClC1=NC=C(Cl)C=N1, MDL MFCD00673131 |
| Drug_Names: ACT 080803, CAS: 1433875-21-8, stock 779.5g, assay 98.9%, MWt 467.11, Formula C16H13Br2N5O2, Purity >98%, SMILES BrC1=CN=C(OCCOC2=C(C3=CC=C(Br)C=C3)C(N)=NC=N2)N=C1, MDL NA |
| Drug_Names: N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, CAS: 923036-30-0, stock 600.5g, assay 98.1%, MWt 489.63, Formula C27H31N5O2S, Purity >98%, SMILES O=S(N1C=CC2=C(N(C)[C@H]3CN(CC4=CC=CC=C4)CC[C@H]3C)N=CN=C21)(C5=CC=C(C)C=C5)=O, MDL NA |
| Drug_Names: 3-(2-Thienyl)-D-alanine, CAS: 62561-76-6, stock 622.2g, assay 98.2%, MWt 171.22, Formula C7H9NO2S, Purity >98%, SMILES N[C@H](CC1=CC=CS1)C(O)=O, MDL MFCD00077166 |
| Drug_Names: (R,E)-N-(1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide, CAS: 1095393-66-0, stock 652.2g, assay 98.9%, MWt 369.38, Formula C22H18F3NO, Purity >98%, SMILES FC(F)(F)C1=CC=CC(/C=C/C(N[C@@H](C2=C(C=CC=C3)C3=CC=C2)C)=O)=C1, MDL NA |
| Drug_Names: Methanesulfonic acid 3-(3-trifluoromethylphenyl)propyl ester, CAS: 21172-43-0, stock 503.9g, assay 98.3%, MWt 282.28, Formula C11H13F3O3S, Purity >98%, SMILES FC(F)(F)C1=CC=CC(CCCOS(=O)(C)=O)=C1, MDL NA |
| Drug_Names: 2-Phenylthiophene, CAS: 825-55-8, stock 564.7g, assay 98.1%, MWt 160.24, Formula C10H8S, Purity >98%, SMILES C1(C2=CC=CC=C2)=CC=CS1, MDL MFCD00130080 |
| Drug_Names: (5-Iodo-2-methylphenyl)(5-phenylthiophen-2-yl)methanone, CAS: 2070015-44-8, stock 676.3g, assay 99%, MWt 404.26, Formula C18H13IOS, Purity >98%, SMILES CC1=C(C(C2=CC=C(C3=CC=CC=C3)S2)=O)C=C(I)C=C1, MDL NA |
| Drug_Names: 1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, CAS: 184177-83-1, stock 586g, assay 98.7%, MWt 513.63, Formula C30H35N5O3, Purity >98%, SMILES O=C1N([C@@H](CC)[C@@H](OCC2=CC=CC=C2)C)N=CN1C3=CC=C(N4CCN(C5=CC=C(O)C=C5)CC4)C=C3, MDL MFCD18374617 |
| Drug_Names: (S)-2-(((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamoyl)benzoic acid, CAS: 1365267-37-3, stock 426.5g, assay 98.2%, MWt 439.42, Formula C22H21N3O7, Purity >98%, SMILES O=C1COCCN1C2=CC=C(N3C(O[C@@H](CNC(C4=C(C(O)=O)C=CC=C4)=O)C3)=O)C=C2, MDL NA |
| Drug_Names: N1,N2-bis(((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)phthalamide, CAS: 1365267-36-2, stock 767.2g, assay 98.1%, MWt 712.71, Formula C36H36N6O10, Purity >98%, SMILES O=C1COCCN1C2=CC=C(N3C(O[C@@H](CNC(C4=C(C(NC[C@H](OC5=O)CN5C6=CC=C(N7CCOCC7=O)C=C6)=O)C=CC=C4)=O)C3)=O)C=C2, MDL NA |
| Drug_Names: 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione, CAS: 666816-98-4, stock 570.4g, assay 99%, MWt 297.11, Formula C10H9BrN4O2, Purity >98%, SMILES O=C(N1)N(C)C2=C(N(CC#CC)C(Br)=N2)C1=O, MDL MFCD22126091 |
| Drug_Names: 2-(Chloromethyl)-4-methylquinazoline, CAS: 109113-72-6, stock 639.9g, assay 98.1%, MWt 192.64, Formula C10H9ClN2, Purity >98%, SMILES CC1=C2C=CC=CC2=NC(CCl)=N1, MDL MFCD09807547 |
| Drug_Names: 2,3-Dihydrobenzo[b]furan-5-carbaldehyde, CAS: 55745-70-5, stock 794g, assay 98%, MWt 148.16, Formula C9H8O2, Purity >98%, SMILES O=CC(C=C1)=CC2=C1OCC2, MDL MFCD00068058 |
| Drug_Names: Ethyl (E)-3-(2,3-dihydrobenzofuran-5-yl)-2-propenoate, CAS: 196597-65-6, stock 625.3g, assay 98.2%, MWt 218.25, Formula C13H14O3, Purity >98%, SMILES O=C(OCC)/C=C/C1=CC=C(OCC2)C2=C1, MDL MFCD09955079 |
| Drug_Names: N-(2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl)propionamide, CAS: 196597-17-8, stock 322.1g, assay 98.1%, MWt 259.34, Formula C16H21NO2, Purity >98%, SMILES O=C(CC)NCCC1C2=C3C(OCC3)=CC=C2CC1, MDL NA |
| Drug_Names: (S)-Methyl piperidine-3-carboxylate hydrochloride, CAS: 164323-84-6, stock 201.9g, assay 98.6%, MWt 179.64, Formula C7H14ClNO2, Purity >98%, SMILES O=C(OC)[C@@H]1CNCCC1.Cl, MDL NA |
| Drug_Names: 2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol hydrochloride, CAS: 250214-40-5, stock 449.5g, assay 98.6%, MWt 377.95, Formula C22H32ClNO2, Purity >98%, SMILES OC1=C(C(C2=CC=CC=C2)CCN(C(C)C)C(C)C)C=C(CO)C=C1.Cl, MDL NA |
| Drug_Names: (1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-1H-indene, CAS: 104846-62-0, stock 195g, assay 98.8%, MWt 510.91, Formula C34H58OSi, Purity >98%, SMILES C[C@]1(CCC/2)[C@](CC[C@@H]1[C@@H](/C=C/[C@H](C)C(C)C)C)([H])C2=C\C=C(C[C@@H](O[Si](C)(C)C(C)(C)C)CC3)/C3=C, MDL NA |
| Drug_Names: 2-Amino-7-benzyl-1,7-dihydro-6H-purin-6-one hydrochloride, CAS: 20755-15-1, stock 220.4g, assay 98.3%, MWt 277.71, Formula C12H12ClN5O, Purity >98%, SMILES O=C1C(N2CC3=CC=CC=C3)=C(N=C2)N=C(N)N1.Cl, MDL NA |
| Drug_Names: 5-Cyano-1H-pyrrolo[2,3-b]pyridine 7-oxide, CAS: 1935462-65-9, stock 123.6g, assay 98.5%, MWt 159.14, Formula C8H5N3O, Purity >98%, SMILES N#CC1=C[N+]([O-])=C(NC=C2)C2=C1, MDL NA |
| Drug_Names: 4-Methoxybenzyl (1S,2S)-2-((R)-4-((9H-xanthen-9-yl)methyl)-1-(4-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)cyclopropane-1-carboxylate, CAS: 203209-15-8, stock 791.7g, assay 98.5%, MWt 618.68, Formula C37H34N2O7, Purity >98%, SMILES O=C([C@@H]1[C@@H]([C@@](C(N2CC3=CC=C(OC)C=C3)=O)(CC4C5=C(OC6=C4C=CC=C6)C=CC=C5)NC2=O)C1)OCC7=CC=C(OC)C=C7, MDL NA |
| Drug_Names: 5-(o-Methoxyphenoxy)-4,6-dihydroxy-2-(4-pyridyl)pyrimidine, CAS: 150728-08-8, stock 721.7g, assay 98.3%, MWt 311.29, Formula C16H13N3O4, Purity >98%, SMILES O=C(N=C(C1=CC=NC=C1)N2)C(OC(C=CC=C3)=C3OC)C2=O, MDL NA |
| Drug_Names: 5-(o-Methoxyphenoxy)-4,6-dichloro-2-(4-pyridyl)pyrimidine, CAS: 150727-72-3, stock 298.8g, assay 98.8%, MWt 348.18, Formula C16H11Cl2N3O2, Purity >98%, SMILES ClC1=NC(C2=CC=NC=C2)=NC(Cl)=C1OC(C=CC=C3)=C3OC, MDL NA |
| Drug_Names: (S)-4-(Oxiran-2-ylmethyl)morpholine, CAS: 141395-84-8, stock 425.6g, assay 98.3%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES [C@@H]1(CN2CCOCC2)OC1, MDL NA |
| Drug_Names: 3-Amino-N-(3-methyl-4-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide, CAS: 1437315-24-6, stock 93.5g, assay 98.3%, MWt 396.44, Formula C23H20N6O, Purity >98%, SMILES O=C(C1=CC=CC(N)=C1)NC2=CC=C(C(C)=C2)NC3=NC=CC(C4=CN=CC=C4)=N3, MDL NA |
| Drug_Names: Benzo-12-crown-4, CAS: 14174-08-4, stock 809.1g, assay 98.2%, MWt 224.25, Formula C12H16O4, Purity >98%, SMILES C12=CC=CC=C1OCCOCCOCCO2, MDL NA |
| Drug_Names: 4'-Nitrobenzo-12-crown-4, CAS: 78554-67-3, stock 850.6g, assay 98.1%, MWt 269.25, Formula C12H15NO6, Purity >98%, SMILES [O-][N+](C1=CC(OCCOCCOCCO2)=C2C=C1)=O, MDL NA |
| Drug_Names: 4-Aminobenzo-12-crown-4, CAS: 78554-68-4, stock 203.5g, assay 98.7%, MWt 239.27, Formula C12H17NO4, Purity >98%, SMILES NC1=CC2=C(C=C1)OCCOCCOCCO2, MDL NA |
| Drug_Names: 5-[Bis(methylsulfanyl)methylene]-2,2-dimethyl-[1,3]dioxan-4,6-dione, CAS: 100981-05-3, stock 807.9g, assay 98.8%, MWt 248.32, Formula C9H12O4S2, Purity >98%, SMILES O=C1/C(C(OC(C)(C)O1)=O)=C(SC)/SC, MDL NA |
| Drug_Names: Methyl pyrimidine-2-carboxylate, CAS: 34253-03-7, stock 585.9g, assay 98.5%, MWt 138.12, Formula C6H6N2O2, Purity >98%, SMILES O=C(OC)C1=NC=CC=N1, MDL MFCD03426929 |
| Drug_Names: 1-(5-Bromopyridin-3-yl)-4-chlorobutan-1-one, CAS: 1823829-33-9, stock 119.5g, assay 98.8%, MWt 262.53, Formula C9H9BrClNO, Purity >98%, SMILES O=C(CCCCl)C1=CN=CC(Br)=C1, MDL NA |
| Drug_Names: 3-(N'-Hydroxycarbamimidoyl)benzoic acid, CAS: 199447-10-4, stock 181.5g, assay 99%, MWt 180.16, Formula C8H8N2O3, Purity >98%, SMILES O=C(O)C1=CC=CC(/C(N)=N/O)=C1, MDL NA |
| Drug_Names: 3-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic acid, CAS: 264264-32-6, stock 245.5g, assay 98.4%, MWt 204.18, Formula C10H8N2O3, Purity >98%, SMILES O=C(O)C1=CC=CC(C2=NOC(C)=N2)=C1, MDL MFCD06797485 |
| Drug_Names: Methyl 3-carbamimidoylbenzoate acetate, CAS: 1092568-84-7, stock 167.6g, assay 98.8%, MWt 238.24, Formula C11H14N2O4, Purity >98%, SMILES O=C(OC)C1=CC=CC(C(N)=N)=C1.CC(O)=O, MDL NA |
| Drug_Names: 4-Methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-amine, CAS: 1357476-69-7, stock 223.9g, assay 98.6%, MWt 301.33, Formula C13H14F3N3S, Purity >98%, SMILES NC1=NC(C)=C(C2=CC(C(C)(C)C(F)(F)F)=NC=C2)S1, MDL NA |
| Drug_Names: 2-(2-Formylphenoxy)hexanoic acid, CAS: 138320-27-1, stock 4.9g, assay 98.5%, MWt 236.26, Formula C13H16O4, Purity >98%, SMILES O=C(O)C(CCCC)OC1=C(C=CC=C1)C=O, MDL NA |
| Drug_Names: 2-(4-Nitrophenoxy)hexanal, CAS: 2070015-33-5, stock 61.9g, assay 98.9%, MWt 237.25, Formula C12H15NO4, Purity >98%, SMILES CCCCC(OC1=CC=C([N+]([O-])=O)C=C1)C=O, MDL NA |
| Drug_Names: (R)-Methyl 2-aminopentanoate hydrochloride, CAS: 619330-91-5, stock 821g, assay 98.7%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES O=C(OC)[C@@H](CCC)N.Cl, MDL NA |
| Drug_Names: Methyl (2R)-2-{[(tert-butoxy)carbonyl]amino}pentanoate, CAS: 116611-58-6, stock 238.6g, assay 98.7%, MWt 231.29, Formula C11H21NO4, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H](CCC)C(OC)=O, MDL NA |
| Drug_Names: (S)-2-amino-4-methyl-1-((S)-2-methyloxiran-2-yl)pentan-1-one 2,2,2-trifluoroacetate, CAS: 1528769-14-3, stock 464.9g, assay 98%, MWt 285.26, Formula C11H18F3NO4, Purity >98%, SMILES FC(F)(C(O)=O)F.N[C@H](C([C@@]1(CO1)C)=O)CC(C)C, MDL NA |
| Drug_Names: tert-Butyl ((S)-4-methyl-1-((S)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate, CAS: 247068-83-3, stock 673.1g, assay 98.9%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES O=C([C@@]1(CO1)C)[C@H](CC(C)C)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: tert-Butyl ((R)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate, CAS: 2177287-68-0, stock 279.5g, assay 98.4%, MWt 271.35, Formula C14H25NO4, Purity >98%, SMILES O=C([C@]1(CO1)C)[C@@H](CC(C)C)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: 7-(But-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, CAS: 2074688-84-7, stock 529.9g, assay 98.6%, MWt 433.46, Formula C22H23N7O3, Purity >98%, SMILES O=C(N1CC2=NC(C)=C3C=CC=CC3=N2)N(C)C4=C(N(CC#CC)C(NCCO)=N4)C1=O, MDL NA |
| Drug_Names: (R,E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, CAS: 1446263-39-3, stock 8.2g, assay 98.5%, MWt 553.45, Formula C25H29BrN8O2, Purity >98%, SMILES O=C(N1CC2=NC(C)=C3C=CC=CC3=N2)N(C)C4=C(N(C/C=C(Br)\C)C(N5C[C@H](N)CCC5)=N4)C1=O, MDL NA |
| Drug_Names: (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid, CAS: 2074688-81-4, stock 378.5g, assay 98.3%, MWt 620.66, Formula C33H32N8O5, Purity >98%, SMILES O=C(N1CC2=NC(C)=C3C=CC=CC3=N2)N(C)C4=C(N(CC#CC)C(N5CCC[C@@H](NC(C6=C(C(O)=O)C=CC=C6)=O)C5)=N4)C1=O, MDL NA |
| Drug_Names: (4-methylquinazolin-2-yl)methanol, CAS: 13535-91-6, stock 417.6g, assay 98.2%, MWt 174.20, Formula C10H10N2O, Purity >98%, SMILES OCC1=NC(C)=C2C=CC=CC2=N1, MDL NA |
| Drug_Names: 2-Fluoroaniline, CAS: 348-54-9, stock 628.8g, assay 98.1%, MWt 111.12, Formula C6H6FN, Purity >98%, SMILES NC1=CC=CC=C1F, MDL NA |
| Drug_Names: (S)-4-Amino-2,6-dimethylhept-1-en-3-one 2,2,2-trifluoroacetate, CAS: 1619233-32-7, stock 493.9g, assay 98.6%, MWt 269.26, Formula C11H18F3NO3, Purity >98%, SMILES FC(F)(C(O)=O)F.N[C@H](C(C(C)=C)=O)CC(C)C, MDL NA |
| Drug_Names: tert-Butyl (R)-(1-(methoxy(methyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate, CAS: 129603-01-6, stock 513.8g, assay 98.2%, MWt 274.36, Formula C13H26N2O4, Purity >98%, SMILES O=C(N(C)OC)[C@@H](CC(C)C)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (R)-1-(naphthalen-1-yl)-N-(3-(trifluoromethyl)benzyl)ethanamine hydrochloride, CAS: 1229225-42-6, stock 851.1g, assay 98.6%, MWt 365.82, Formula C20H19ClF3N, Purity >98%, SMILES C[C@@]([H])(NCC1=CC=CC(C(F)(F)F)=C1)C2=CC=CC3=C2C=CC=C3.Cl, MDL NA |
| Drug_Names: (Z)-3-(3-Chloro-2-fluorophenyl)-2-(4-chloro-2-fluorophenyl)-2-propenenitrile, CAS: 1219086-87-9, stock 846.6g, assay 98.1%, MWt 310.13, Formula C15H7Cl2F2N, Purity >98%, SMILES FC1=CC(Cl)=CC=C1/C(C#N)=C/C2=C(F)C(Cl)=CC=C2, MDL NA |
| Drug_Names: rel-(2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carboxylic acid tert-butyl ester, CAS: 1219086-88-0, stock 883.9g, assay 98.5%, MWt 523.44, Formula C27H30Cl2F2N2O2, Purity >98%, SMILES O=C([C@@H]1N[C@@H](CC(C)(C)C)[C@@](C2=CC=C(Cl)C=C2F)(C#N)[C@H]1C3=CC=CC(Cl)=C3F)OC(C)(C)C, MDL NA |
| Drug_Names: (2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxylic acid, CAS: 1219089-31-2, stock 10.7g, assay 98.9%, MWt 467.34, Formula C23H22Cl2F2N2O2, Purity >98%, SMILES OC([C@@H]1N[C@@H](CC(C)(C)C)[C@@](C2=CC=C(Cl)C=C2F)(C#N)[C@H]1C3=CC=CC(Cl)=C3F)=O, MDL NA |
| Drug_Names: (2S,3R,4S,5R)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxylic acid, CAS: 1219089-32-3, stock 576.8g, assay 98.2%, MWt 467.34, Formula C23H22Cl2F2N2O2, Purity >98%, SMILES OC([C@H]1N[C@H](CC(C)(C)C)[C@](C2=CC=C(Cl)C=C2F)(C#N)[C@@H]1C3=CC=CC(Cl)=C3F)=O, MDL NA |
| Drug_Names: 4-Methoxy-3-nitrobenzylthioacetic acid, CAS: 22216-44-0, stock 149.2g, assay 98.8%, MWt 257.26, Formula C10H11NO5S, Purity >98%, SMILES COC1=CC=C(CSCC(O)=O)C=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 2-(4-Methoxy-3-nitrobenzylsulfonyl)acetic acid, CAS: 592542-51-3, stock 750.6g, assay 99%, MWt 289.26, Formula C10H11NO7S, Purity >98%, SMILES COC1=CC=C(CS(CC(O)=O)(=O)=O)C=C1[N+]([O-])=O, MDL NA |
| Drug_Names: (E)-2,4,6-Trimethoxystyryl 4-Methoxy-3-Nitrobenzyl sulfone, CAS: 592542-52-4, stock 747.3g, assay 98.2%, MWt 423.44, Formula C19H21NO8S, Purity >98%, SMILES O=S(CC1=CC=C(OC)C([N+]([O-])=O)=C1)(/C=C/C2=C(OC)C=C(OC)C=C2OC)=O, MDL NA |
| Drug_Names: (E)-2,4,6-Trimethoxystyryl 3-(carbomethoxymethylamino)-4-methoxybenzyl sulfone, CAS: 592542-61-5, stock 365.7g, assay 98.7%, MWt 465.52, Formula C22H27NO8S, Purity >98%, SMILES O=C(OC)CNC1=CC(CS(=O)(/C=C/C2=C(OC)C=C(OC)C=C2OC)=O)=CC=C1OC, MDL NA |
| Drug_Names: 4-Acetoxyaniline, CAS: 13871-68-6, stock 887.7g, assay 98.7%, MWt 151.16, Formula C8H9NO2, Purity >98%, SMILES NC1=CC=C(OC(C)=O)C=C1, MDL NA |
| Drug_Names: [(1R)-1-(naphthalen-1-yl)ethyl]bis({3-[3-(trifluoromethyl)phenyl]propyl})amine, CAS: 1271930-15-4, stock 532.6g, assay 98.9%, MWt 543.59, Formula C32H31F6N, Purity >98%, SMILES FC(F)(F)C1=CC=CC(CCCN(CCCC2=CC(C(F)(F)F)=CC=C2)[C@@H](C3=C(C=CC=C4)C4=CC=C3)C)=C1, MDL NA |
| Drug_Names: (R)-N-[1-(5,6,7,8-Tetrahydronaphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-propylamine, CAS: 1229224-93-4, stock 857.5g, assay 98.6%, MWt 361.44, Formula C22H26F3N, Purity >98%, SMILES FC(F)(F)C1=CC=CC(CCCN[C@@H](C2=C(CCCC3)C3=CC=C2)C)=C1, MDL MFCD28167920 |
| Drug_Names: 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid, CAS: 503614-92-4, stock 36.8g, assay 98.6%, MWt 460.48, Formula C25H24N4O5, Purity >98%, SMILES O=C(C1=NN(C2=CC=C(OC)C=C2)C3=C1CCN(C4=CC=C(N5C(CCCC5)=O)C=C4)C3=O)O, MDL NA |
| Drug_Names: Methyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate, CAS: 1074365-84-6, stock 890.5g, assay 98.8%, MWt 474.51, Formula C26H26N4O5, Purity >98%, SMILES O=C(C1=NN(C2=CC=C(OC)C=C2)C3=C1CCN(C4=CC=C(N5C(CCCC5)=O)C=C4)C3=O)OC, MDL NA |
| Drug_Names: 1-(4-Chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide, CAS: 2029205-64-7, stock 277.8g, assay 98.7%, MWt 463.92, Formula C24H22ClN5O3, Purity >98%, SMILES O=C1C2=C(C(C(N)=O)=NN2C3=CC=C(Cl)C=C3)CCN1C4=CC=C(N(CCCC5)C5=O)C=C4, MDL NA |
| Drug_Names: 6-(4-((5-Amino-5-oxopentyl)amino)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide, CAS: 2187409-01-2, stock 773.2g, assay 98.3%, MWt 476.53, Formula C25H28N6O4, Purity >98%, SMILES O=C1C2=C(C(C(N)=O)=NN2C3=CC=C(OC)C=C3)CCN1C4=CC=C(NCCCCC(N)=O)C=C4, MDL NA |
| Drug_Names: 1-(4-Methoxyphenyl)-6-(4-(2-methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide, CAS: 2098457-92-0, stock 717.5g, assay 98.9%, MWt 473.52, Formula C26H27N5O4, Purity >98%, SMILES O=C1C2=C(C(C(N)=O)=NN2C3=CC=C(OC)C=C3)CCN1C4=CC=C(N(C(C)CCC5)C5=O)C=C4, MDL NA |
| Drug_Names: (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol, CAS: 842133-16-8, stock 170g, assay 98.1%, MWt 426.53, Formula C24H26O5S, Purity >98%, SMILES CC1=C(CC2=CC=C(C3=CC=CC=C3)S2)C=C([C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)C=C1, MDL NA |
| Drug_Names: 4-Chloro-1-(triisopropylsilyl)-7-azaindole, CAS: 651744-48-8, stock 168.4g, assay 98.8%, MWt 308.92, Formula C16H25ClN2Si, Purity >98%, SMILES ClC1=C2C(N(C=C2)[Si](C(C)C)(C(C)C)C(C)C)=NC=C1, MDL MFCD09763673 |
| Drug_Names: N-(3-Fluorophenyl)piperidin-4-amine hydrochloride, CAS: 923565-91-7, stock 177.7g, assay 98.7%, MWt 230.71, Formula C11H16ClFN2, Purity >98%, SMILES FC1=CC(NC2CCNCC2)=CC=C1.Cl, MDL MFCD09749865 |
| Drug_Names: (S)-tert-Butyl 3-(bromomethyl)piperidine-1-carboxylate, CAS: 158406-99-6, stock 176g, assay 98.8%, MWt 278.19, Formula C11H20BrNO2, Purity >98%, SMILES BrC[C@H]1CCCN(C(OC(C)(C)C)=O)C1, MDL MFCD11111933 |
| Drug_Names: (3S,5S,6S,8R,9S,1R,13S,14S,17S)-1,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,6,17-triol, CAS: 49644-04-4, stock 893.1g, assay 98.2%, MWt 308.46, Formula C19H32O3, Purity >98%, SMILES O[C@H]1CC[C@]2(C)[C@@]3([H])CC[C@]4(C)[C@@H](O)CC[C@@]4([H])[C@]3([H])C[C@H](O)[C@@]2([H])C1, MDL NA |
| Drug_Names: 2-(Aminooxy)ethanamine dihydrochloride, CAS: 37866-45-8, stock 474.9g, assay 98.7%, MWt 149.02, Formula C2H10Cl2N2O, Purity >98%, SMILES NOCCN.Cl.Cl, MDL MFCD04117898 |
| Drug_Names: (S)-tert-butyl 4-(4-(2-methoxy-2-oxoethyl)benzyl)-2-methylpiperazine-1-carboxylate, CAS: 923565-72-4, stock 315.2g, assay 98.9%, MWt 362.46, Formula C20H30N2O4, Purity >98%, SMILES C[C@H]1CN(CC2=CC=C(CC(OC)=O)C=C2)CCN1C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (S)-tert-butyl 4-(4-(2-(4-((3-fluorophenyl)amino)piperidin-1-yl)-2-oxoethyl)benzyl)-2-methylpiperazine-1-carboxylate, CAS: 923565-74-6, stock 224.1g, assay 98.1%, MWt 524.67, Formula C30H41FN4O3, Purity >98%, SMILES C[C@H]1CN(CC2=CC=C(CC(N3CCC(NC4=CC=CC(F)=C4)CC3)=O)C=C2)CCN1C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: 1-(4-Amino-3-ethoxyphenyl)piperidin-4-ol (hydrochloride), CAS: 2070014-79-6, stock 817.8g, assay 98.2%, MWt 272.77, Formula C13H21ClN2O2, Purity >98%, SMILES NC1=CC=C(C=C1OCC)N2CCC(O)CC2.Cl, MDL NA |
| Drug_Names: 4-Chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid, CAS: 920966-03-6, stock 511.9g, assay 98.5%, MWt 196.59, Formula C8H5ClN2O2, Purity >98%, SMILES O=C(O)C1=CN=C2NC=CC2=C1Cl, MDL MFCD10574983 |
| Drug_Names: Methyl 4-chloro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate, CAS: 685513-97-7, stock 224.1g, assay 98.1%, MWt 366.96, Formula C18H27ClN2O2Si, Purity >98%, SMILES O=C(OC)C1=CN=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1Cl, MDL MFCD11616411 |
| Drug_Names: 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxy-methylphenyl isobutyrate mandelate, CAS: 1206695-46-6, stock 252.6g, assay 98.7%, MWt 563.72, Formula C34H45NO6, Purity >98%, SMILES O[C@H](C(O)=O)C1=CC=CC=C1.O=C(C(C)C)OC2=CC=C(CO)C=C2[C@@H](C3=CC=CC=C3)CCN(C(C)C)C(C)C, MDL NA |
| Drug_Names: 4-Chlorophenacylcyanide, CAS: 4640-66-8, stock 2.7g, assay 98.8%, MWt 179.60, Formula C9H6ClNO, Purity >98%, SMILES ClC1=CC=C(C(CC#N)=O)C=C1, MDL MFCD00051625 |
| Drug_Names: (2-Amino-4,5-dimethylthiophen-3-yl)(4-chlorophenyl)methanone, CAS: 50508-66-2, stock 353.8g, assay 98.8%, MWt 265.76, Formula C13H12ClNOS, Purity >98%, SMILES ClC1=CC=C(C(C2=C(N)SC(C)=C2C)=O)C=C1, MDL NA |
| Drug_Names: 4-Chloro-N-methyl-2-pyridinecarboxamide, CAS: 220000-87-3, stock 297.7g, assay 98.7%, MWt 170.60, Formula C7H7ClN2O, Purity >98%, SMILES ClC1=CC(C(NC)=O)=NC=C1, MDL MFCD02185921 |
| Drug_Names: 4-Chloro-N-methylpicolinamide hydrochloride, CAS: 882167-77-3, stock 333.9g, assay 98.1%, MWt 207.06, Formula C7H8Cl2N2O, Purity >98%, SMILES ClC1=CC(C(NC)=O)=NC=C1.Cl, MDL MFCD13368182 |
| Drug_Names: 2-Cyano-N-[4-(trifluoromethyl)phenyl]acetamide, CAS: 24522-30-3, stock 17.5g, assay 98.3%, MWt 228.17, Formula C10H7F3N2O, Purity >98%, SMILES O=C(NC1=CC=C(C(F)(F)F)C=C1)CC#N, MDL MFCD05669245 |
| Drug_Names: (5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid, CAS: 863971-44-2, stock 134.9g, assay 98.7%, MWt 637.81, Formula C36H51N3O7, Purity >98%, SMILES O=C(N([C@H](C(N[C@H](C(N(C)[C@@]([C@H](OC)CC(O)=O)([H])[C@@H](C)CC)=O)C(C)C)=O)C(C)C)C)OCC(C1=CC=CC=C12)C3=C2C=CC=C3, MDL NA |
| Drug_Names: (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate, CAS: 474645-26-6, stock 115.6g, assay 98.6%, MWt 940.22, Formula C54H77N5O9, Purity >98%, SMILES CC[C@H](C)[C@@H]([C@@H](CC(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C)[C@@H](O)C2=CC=CC=C2)=O)OC)=O)OC)N(C([C@H](C(C)C)NC([C@H](C(C)C)N(C(OCC3C4=C(C=CC=C4)C5=C3C=CC=C5)=O)C)=O)=O)C, MDL NA |
| Drug_Names: 4-(3-(4-benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl)phenol, CAS: 375856-62-5, stock 186.5g, assay 98.7%, MWt 339.47, Formula C22H29NO2, Purity >98%, SMILES OC1=CC=C(C(O)C(C)CN2CCC(CC3=CC=CC=C3)CC2)C=C1, MDL NA |
| Drug_Names: tert-Butyl 4-chloro-1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylate, CAS: 1951439-87-4, stock 108.7g, assay 98.8%, MWt 409.04, Formula C21H33ClN2O2Si, Purity >98%, SMILES ClC1=C2C(N([Si](C(C)C)(C(C)C)C(C)C)C=C2)=NC=C1C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: Lithium 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carboxylate, CAS: 2070015-37-9, stock 427g, assay 99%, MWt 202.52, Formula C8H4ClLiN2O2, Purity >98%, SMILES [O-]C(C1=CN=C(NC=C2)C2=C1Cl)=O.[Li+], MDL NA |
| Drug_Names: 2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine, CAS: 934524-10-4, stock 596.8g, assay 98.1%, MWt 342.20, Formula C13H9Cl2N3O2S, Purity >98%, SMILES O=S(N1C=CC2=C(Cl)N=C(Cl)N=C21)(C3=CC=C(C)C=C3)=O, MDL MFCD13193624 |
| Drug_Names: (4-(2-(Azepan-1-yl)ethoxy)phenyl)methanol hydrochloride, CAS: 328933-65-9, stock 343.2g, assay 98.7%, MWt 285.81, Formula C15H24ClNO2, Purity >98%, SMILES OCC(C=C1)=CC=C1OCCN2CCCCCC2.Cl, MDL NA |
| Drug_Names: 2,5-Bis(4-fluorophenyl)thiophene, CAS: 883793-48-4, stock 855.9g, assay 98.8%, MWt 272.31, Formula C16H10F2S, Purity >98%, SMILES FC(C=C1)=CC=C1C2=CC=C(C3=CC=C(F)C=C3)S2, MDL NA |
| Drug_Names: 1-(4-Methoxyphenyl)-6-(4-(5-methyl-2-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide, CAS: 1686149-74-5, stock 467.7g, assay 98.9%, MWt 473.52, Formula C26H27N5O4, Purity >98%, SMILES O=C1C2=C(C(C(N)=O)=NN2C3=CC=C(OC)C=C3)CCN1C4=CC=C(N(CC(C)CC5)C5=O)C=C4, MDL NA |
| Drug_Names: (R)-2-(Piperidin-3-yl)isoindoline-1,3-dione (2S,3S)-2,3-dihydroxysuccinate, CAS: 886588-62-1, stock 888.3g, assay 99%, MWt 380.35, Formula C17H20N2O8, Purity >98%, SMILES O[C@H](C(O)=O)[C@@H](C(O)=O)O.O=C1C2=C(C=CC=C2)C(N1[C@H]3CNCCC3)=O, MDL NA |
| Drug_Names: 1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, CAS: 1496551-72-4, stock 209.6g, assay 98.3%, MWt 276.67, Formula C10H13ClN2O5, Purity >98%, SMILES O=C(N1)N([C@H]2[C@]([C@@H]([C@@H](CO)O2)O)(C)Cl)C=CC1=O, MDL NA |
| Drug_Names: 4,4'-Difluoro-1,1'-biphenyl, CAS: 398-23-2, stock 307.3g, assay 98.3%, MWt 190.19, Formula C12H8F2, Purity >98%, SMILES FC(C=C1)=CC=C1C2=CC=C(F)C=C2, MDL MFCD00000349 |
| Drug_Names: 2-(5-Bromo-2-methylbenzyl)thiophene, CAS: 1823462-28-7, stock 787.8g, assay 98.5%, MWt 267.18, Formula C12H11BrS, Purity >98%, SMILES CC1=C(CC2=CC=CS2)C=C(Br)C=C1, MDL NA |
| Drug_Names: (5-Iodo-2-methylphenyl)(thiophen-2-yl)methanone, CAS: 1823966-94-4, stock 756.1g, assay 98.6%, MWt 328.17, Formula C12H9IOS, Purity >98%, SMILES CC1=C(C(C2=CC=CS2)=O)C=C(I)C=C1, MDL NA |
| Drug_Names: 2-(5-Iodo-2-methylbenzyl)thiophene, CAS: 1823416-37-0, stock 132g, assay 98.9%, MWt 314.19, Formula C12H11IS, Purity >98%, SMILES CC1=C(CC2=CC=CS2)C=C(I)C=C1, MDL NA |
| Drug_Names: ((2S,3S,4S)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate, CAS: 1946820-91-2, stock 357.9g, assay 98.5%, MWt 372.34, Formula C20H17FO6, Purity >98%, SMILES O=C1[C@@](C)(F)[C@@H](OC(C2=CC=CC=C2)=O)[C@H](COC(C3=CC=CC=C3)=O)O1, MDL NA |
| Drug_Names: ((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate, CAS: 1496551-65-5, stock 612.3g, assay 98.7%, MWt 388.80, Formula C20H17ClO6, Purity >98%, SMILES O=C(O[C@@H]1COC(C2=CC=CC=C2)=O)[C@@](Cl)(C)[C@@H]1OC(C3=CC=CC=C3)=O, MDL NA |
| Drug_Names: 1-((2S,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, CAS: 2041584-99-8, stock 832g, assay 98.2%, MWt 260.22, Formula C10H13FN2O5, Purity >98%, SMILES O=C(N1)N([C@@H]2[C@]([C@@H]([C@@H](CO)O2)O)(C)F)C=CC1=O, MDL NA |
| Drug_Names: 1-((2S,3S,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, CAS: 1946820-96-7, stock 268.8g, assay 98.2%, MWt 260.22, Formula C10H13FN2O5, Purity >98%, SMILES O[C@@H]1[C@](C)(F)[C@@H](N(C(N2)=O)C=CC2=O)O[C@H]1CO, MDL NA |
| Drug_Names: (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine salt, CAS: 608141-43-1, stock 683.2g, assay 98.3%, MWt 446.56, Formula C20H34N2O7S, Purity >98%, SMILES [NH3+][C@@H](C1=CC=C(OC)C(OCC)=C1)CS(=O)(C)=O.CC(C)C[C@@H](C([O-])=O)NC(C)=O, MDL MFCD28167941 |
| Drug_Names: 3-Aminophthalic acid, CAS: 5434-20-8, stock 345.9g, assay 98.3%, MWt 181.15, Formula C8H7NO4, Purity >98%, SMILES OC(C1=CC=CC(N)=C1C(O)=O)=O, MDL MFCD00075053 |
| Drug_Names: 3-Acetamidophthalic anhydride, CAS: 6296-53-3, stock 875.1g, assay 98.4%, MWt 205.17, Formula C10H7NO4, Purity >98%, SMILES O=C(C)NC1=C(C(OC2=O)=O)C2=CC=C1, MDL MFCD00453138 |
| Drug_Names: 4-(3-Fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-N-methylpicolinamide, CAS: 1855006-12-0, stock 343.9g, assay 99%, MWt 395.39, Formula C20H18FN5O3, Purity >98%, SMILES FC1=CC(OC2=CC=NC(C(NC)=O)=C2)=CC=C1NC3=CC=NC(C(NC)=O)=C3, MDL NA |
| Drug_Names: 4-(3-Fluoro-4-(3-(3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide, CAS: 2188236-16-8, stock 91.6g, assay 98.6%, MWt 448.37, Formula C21H16F4N4O3, Purity >98%, SMILES FC1=CC(OC2=CC=NC(C(NC)=O)=C2)=CC=C1NC(NC3=CC(C(F)(F)F)=CC=C3)=O, MDL NA |
| Drug_Names: 4-(4-Acetamido-3-fluorophenoxy)-N-methylpicolinamide, CAS: 2141961-84-2, stock 714.5g, assay 98.6%, MWt 303.29, Formula C15H14FN3O3, Purity >98%, SMILES FC1=CC(OC2=CC=NC(C(NC)=O)=C2)=CC=C1NC(C)=O, MDL NA |
| Drug_Names: 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea, CAS: 1333390-56-9, stock 485.9g, assay 98%, MWt 348.68, Formula C14H9ClF4N2O2, Purity >98%, SMILES FC1=CC(O)=CC=C1NC(NC2=CC(C(F)(F)F)=C(Cl)C=C2)=O, MDL NA |
| Drug_Names: (2R,3R,4R,5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, CAS: 874638-94-5, stock 503.1g, assay 98.1%, MWt 571.55, Formula C31H26FN3O7, Purity >98%, SMILES F[C@@]([C@@H]1OC(C2=CC=CC=C2)=O)(C)[C@@H](N3C=CC(NC(C4=CC=CC=C4)=O)=NC3=O)O[C@@H]1COC(C5=CC=CC=C5)=O, MDL NA |
| Drug_Names: (2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-chloro-4-methyltetrahydrofuran-3-yl benzoate, CAS: 1496551-70-2, stock 473.6g, assay 98.3%, MWt 588.01, Formula C31H26ClN3O7, Purity >98%, SMILES Cl[C@@]([C@@H]1OC(C2=CC=CC=C2)=O)(C)[C@H](N3C=CC(NC(C4=CC=CC=C4)=O)=NC3=O)O[C@@H]1COC(C5=CC=CC=C5)=O, MDL NA |
| Drug_Names: ((2R,3R,4S,5R)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-4-methyltetrahydrofuran-2-yl)methyl benzoate, CAS: 1910099-11-4, stock 463.3g, assay 98.5%, MWt 466.44, Formula C24H22N2O8, Purity >98%, SMILES O=C(OC[C@H]1O[C@@H](N(C(N2)=O)C=CC2=O)[C@](O)(C)[C@@H]1OC(C3=CC=CC=C3)=O)C4=CC=CC=C4, MDL NA |
| Drug_Names: ((2S,3S,4S,5S)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate, CAS: 1946820-95-6, stock 768.3g, assay 98.1%, MWt 468.43, Formula C24H21FN2O7, Purity >98%, SMILES C[C@@]1(F)[C@@H](N(C(N2)=O)C=CC2=O)O[C@@H](COC(C3=CC=CC=C3)=O)[C@@H]1OC(C4=CC=CC=C4)=O, MDL NA |
| Drug_Names: ((2R,3R,4R,5R)-3-(benzoyloxy)-4-chloro-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methyltetrahydrofuran-2-yl)methyl benzoate, CAS: 1496551-71-3, stock 152.6g, assay 98%, MWt 484.89, Formula C24H21ClN2O7, Purity >98%, SMILES Cl[C@@]([C@@H]1OC(C2=CC=CC=C2)=O)(C)[C@H](N(C(N3)=O)C=CC3=O)O[C@@H]1COC(C4=CC=CC=C4)=O, MDL NA |
| Drug_Names: 1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, CAS: 114262-49-6, stock 784.7g, assay 98.1%, MWt 258.23, Formula C10H14N2O6, Purity >98%, SMILES O[C@H]1[C@@](O)(C)[C@H](N(C(N2)=O)C=CC2=O)O[C@@H]1CO, MDL NA |
| Drug_Names: 2,6-Difluoro-3-(propylsulfonamido)benzoic acid, CAS: 1103234-56-5, stock 455.4g, assay 98.2%, MWt 279.26, Formula C10H11F2NO4S, Purity >98%, SMILES FC1=C(NS(CCC)(=O)=O)C=CC(F)=C1C(O)=O, MDL MFCD18157658 |
| Drug_Names: 3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylic acid, CAS: 104239-97-6, stock 790.8g, assay 98.8%, MWt 317.42, Formula C19H27NO3, Purity >98%, SMILES O=C1C=C[C@@]2(C)[C@](CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@H]4C(O)=O)([H])N1, MDL NA |
| Drug_Names: 2,5-Dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine, CAS: 761440-16-8, stock 520.8g, assay 98.5%, MWt 346.23, Formula C13H13Cl2N3O2S, Purity >98%, SMILES O=S(C1=CC=CC=C1NC2=NC(Cl)=NC=C2Cl)(C(C)C)=O, MDL MFCD12827956 |
| Drug_Names: tert-Butyl (4-(trifluoromethyl)phenyl)carbamate, CAS: 141940-37-6, stock 18.9g, assay 98%, MWt 261.24, Formula C12H14F3NO2, Purity >98%, SMILES CC(C)(C)OC(NC1=CC=C(C(F)(F)F)C=C1)=O, MDL NA |
| Drug_Names: 2-Fluoro-6-(methylamino)benzonitrile, CAS: 96783-85-6, stock 140.2g, assay 99%, MWt 150.15, Formula C8H7FN2, Purity >98%, SMILES FC1=C(C#N)C(NC)=CC=C1, MDL MFCD12193344 |
| Drug_Names: 2-Methylamino-6-methoxybenzoic acid, CAS: 254964-68-6, stock 497.6g, assay 98.3%, MWt 181.19, Formula C9H11NO3, Purity >98%, SMILES OC(C1=C(OC)C=CC=C1NC)=O, MDL MFCD20268109 |
| Drug_Names: 4-Hydroxy-5-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid, CAS: 248282-18-0, stock 328.7g, assay 98.8%, MWt 249.22, Formula C12H11NO5, Purity >98%, SMILES O=C(C1=C(O)C2=C(N(C)C1=O)C=CC=C2OC)O, MDL NA |
| Drug_Names: 4-Hydroxy-5-methoxy-1-methylquinolin-2(1H)-one, CAS: 137441-18-0, stock 574.5g, assay 98.1%, MWt 205.21, Formula C11H11NO3, Purity >98%, SMILES O=C1N(C)C2=CC=CC(OC)=C2C(O)=C1, MDL NA |
| Drug_Names: Methyl cyclopentylphenylglycolate, CAS: 19833-96-6, stock 35.4g, assay 98.5%, MWt 234.29, Formula C14H18O3, Purity >98%, SMILES OC(C(OC)=O)(C1=CC=CC=C1)C2CCCC2, MDL MFCD00019295 |
| Drug_Names: 1-Methyl-3-pyrrolidinol, CAS: 13220-33-2, stock 766.5g, assay 98.9%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES OC1CN(C)CC1, MDL MFCD00003176 |
| Drug_Names: 6-Chloro-3-[(3-chloro-2-fluorophenyl)methylene]-1,3-dihydro-2H-indol-2-one, CAS: 897365-76-3, stock 225.2g, assay 98.1%, MWt 308.13, Formula C15H8Cl2FNO, Purity >98%, SMILES ClC1=CC=C(/C(C(N2)=O)=C\C3=C(F)C(Cl)=CC=C3)C2=C1, MDL NA |
| Drug_Names: (2'R,3S,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-1'-[(1R,2S)-2-hydroxy-1,2-diphenylethyl]-2-oxospiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide, CAS: 1303609-36-0, stock 435.3g, assay 98.6%, MWt 758.75, Formula C43H46Cl2FN3O4, Purity >98%, SMILES CC(C)(C)C[C@@H]1[C@@]2(C3=CC=C(Cl)C=C3NC2=O)[C@@H](C4=CC=CC(Cl)=C4F)[C@H](C(N[C@H]5CC[C@H](O)CC5)=O)N1[C@H](C6=CC=CC=C6)[C@H](C7=CC=CC=C7)O, MDL NA |
| Drug_Names: 5-(((5-Chloro-2-methylpyridin-3-yl)amino)methyl)thiophene-2-carboxylic acid, CAS: 1404456-63-8, stock 372.7g, assay 98.3%, MWt 282.75, Formula C12H11ClN2O2S, Purity >98%, SMILES O=C(C1=CC=C(CNC2=CC(Cl)=CN=C2C)S1)O, MDL NA |
| Drug_Names: 3-Amino-5-chloro-2-methylpyridine, CAS: 89639-36-1, stock 715.9g, assay 98.2%, MWt 142.59, Formula C6H7ClN2, Purity >98%, SMILES NC1=CC(Cl)=CN=C1C, MDL NA |
| Drug_Names: N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine, CAS: 1421372-94-2, stock 875.3g, assay 98.7%, MWt 393.37, Formula C20H16FN5O3, Purity >98%, SMILES CN1C=C(C2=NC(NC3=CC([N+]([O-])=O)=C(F)C=C3OC)=NC=C2)C4=C1C=CC=C4, MDL MFCD28167946 |
| Drug_Names: N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1,4-diamine, CAS: 1421372-67-9, stock 856.6g, assay 98.4%, MWt 475.54, Formula C25H29N7O3, Purity >98%, SMILES O=[N+](C1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)[O-], MDL NA |
| Drug_Names: N-benzyl-2-(2-phenyl-1H-benzo[d]imidazol-1-yl)-2-(piperidin-4-yl)acetamide, CAS: 1440753-53-6, stock 30.7g, assay 98.4%, MWt 424.54, Formula C27H28N4O, Purity >98%, SMILES O=C(NCC1=CC=CC=C1)C(N2C(C3=CC=CC=C3)=NC4=CC=CC=C24)C5CCNCC5, MDL NA |
| Drug_Names: tert-Butyl 4-(2-(benzyl(tert-butoxycarbonyl)amino)-2-oxo-1-(2-phenyl-1H-benzo[d]imidazol-1-yl)ethyl)piperidine-1-carboxylate, CAS: 1440753-63-8, stock 799g, assay 98.3%, MWt 624.77, Formula C37H44N4O5, Purity >98%, SMILES O=C(N(C(OC(C)(C)C)=O)CC1=CC=CC=C1)C(N2C(C3=CC=CC=C3)=NC4=CC=CC=C24)C5CCN(C(OC(C)(C)C)=O)CC5, MDL NA |
| Drug_Names: tert-Butyl 4-(2-hydroxy-1-(2-phenyl-1H-benzo[d]imidazol-1-yl)ethyl)piperidine-1-carboxylate, CAS: 1440753-74-1, stock 759.8g, assay 98.5%, MWt 421.53, Formula C25H31N3O3, Purity >98%, SMILES OCC(N1C(C2=CC=CC=C2)=NC3=CC=CC=C13)C4CCN(C(OC(C)(C)C)=O)CC4, MDL NA |
| Drug_Names: tert-Butyl 4-(2-(4-(1-benzyl-1H-benzo[d]imidazol-2-yl)phenoxy)-1-(2-phenyl-1H-benzo[d]imidazol-1-yl)ethyl)piperidine-1-carboxylate, CAS: 1440754-07-3, stock 468.5g, assay 98.6%, MWt 703.87, Formula C45H45N5O3, Purity >98%, SMILES CC(C)(C)OC(N1CCC(C(N2C(C3=CC=CC=C3)=NC4=CC=CC=C24)COC5=CC=C(C6=NC7=CC=CC=C7N6CC8=CC=CC=C8)C=C5)CC1)=O, MDL NA |
| Drug_Names: Benzyl isocyanide, CAS: 10340-91-7, stock 789.1g, assay 98.5%, MWt 117.15, Formula C8H7N, Purity >98%, SMILES [C-]#[N+]CC1=CC=CC=C1, MDL NA |
| Drug_Names: N-Benzyl-2-nitroaniline, CAS: 5729-06-6, stock 79g, assay 98.3%, MWt 228.25, Formula C13H12N2O2, Purity >98%, SMILES O=[N+]([O-])C1=CC=CC=C1NCC2=CC=CC=C2, MDL NA |
| Drug_Names: 2-(Benzylamino)aniline, CAS: 5822-13-9, stock 348g, assay 98.4%, MWt 198.26, Formula C13H14N2, Purity >98%, SMILES NC1=CC=CC=C1NCC2=CC=CC=C2, MDL NA |
| Drug_Names: 4-(1-Benzyl-1H-1,3-benzodiazol-2-yl)phenol, CAS: 10206-01-6, stock 147.9g, assay 98.2%, MWt 300.35, Formula C20H16N2O, Purity >98%, SMILES OC1=CC=C(C2=NC3=CC=CC=C3N2CC4=CC=CC=C4)C=C1, MDL NA |
| Drug_Names: 1-Benzyl-2-(4-(2-(2-phenyl-1H-benzo[d]imidazol-1-yl)-2-(piperidin-4-yl)ethoxy)phenyl)-1H-benzo[d]imidazole, CAS: 1440754-12-0, stock 37g, assay 98.7%, MWt 603.75, Formula C40H37N5O, Purity >98%, SMILES C1(C2=CC=C(OCC(N3C(C4=CC=CC=C4)=NC5=CC=CC=C35)C6CCNCC6)C=C2)=NC7=CC=CC=C7N1CC8=CC=CC=C8, MDL NA |
| Drug_Names: 2-(4-Iodobutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 1236275-93-6, stock 490.6g, assay 98.9%, MWt 309.98, Formula C10H20BIO2, Purity >98%, SMILES CC1(C)C(C)(C)OB(CCCCI)O1, MDL NA |
| Drug_Names: rel-Methyl (3S,4S)-1-benzyl-4-methylpyrrolidine-3-carboxylate, CAS: 473914-76-0, stock 190.1g, assay 98.6%, MWt 233.31, Formula C14H19NO2, Purity >98%, SMILES C[C@@H]([C@H](C(OC)=O)C1)CN1CC2=CC=CC=C2, MDL MFCD13190627 |
| Drug_Names: Dimethyl 5-(((methylsulfonyl)oxy)methyl)isophthalate, CAS: 1823431-36-2, stock 458.1g, assay 98.7%, MWt 302.30, Formula C12H14O7S, Purity >98%, SMILES O=C(OC)C1=CC(COS(C)(=O)=O)=CC(C(OC)=O)=C1, MDL NA |
| Drug_Names: 4-Methoxyphenyl (1S,2S)-2-((R)-4-((9H-xanthen-9-yl)methyl)-1-(4-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)cyclopropane-1-carboxylate, CAS: 201851-12-9, stock 889.2g, assay 98.1%, MWt 668.78, Formula C36H32N2O7S2, Purity >98%, SMILES O=C(N(CC1=CC=C(OC)C=C1)C2=O)[C@](N2)([C@]3([H])[C@H](C(OC4=CC=C(OC)C=C4)=O)C3)CC5C6=C(C=CC=C6)OC7=CC=CC=C57, MDL NA |
| Drug_Names: Methyl xanthanoate, CAS: 39497-06-8, stock 608.8g, assay 98.7%, MWt 240.25, Formula C15H12O3, Purity >98%, SMILES O=C(OC)C1C2=CC=CC=C2OC3=C1C=CC=C3, MDL MFCD00100676 |
| Drug_Names: (Sulfamoylamino)methylbenzene, CAS: 14101-58-7, stock 213.6g, assay 98.3%, MWt 186.23, Formula C7H10N2O2S, Purity >98%, SMILES O=S(N)(NCC1=CC=CC=C1)=O, MDL NA |
| Drug_Names: (S)-tert-Butyl (1-amino-3-(4-bromophenyl)-1-oxopropan-2-yl)carbamate, CAS: 854760-84-2, stock 317.9g, assay 98.3%, MWt 330.22, Formula C14H20BrNO3, Purity >98%, SMILES BrC1=CC=C(C=C1)C[C@H](NC(OC(C)(C)C)=O)CO, MDL NA |
| Drug_Names: 4-(Morpholinomethyl)phenylboronic acid,, CAS: 1335234-36-0, stock 402.9g, assay 98.1%, MWt 257.52, Formula C11H17BClNO3, Purity >98%, SMILES OB(O)C1=CC=C(CN2CCOCC2)C=C1.Cl, MDL MFCD16661158 |
| Drug_Names: (2R,3R)-N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)-3-methoxy-2-methyl-3-((S)-pyrrolidin-2-yl)propanamide (hydrochloride), CAS: 2019182-02-4, stock 311.7g, assay 98.5%, MWt 356.89, Formula C18H29ClN2O3, Purity >98%, SMILES O=C(N[C@H](C)[C@@H](O)C1=CC=CC=C1)[C@H](C)[C@@H](OC)[C@H]2NCCC2.Cl, MDL NA |
| Drug_Names: L-Biphenylalanine, CAS: 155760-02-4, stock 559.9g, assay 98.6%, MWt 241.29, Formula C15H15NO2, Purity >98%, SMILES OC([C@H](CC(C=C1)=CC=C1C2=CC=CC=C2)N)=O, MDL MFCD01318878 |
| Drug_Names: D-Biphenylalanine, CAS: 170080-13-4, stock 21g, assay 98.1%, MWt 241.29, Formula C15H15NO2, Purity >98%, SMILES OC([C@@H](CC(C=C1)=CC=C1C2=CC=CC=C2)N)=O, MDL MFCD01318879 |
| Drug_Names: (R)-methyl 3-([1,1'-biphenyl]-4-yl)-2-aminopropanoate hydrochloride, CAS: 169885-19-2, stock 899.1g, assay 98.6%, MWt 291.77, Formula C16H18ClNO2, Purity >98%, SMILES N[C@H](CC(C=C1)=CC=C1C2=CC=CC=C2)C(OC)=O.Cl, MDL NA |
| Drug_Names: (S)-tert-butyl (3-cyclopentyl-1-(cyclopropylamino)-1-oxopropan-2-yl)carbamate, CAS: 1404457-07-3, stock 100.1g, assay 98.4%, MWt 296.41, Formula C16H28N2O3, Purity >98%, SMILES O=C(NC1CC1)[C@@H](NC(OC(C)(C)C)=O)CC2CCCC2, MDL NA |
| Drug_Names: (S)-2-amino-3-cyclopentyl-N-cyclopropylpropanamide hydrochloride, CAS: 1404457-08-4, stock 91.1g, assay 98.8%, MWt 232.75, Formula C11H21ClN2O, Purity >98%, SMILES O=C(NC1CC1)[C@@H](N)CC2CCCC2.Cl, MDL NA |
| Drug_Names: 2-Amino-3-cyclopentyl-N-cyclopropylpropanamide hydrochloride, CAS: 2070014-73-0, stock 234g, assay 98.8%, MWt 232.75, Formula C11H21ClN2O, Purity >98%, SMILES O=C(NC1CC1)C(CC2CCCC2)N.Cl, MDL NA |
| Drug_Names: (S)-2-amino-3-cyclopentyl-N-cyclopropylpropanamide, CAS: 1404618-08-1, stock 748.4g, assay 98.4%, MWt 196.29, Formula C11H20N2O, Purity >98%, SMILES O=C(NC1CC1)[C@@H](N)CC2CCCC2, MDL NA |
| Drug_Names: Ni-(S)-BPB-GLy, CAS: 96293-19-5, stock 757.1g, assay 98.7%, MWt 498.20, Formula C27H25N3NiO3, Purity >98%, SMILES O=C([N-]1[Ni+2]23[N](CC([O-]2)=O)=C(C4=CC=CC=C4)C5=CC=CC=C15)C6[N]3(CC7=CC=CC=C7)CCC6, MDL MFCD00216960 |
| Drug_Names: NSC 14972, CAS: 119-24-4, stock 636.7g, assay 98.5%, MWt 312.28, Formula C14H12N6O3, Purity >98%, SMILES OC(C1=CC=C(NCC2=NC3=C(N=C2)N=C(N)NC3=O)C=C1)=O, MDL NA |
| Drug_Names: Methyl (4S)-4-(tritylamino)cyclopent-1-ene-1-carboxylate, CAS: 1113025-21-0, stock 420.6g, assay 98.1%, MWt 383.48, Formula C26H25NO2, Purity >98%, SMILES O=C(OC)C1=CC[C@H](NC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C1, MDL NA |
| Drug_Names: 4-(3-Chloro-4-methoxybenzylamino)-5-ethoxycarbonyl-2-methylthiopyrimidine, CAS: 330785-81-4, stock 439.3g, assay 99%, MWt 367.85, Formula C16H18ClN3O3S, Purity >98%, SMILES O=C(C1=CN=C(SC)N=C1NCC2=CC=C(OC)C(Cl)=C2)OCC, MDL MFCD17012695 |
| Drug_Names: 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, CAS: 853029-57-9, stock 137.7g, assay 98%, MWt 453.29, Formula C20H17BrN6O2, Purity >98%, SMILES O=C(N1CC2=NC(C)=C3C=CC=CC3=N2)N(C)C4=C(N(CC#CC)C(Br)=N4)C1=O, MDL MFCD18642578 |
| Drug_Names: (S)-2-((S)-4-Methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid, CAS: 868540-16-3, stock 191.3g, assay 98.4%, MWt 566.69, Formula C31H42N4O6, Purity >98%, SMILES OC([C@@H](NC([C@H](CC(C)C)NC([C@@H](NC(CN1CCOCC1)=O)CCC2=CC=CC=C2)=O)=O)CC3=CC=CC=C3)=O, MDL NA |
| Drug_Names: Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol, CAS: 1034305-11-7, stock 859.9g, assay 98.6%, MWt 337.21, Formula C15H10BrFOS, Purity >98%, SMILES OC(C1=CC(C=CC=C2)=C2S1)C3=C(F)C=CC(Br)=C3, MDL NA |
| Drug_Names: 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene, CAS: 1034305-17-3, stock 869.6g, assay 98.1%, MWt 321.21, Formula C15H10BrFS, Purity >98%, SMILES FC1=C(CC2=CC(C=CC=C3)=C3S2)C=C(Br)C=C1, MDL NA |
| Drug_Names: (S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine, CAS: 608141-42-0, stock 621.5g, assay 98.4%, MWt 273.35, Formula C12H19NO4S, Purity >98%, SMILES N[C@@H](C1=CC=C(OC)C(OCC)=C1)CS(=O)(C)=O, MDL NA |
| Drug_Names: 1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine, CAS: 253168-94-4, stock 94.8g, assay 98.9%, MWt 273.35, Formula C12H19NO4S, Purity >98%, SMILES NC(C1=CC=C(OC)C(OCC)=C1)CS(=O)(C)=O, MDL NA |
| Drug_Names: (S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate, CAS: 868539-98-4, stock 839.6g, assay 98.1%, MWt 453.57, Formula C26H35N3O4, Purity >98%, SMILES O=C([C@@H](NC([C@H](CC(C)C)NC([C@@H](N)CCC1=CC=CC=C1)=O)=O)CC2=CC=CC=C2)OC, MDL NA |
| Drug_Names: (S)-Methyl 2-((S)-2-amino-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate, CAS: 90072-18-7, stock 150.7g, assay 98.4%, MWt 406.40, Formula C18H25F3N2O5, Purity >98%, SMILES FC(F)(C(O)=O)F.O=C(OC)[C@@H](NC([C@H](CC(C)C)N)=O)CC1=CC=CC=C1, MDL NA |
| Drug_Names: (6S,9S,12S)-Methyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate, CAS: 868539-96-2, stock 494.7g, assay 98.2%, MWt 553.69, Formula C31H43N3O6, Purity >98%, SMILES O=C([C@@H](NC([C@H](CC(C)C)NC([C@@H](NC(OC(C)(C)C)=O)CCC1=CC=CC=C1)=O)=O)CC2=CC=CC=C2)OC, MDL NA |
| Drug_Names: 4-Morpholineacetic acid hydrochloride, CAS: 89531-58-8, stock 300.2g, assay 98.2%, MWt 181.62, Formula C6H12ClNO3, Purity >98%, SMILES O=C(O)CN1CCOCC1.Cl, MDL MFCD03540888 |
| Drug_Names: 2-(Isopropylsulfonyl)aniline, CAS: 76697-50-2, stock 478.7g, assay 98.6%, MWt 199.27, Formula C9H13NO2S, Purity >98%, SMILES NC1=C(S(C(C)C)(=O)=O)C=CC=C1, MDL MFCD08445603 |
| Drug_Names: 2,5-Dichloro-N-(2-(isopropylthio)phenyl)pyrimidin-4-amine, CAS: 1632485-14-3, stock 196.1g, assay 98.9%, MWt 314.23, Formula C13H13Cl2N3S, Purity >98%, SMILES ClC1=CN=C(Cl)N=C1NC2=C(SC(C)C)C=CC=C2, MDL NA |
| Drug_Names: 1-Chloro-2-methyl-4-nitro-5-(propan-2-yloxy)benzene, CAS: 1032903-50-6, stock 879.7g, assay 98.9%, MWt 229.66, Formula C10H12ClNO3, Purity >98%, SMILES ClC1=CC(OC(C)C)=C([N+]([O-])=O)C=C1C, MDL MFCD11499001 |
| Drug_Names: 4-(5-Isopropoxy-2-methyl-4-nitrophenyl)pyridine, CAS: 1032903-62-0, stock 726.7g, assay 98.6%, MWt 272.30, Formula C15H16N2O3, Purity >98%, SMILES CC1=CC([N+]([O-])=O)=C(OC(C)C)C=C1C2=CC=NC=C2, MDL MFCD26407007 |
| Drug_Names: tert-Butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate, CAS: 1032903-63-1, stock 191.8g, assay 98.6%, MWt 348.48, Formula C20H32N2O3, Purity >98%, SMILES NC1=C(OC(C)C)C=C(C2CCN(C(OC(C)(C)C)=O)CC2)C(C)=C1, MDL MFCD26407295 |
| Drug_Names: 4-[4-[[5-Chloro-4-[[2-[(propan-2-yl)sulfonyl]phenyl]amino]pyrimidin-2-yl]amino]-5-isopropoxy-2-methylphenyl]piperidine-1-carboxylic acid tert-butyl ester, CAS: 1032903-64-2, stock 351.4g, assay 98.1%, MWt 658.25, Formula C33H44ClN5O5S, Purity >98%, SMILES CC1=CC(NC2=NC=C(Cl)C(NC3=C(S(C(C)C)(=O)=O)C=CC=C3)=N2)=C(OC(C)C)C=C1C4CCN(C(OC(C)(C)C)=O)CC4, MDL NA |
| Drug_Names: 4-Morpholine acetic acid, CAS: 3235-69-6, stock 560.2g, assay 98.6%, MWt 145.16, Formula C6H11NO3, Purity >98%, SMILES O=C(O)CN1CCOCC1, MDL MFCD00504633 |
| Drug_Names: 3-Methyl-4-(piperidin-4-yl)aniline, CAS: 1260864-79-6, stock 780.5g, assay 98.6%, MWt 190.28, Formula C12H18N2, Purity >98%, SMILES NC1=CC=C(C2CCNCC2)C(C)=C1, MDL NA |
| Drug_Names: (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester, CAS: 149809-43-8, stock 398.3g, assay 98.3%, MWt 449.47, Formula C21H21F2N3O4S, Purity >98%, SMILES O=S(OC[C@H](CO1)C[C@@]1(C2=CC=C(F)C=C2F)CN3C=NC=N3)(C4=CC=C(C)C=C4)=O, MDL NA |
| Drug_Names: L-Homophenylalanine, CAS: 943-73-7, stock 395.7g, assay 98.2%, MWt 179.22, Formula C10H13NO2, Purity >98%, SMILES N[C@H](C(O)=O)CCC1=CC=CC=C1, MDL MFCD00002619 |
| Drug_Names: N-Benzyl-L-isoleucine, CAS: 1859-49-0, stock 235.4g, assay 98.3%, MWt 221.30, Formula C13H19NO2, Purity >98%, SMILES CC[C@H](C)[C@@H](C(O)=O)NCC1=CC=CC=C1, MDL MFCD00038331 |
| Drug_Names: (2S,3S)-2-(Benzyl(methyl)amino)-3-methylpentanoic acid, CAS: 4125-97-7, stock 894.5g, assay 98.3%, MWt 235.32, Formula C14H21NO2, Purity >98%, SMILES CC[C@H](C)[C@@H](C(O)=O)N(CC1=CC=CC=C1)C, MDL NA |
| Drug_Names: (2S,3S)-2-(benzyl(methyl)amino)-3-methylpentan-1-ol, CAS: 870640-62-3, stock 391.2g, assay 98.5%, MWt 221.34, Formula C14H23NO, Purity >98%, SMILES CC[C@H](C)[C@@H](CO)N(CC1=CC=CC=C1)C, MDL NA |
| Drug_Names: (2S,3S)-N-benzyl-1,1-dimethoxy-N,3-dimethylpentan-2-amine, CAS: 870640-61-2, stock 100.6g, assay 98.9%, MWt 265.39, Formula C16H27NO2, Purity >98%, SMILES CN(CC1=CC=CC=C1)[C@H](C(OC)OC)[C@@H](C)CC, MDL NA |
| Drug_Names: (3R,4S,5S)-tert-butyl 4-(benzyl(methyl)amino)-3-methoxy-5-methylheptanoate, CAS: 870640-64-5, stock 485.9g, assay 98.9%, MWt 349.51, Formula C21H35NO3, Purity >98%, SMILES CC[C@H](C)[C@H](N(CC1=CC=CC=C1)C)[C@H](OC)CC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (S)-tert-butyl 2-((1R,2R)-3-(benzyloxy)-1-hydroxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate, CAS: 163768-51-2, stock 843.8g, assay 98.5%, MWt 363.45, Formula C20H29NO5, Purity >98%, SMILES O[C@H]([C@@H](C)C(OCC1=CC=CC=C1)=O)[C@H]2N(C(OC(C)(C)C)=O)CCC2, MDL NA |
| Drug_Names: (S)-tert-butyl 2-((1R,2R)-3-(benzyloxy)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate, CAS: 149606-97-3, stock 613.7g, assay 98.3%, MWt 377.47, Formula C21H31NO5, Purity >98%, SMILES O=C(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(OCC2=CC=CC=C2)=O)OC)OC(C)(C)C, MDL NA |
| Drug_Names: 2-Methoxy-6-(methylamino)benzonitrile, CAS: 1332581-19-7, stock 551.3g, assay 98.4%, MWt 162.19, Formula C9H10N2O, Purity >98%, SMILES CNC1=CC=CC(OC)=C1C#N, MDL MFCD20268108 |
| Drug_Names: 2-methoxy-6-(methylamino)benzamide, CAS: 1369776-22-6, stock 336.1g, assay 98.1%, MWt 180.20, Formula C9H12N2O2, Purity >98%, SMILES NC(C1=C(OC)C=CC=C1NC)=O, MDL NA |
| Drug_Names: 2-Chloroacetamidine, CAS: 20846-52-0, stock 891.2g, assay 98.1%, MWt 92.53, Formula C2H5ClN2, Purity >98%, SMILES ClCC(N)=N, MDL NA |
| Drug_Names: tert-Butyl N-(cyclopropylmethyl)carbamate, CAS: 897932-58-0, stock 795.4g, assay 98.3%, MWt 171.24, Formula C9H17NO2, Purity >98%, SMILES CC(C)(C)OC(NCC1CC1)=O, MDL NA |
| Drug_Names: (4-Methoxyphenyl)(piperidin-4-yl)methanone, CAS: 76362-12-4, stock 174g, assay 98.1%, MWt 219.28, Formula C13H17NO2, Purity >98%, SMILES O=C(C1=CC=C(OC)C=C1)C2CCNCC2, MDL MFCD00835819 |
| Drug_Names: [4-(4-Methoxybenzoyl)piperidin-1-yl]acetic acid, CAS: 1419957-49-5, stock 218.6g, assay 98.2%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES O=C(C1=CC=C(OC)C=C1)C2CCN(CC(O)=O)CC2, MDL NA |
| Drug_Names: (S)-2-acetamido-3-(3,4-difluorophenyl)propanoic acid, CAS: 266360-51-4, stock 300.8g, assay 98.6%, MWt 243.21, Formula C11H11F2NO3, Purity >98%, SMILES OC(C(NC(C)=O)CC1=CC(F)=C(F)C=C1)=O, MDL NA |
| Drug_Names: (2S)-2-[(tert-Butoxycarbonyl)amino]-3-(3,4-difluorophenyl)propionic acid, CAS: 198474-90-7, stock 214.8g, assay 98.9%, MWt 301.29, Formula C14H17F2NO4, Purity >98%, SMILES OC([C@@H](NC(OC(C)(C)C)=O)CC1=CC(F)=C(F)C=C1)=O, MDL MFCD00672518 |
| Drug_Names: (S)-tert-butyl (1-(3,4-difluorophenyl)-3-hydroxypropan-2-yl)carbamate, CAS: 1239576-61-4, stock 338.3g, assay 98.4%, MWt 287.30, Formula C14H19F2NO3, Purity >98%, SMILES OC[C@@H](NC(OC(C)(C)C)=O)CC1=CC(F)=C(F)C=C1, MDL NA |
| Drug_Names: 4-Bromofuran-2-carboxylic acid methyl ester, CAS: 58235-80-6, stock 474.1g, assay 98.5%, MWt 205.01, Formula C6H5BrO3, Purity >98%, SMILES O=C(C1=CC(Br)=CO1)OC, MDL MFCD00092559 |
| Drug_Names: 5-Chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxylic acid, CAS: 1047629-15-1, stock 654.9g, assay 99%, MWt 261.06, Formula C9H6Cl2N2O3, Purity >98%, SMILES O=C(C1=CC(C2=C(Cl)C=NN2C)=C(Cl)O1)O, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrazole-5-boronic acid pinacol ester, CAS: 847818-74-0, stock 728.7g, assay 98.1%, MWt 208.07, Formula C10H17BN2O2, Purity >98%, SMILES CC1(C)C(C)(C)OB(C2=CC=NN2C)O1, MDL MFCD05861380 |
| Drug_Names: 2-Chloro-6-[(4-cyclopropylmethylpiperazin-1-yl)methyl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidine, CAS: 885699-88-7, stock 712.8g, assay 98.3%, MWt 407.96, Formula C19H26ClN5OS, Purity >98%, SMILES ClC1=NC2=C(C(N3CCOCC3)=N1)SC(CN4CCN(CC5CC5)CC4)=C2, MDL NA |
| Drug_Names: 1-(Cyclopropylmethyl)piperazine dihydrochloride, CAS: 373608-42-5, stock 898.9g, assay 98.8%, MWt 213.15, Formula C8H18Cl2N2, Purity >98%, SMILES N1(CC2CC2)CCNCC1.Cl.Cl, MDL MFCD08544420 |
| Drug_Names: 4-Nitrophenyl trifluoromethanesulfonate, CAS: 17763-80-3, stock 732.9g, assay 98.6%, MWt 271.17, Formula C7H4F3NO5S, Purity >98%, SMILES FC(F)(S(OC1=CC=C([N+]([O-])=O)C=C1)(=O)=O)F, MDL MFCD00192354 |
| Drug_Names: 5-(Methoxymethoxy)benzo[d][1,3]dioxole, CAS: 111726-43-3, stock 862.6g, assay 98.8%, MWt 182.17, Formula C9H10O4, Purity >98%, SMILES COCOC1=CC=C2C(OCO2)=C1, MDL NA |
| Drug_Names: 5-(Methoxymethoxy)benzo[d][1,3]dioxol-4-ol, CAS: 244126-41-8, stock 611.6g, assay 98%, MWt 198.17, Formula C9H10O5, Purity >98%, SMILES OC1=C(OCO2)C2=CC=C1OCOC, MDL NA |
| Drug_Names: Ethyl 2-hydroxy-2-(7-hydroxy-6-(methoxymethoxy)benzo[d][1,3]dioxol-4-yl)acetate, CAS: 874758-53-9, stock 825.8g, assay 98.1%, MWt 300.26, Formula C13H16O8, Purity >98%, SMILES OC1=C(OCO2)C2=C(C(C(OCC)=O)O)C=C1OCOC, MDL NA |
| Drug_Names: Ethyl 2-hydroxy-2-(6-(methoxymethoxy)-7-(((trifluoromethyl)sulfonyl)oxy)benzo[d][1,3]dioxol-4-yl)acetate, CAS: 874758-54-0, stock 478.5g, assay 98.8%, MWt 432.32, Formula C14H15F3O10S, Purity >98%, SMILES OC(C(OCC)=O)C1=C2C(OCO2)=C(OS(C(F)(F)F)(=O)=O)C(OCOC)=C1, MDL NA |
| Drug_Names: 3-((Dimethylamino)methyl)benzeneboronic acid, CAS: 819849-22-4, stock 863.8g, assay 98.8%, MWt 179.02, Formula C9H14BNO2, Purity >98%, SMILES CN(CC1=CC(B(O)O)=CC=C1)C, MDL NA |
| Drug_Names: N'-[4-(4-Bromo-1-ethyl-1H-pyrazol-3-yl)phenyl]-N,N-dimethylurea, CAS: 942920-94-7, stock 786.2g, assay 98.2%, MWt 337.22, Formula C14H17BrN4O, Purity >98%, SMILES BrC1=CN(CC)N=C1C2=CC=C(NC(N(C)C)=O)C=C2, MDL NA |
| Drug_Names: (4-Isopropoxy-3-methoxyphenyl)methanol, CAS: 2539-22-2, stock 124.7g, assay 98.7%, MWt 196.24, Formula C11H16O3, Purity >98%, SMILES OCC1=CC=C(OC(C)C)C(OC)=C1, MDL NA |
| Drug_Names: 2-(4-Isopropoxy-3-methoxyphenyl)acetonitrile, CAS: 861069-45-6, stock 689.6g, assay 98.3%, MWt 205.25, Formula C12H15NO2, Purity >98%, SMILES COC1=CC(CC#N)=CC=C1OC(C)C, MDL NA |
| Drug_Names: 2-(4-Isopropoxy-3-methoxyphenyl)acetic acid, CAS: 88449-50-7, stock 538.1g, assay 98.7%, MWt 224.25, Formula C12H16O4, Purity >98%, SMILES COC1=CC(CC(O)=O)=CC=C1OC(C)C, MDL NA |
| Drug_Names: 1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-nitrophenyl)-1,2-dihydroisoquinolin-3(4H)-one, CAS: 1821463-86-8, stock 465g, assay 98.6%, MWt 466.91, Formula C25H23ClN2O5, Purity >98%, SMILES O=C1N(C2=CC=C([N+]([O-])=O)C=C2)C(C3=CC=C(Cl)C=C3)C4=C(C=C(OC)C(OC(C)C)=C4)C1, MDL NA |
| Drug_Names: (S)-methyl 2-((2R,3R)-3-methoxy-2-methyl-3-((S)-pyrrolidin-2-yl)propanamido)-3-phenylpropanoate hydrochloride, CAS: 864238-20-0, stock 164.3g, assay 98.7%, MWt 384.90, Formula C19H29ClN2O4, Purity >98%, SMILES O=C(N[C@H](C(OC)=O)CC1=CC=CC=C1)[C@H](C)[C@@H](OC)[C@H]2NCCC2.Cl, MDL NA |
| Drug_Names: (2R,3R)methyl-2-(N-((2S,3R)-3-((9S)-9-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-methylbutanamido)-3-methoxy-5,10-dimethyl-4-(methylamino)-8-oxoundecanoyl)pyrrolidin-2-yl)propionamido)-3-methoxy-2-methyl-3-phenylpropanoate, CAS: 863971-38-4, stock 487.9g, assay 98.5%, MWt 968.23, Formula C55H77N5O10, Purity >98%, SMILES CC[C@H](C)[C@@H]([C@@H](CC(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C(OC)=O)CC2=CC=CC=C2)=O)OC)=O)OC)N(C([C@H](C(C)C)NC([C@H](C(C)C)N(C(OCC3C4=C(C=CC=C4)C5=C3C=CC=C5)=O)C)=O)=O)C, MDL NA |
| Drug_Names: tert-Butyl (R)-2-bromo-4-methylpentanoate, CAS: 130464-88-9, stock 625.1g, assay 98.5%, MWt 251.16, Formula C10H19BrO2, Purity >98%, SMILES CC(C)C[C@@H](Br)C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (R)-2-(1,3-bis(benzyloxy)-1,3-dioxopropan-2-yl)-4-methylpentanoic acid, CAS: 155947-71-0, stock 595.8g, assay 98.2%, MWt 398.45, Formula C23H26O6, Purity >98%, SMILES [H][C@@](C(C(OCC1=CC=CC=C1)=O)C(OCC2=CC=CC=C2)=O)(C(O)=O)CC(C)C, MDL NA |
| Drug_Names: Dibenzyl 2-((R)-1-(((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-2-hydroxymalonate, CAS: 191792-11-7, stock 265.4g, assay 98.2%, MWt 540.65, Formula C30H40N2O7, Purity >98%, SMILES [H][C@](C(N[C@@H](C(C)(C)C)C(NC)=O)=O)(C(C(OCC1=CC=CC=C1)=O)(C(OCC2=CC=CC=C2)=O)O)CC(C)C, MDL NA |
| Drug_Names: NSC 101027, CAS: 15014-25-2, stock 777.2g, assay 98.2%, MWt 284.31, Formula C17H16O4, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)CC(OCC2=CC=CC=C2)=O, MDL MFCD00004779 |
| Drug_Names: 2-(1,3-Bis(benzyloxy)-1,3-dioxopropan-2-yl)-4-methylpentanoic acid, CAS: 165172-57-6, stock 581.1g, assay 98.2%, MWt 398.45, Formula C23H26O6, Purity >98%, SMILES CC(C)CC(C(C(OCC1=CC=CC=C1)=O)C(OCC2=CC=CC=C2)=O)C(O)=O, MDL NA |
| Drug_Names: Methyl 2-chloro-5-thiophenecarboxylate, CAS: 35475-03-7, stock 190.7g, assay 98.6%, MWt 176.62, Formula C6H5ClO2S, Purity >98%, SMILES O=C(C1=CC=C(Cl)S1)OC, MDL MFCD06203698 |
| Drug_Names: Methyl 4-bromo-5-chlorothiophene-2-carboxylate, CAS: 1047630-72-7, stock 290.3g, assay 98.3%, MWt 255.52, Formula C6H4BrClO2S, Purity >98%, SMILES O=C(C1=CC(Br)=C(Cl)S1)OC, MDL MFCD28359275 |
| Drug_Names: Methyl 5-chloro-4-(1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxylate, CAS: 1047630-52-3, stock 677.8g, assay 98.3%, MWt 256.71, Formula C10H9ClN2O2S, Purity >98%, SMILES O=C(C1=CC(C2=CC=NN2C)=C(Cl)S1)OC, MDL NA |
| Drug_Names: 5-Chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxylic acid, CAS: 1047630-61-4, stock 13.4g, assay 98.8%, MWt 277.13, Formula C9H6Cl2N2O2S, Purity >98%, SMILES O=C(C1=CC(C2=C(Cl)C=NN2C)=C(Cl)S1)O, MDL NA |
| Drug_Names: (βR)-6-Bromo-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol, CAS: 1298044-24-2, stock 408.4g, assay 98.2%, MWt 484.38, Formula C28H22BrNO2, Purity >98%, SMILES BrC1=CC=C(N=C(OC)C(C(C2=CC=CC=C2)C(O)C3=CC=CC4=C3C=CC=C4)=C5)C5=C1, MDL NA |
| Drug_Names: (R)-2-(6-bromo-2-methoxyquinolin-3-yl)-1-(naphthalen-1-yl)-2-phenylethan-1-one, CAS: 1298044-25-3, stock 577.1g, assay 98.2%, MWt 482.37, Formula C28H20BrNO2, Purity >98%, SMILES COC1=NC2=CC=C(Br)C=C2C=C1[C@@H](C3=CC=CC=C3)C(C4=C5C=CC=CC5=CC=C4)=O, MDL NA |
| Drug_Names: Methyl 2-oxoindoline-6-carboxylate, CAS: 14192-26-8, stock 654g, assay 98.5%, MWt 191.18, Formula C10H9NO3, Purity >98%, SMILES O=C1NC2=CC(C(OC)=O)=CC=C2C1, MDL MFCD03095196 |
| Drug_Names: Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate, CAS: 1441673-92-2, stock 892.5g, assay 98.1%, MWt 280.38, Formula C12H19KNO4, Purity >98%, SMILES OC([C@H](CC1(CC1)C2)N2C(OC(C)(C)C)=O)=O.[K], MDL MFCD28385907 |
| Drug_Names: 5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid, CAS: 1454843-77-6, stock 223.7g, assay 98.7%, MWt 241.28, Formula C12H19NO4, Purity >98%, SMILES O=C(N(C(C(O)=O)C1)CC21CC2)OC(C)(C)C, MDL NA |
| Drug_Names: S-tert-Leucine N-methylamide, CAS: 89226-12-0, stock 809.3g, assay 98.1%, MWt 144.21, Formula C7H16N2O, Purity >98%, SMILES N[C@@H](C(C)(C)C)C(NC)=O, MDL MFCD00673329 |
| Drug_Names: 5-Bromo-2H-indazole, CAS: 465529-55-9, stock 527.4g, assay 98.8%, MWt 197.03, Formula C7H5BrN2, Purity >98%, SMILES BrC1=CC2=CNN=C2C=C1.[2H-Indazole], MDL NA |
| Drug_Names: 1-Methyl-5-bromo-1H-indazole, CAS: 465529-57-1, stock 75.5g, assay 98.6%, MWt 211.06, Formula C8H7BrN2, Purity >98%, SMILES BrC1=CC2=C(N(C)N=C2)C=C1, MDL MFCD09878568 |
| Drug_Names: 2-(5-Bromo-2-methyl-2H-indazol-3-yl)propan-2-ol, CAS: 1823787-20-7, stock 107.8g, assay 98.5%, MWt 269.14, Formula C11H13BrN2O, Purity >98%, SMILES BrC1=CC2=C(C(C)(O)C)N(C)N=C2C=C1, MDL NA |
| Drug_Names: 7-Amino-5-(4-methoxybenzyl)-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride, CAS: 1083065-04-6, stock 667.4g, assay 98.5%, MWt 380.87, Formula C22H21ClN2O2, Purity >98%, SMILES O=C1C(N)C2=CC=CC=C2C3=CC=CC=C3N1CC4=CC=C(OC)C=C4.[H]Cl, MDL NA |
| Drug_Names: NSC 28452, CAS: 5471-77-2, stock 582.4g, assay 98.9%, MWt 160.17, Formula C7H12O4, Purity >98%, SMILES O=C(OCC)C(C)(C)C(O)=O, MDL MFCD04003823 |
| Drug_Names: 2,2-Dimethyl-3-oxo-3-((2,2,3,3,3-pentafluoropropyl)amino)propanoic acid, CAS: 847926-89-0, stock 317.6g, assay 98.7%, MWt 263.16, Formula C8H10F5NO3, Purity >98%, SMILES O=C(O)C(C)(C)C(NCC(F)(F)C(F)(F)F)=O, MDL NA |
| Drug_Names: 2-[(2S)-2-Amino-3-(3-fluorophenyl)propyl]-1H-isoindole-1,3(2H)-dione, CAS: 943325-38-0, stock 456.8g, assay 98.6%, MWt 298.31, Formula C17H15FN2O2, Purity >98%, SMILES O=C1N(C[C@@H](N)CC2=CC=CC(F)=C2)C(C3=C1C=CC=C3)=O, MDL NA |
| Drug_Names: 3-Amino-2-((3,8-dimethoxynaphthalen-2-yl)methyl)propanoic acid, CAS: 288389-24-2, stock 629.1g, assay 98.7%, MWt 289.33, Formula C16H19NO4, Purity >98%, SMILES COC1=C2C(C=C(OC)C(CC(CN)C(O)=O)=C2)=CC=C1, MDL NA |
| Drug_Names: 1-Formyladamantane, CAS: 2094-74-8, stock 750.1g, assay 98.3%, MWt 164.24, Formula C11H16O, Purity >98%, SMILES O=CC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3, MDL NA |
| Drug_Names: Methyl 1-acetyl-2-oxoindoline-6-carboxylate, CAS: 676326-36-6, stock 137.6g, assay 98.4%, MWt 233.22, Formula C12H11NO4, Purity >98%, SMILES O=C1N(C(C)=O)C2=CC(C(OC)=O)=CC=C2C1, MDL NA |
| Drug_Names: Methyl (3E)-1-acetyl-3-[methoxy(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate, CAS: 1168152-07-5, stock 542.2g, assay 98.6%, MWt 351.35, Formula C20H17NO5, Purity >98%, SMILES O=C(N(C1=CC(C(OC)=O)=CC=C1/2)C(C)=O)C2=C(OC)/C3=CC=CC=C3, MDL NA |
| Drug_Names: (2R,3S)-ethyl 3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate, CAS: 93636-26-1, stock 692.7g, assay 98.9%, MWt 248.27, Formula C11H20O6, Purity >98%, SMILES O=C(OCC)[C@@](O)(C)[C@@H](O)[C@@H]1OC(C)(C)OC1, MDL NA |
| Drug_Names: (2R,3S)-ethyl 3-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate, CAS: 1946820-88-7, stock 734.8g, assay 98.1%, MWt 248.27, Formula C11H20O6, Purity >98%, SMILES O=C(OCC)[C@@](O)(C)[C@@H](O)[C@@H]1COC(C)(C)O1, MDL NA |
| Drug_Names: Methyl 2-methyl-2-(4-nitro-1H-imidazol-1-yl)propanoate, CAS: 865774-07-8, stock 760.8g, assay 98.1%, MWt 213.19, Formula C8H11N3O4, Purity >98%, SMILES O=[N+](C1=CN(C(C(OC)=O)(C)C)C=N1)[O-], MDL NA |
| Drug_Names: 2,2-Dimethyl-N-(2-methyl-2-(4-nitro-1H-imidazol-1-yl)propyl)propan-1-amine, CAS: 865774-15-8, stock 232.2g, assay 99%, MWt 254.33, Formula C12H22N4O2, Purity >98%, SMILES O=[N+](C1=CN(C(CNCC(C)(C)C)(C)C)C=N1)[O-], MDL NA |
| Drug_Names: (S)-tert-butyl 2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate, CAS: 160800-65-7, stock 536.3g, assay 98%, MWt 420.54, Formula C23H36N2O5, Purity >98%, SMILES O=C(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C)[C@@H](O)C2=CC=CC=C2)=O)OC)OC(C)(C)C, MDL NA |
| Drug_Names: 4-[1-[(Methylsulfonyl)oxy]ethyl]-1-piperidinecarboxylic acid 1,1-dimethylethyl ester, CAS: 1032825-55-0, stock 204.8g, assay 98.6%, MWt 307.41, Formula C13H25NO5S, Purity >98%, SMILES CC(OS(C)(=O)=O)C1CCN(C(OC(C)(C)C)=O)CC1, MDL NA |
| Drug_Names: tert-Butyl 4-(1-(3-(((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-2-methyl-1H-indol-1-yl)ethyl)piperidine-1-carboxylate, CAS: 1450655-10-3, stock 651.6g, assay 98.1%, MWt 536.66, Formula C30H40N4O5, Purity >98%, SMILES O=C(C1=C(C)N(C(C2CCN(C(OC(C)(C)C)=O)CC2)C)C3=C1C=CC=C3)NCC4=C(OC)C=C(C)NC4=O, MDL NA |
| Drug_Names: N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(piperidin-4-yl)ethyl)-1H-indole-3-carboxamide, CAS: 1450655-12-5, stock 335.3g, assay 98.6%, MWt 436.55, Formula C25H32N4O3, Purity >98%, SMILES O=C(C1=C(C)N(C(C2CCNCC2)C)C3=C1C=CC=C3)NCC4=C(OC)C=C(C)NC4=O, MDL NA |
| Drug_Names: (S)-tert-butyl 4-(1-hydroxyethyl)piperidine-1-carboxylate, CAS: 389889-82-1, stock 20.7g, assay 98.8%, MWt 229.32, Formula C12H23NO3, Purity >98%, SMILES O=C(OC(C)(C)C)N1CCC(CC1)[C@H](C)O, MDL NA |
| Drug_Names: (S)-tert-butyl 4-(1-((methylsulfonyl)oxy)ethyl)piperidine-1-carboxylate, CAS: 1932520-97-2, stock 786.4g, assay 98.2%, MWt 307.41, Formula C13H25NO5S, Purity >98%, SMILES C[C@H](OS(C)(=O)=O)C1CCN(C(OC(C)(C)C)=O)CC1, MDL NA |
| Drug_Names: 2,4-Dichloro-6-methylnicotinonitrile, CAS: 38367-36-1, stock 54.8g, assay 98.8%, MWt 187.03, Formula C7H4Cl2N2, Purity >98%, SMILES ClC1=NC(C)=CC(Cl)=C1C#N, MDL NA |
| Drug_Names: 2,4-Dimethoxy-6-methylnicotinonitrile, CAS: 1450662-05-1, stock 113.1g, assay 98.6%, MWt 178.19, Formula C9H10N2O2, Purity >98%, SMILES CC1=CC(OC)=C(C#N)C(OC)=N1, MDL NA |
| Drug_Names: tert-Butyl ((2,4-dimethoxy-6-methylpyridin-3-yl)methyl)carbamate, CAS: 1450662-06-2, stock 207.3g, assay 98.5%, MWt 282.34, Formula C14H22N2O4, Purity >98%, SMILES CC1=CC(OC)=C(CNC(OC(C)(C)C)=O)C(OC)=N1, MDL NA |
| Drug_Names: 4-Chloro-6-methyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile, CAS: 582300-58-1, stock 29.7g, assay 99%, MWt 168.58, Formula C7H5ClN2O, Purity >98%, SMILES O=C1C(C#N)=C(Cl)C=C(C)N1, MDL MFCD11847536 |
| Drug_Names: 4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, CAS: 1354528-16-7, stock 555.6g, assay 98.1%, MWt 164.16, Formula C8H8N2O2, Purity >98%, SMILES O=C1NC(C)=CC(OC)=C1C#N, MDL NA |
| Drug_Names: 2-((4-((2-Isopropoxyethoxy)methyl)phenoxy)methyl)oxirane, CAS: 66722-57-4, stock 289.3g, assay 98.5%, MWt 266.33, Formula C15H22O4, Purity >98%, SMILES CC(C)OCCOCC1=CC=C(OCC2CO2)C=C1, MDL NA |
| Drug_Names: (S)-N-Methyl-N-methoxy-2-(tert-butoxycarbonylamino)-4-methylpentanamide, CAS: 87694-50-6, stock 464.7g, assay 98.9%, MWt 274.36, Formula C13H26N2O4, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H](C(N(OC)C)=O)CC(C)C, MDL NA |
| Drug_Names: 5-Amino-4-phenyl-1,2,3-thiadiazole, CAS: 78301-72-1, stock 690.3g, assay 98.1%, MWt 177.23, Formula C8H7N3S, Purity >98%, SMILES NC1=C(C2=CC=CC=C2)N=NS1, MDL MFCD00100232 |
| Drug_Names: (S)-N-(4-phenyl-1,2,3-thiadiazol-5-yl)pyrrolidine-2-carboxamide hydrochloride, CAS: 873581-19-2, stock 858.6g, assay 98%, MWt 310.80, Formula C13H15ClN4OS, Purity >98%, SMILES O=C([C@@H]1CCCN1)NC2=C(C3=CC=CC=C3)N=NS2.Cl, MDL NA |
| Drug_Names: NSC 68806, CAS: 13365-26-9, stock 350.7g, assay 98.6%, MWt 239.18, Formula C10H9NO6, Purity >98%, SMILES O=C(C(C=CC=C1[N+]([O-])=O)=C1C(OC)=O)OC, MDL MFCD00017184 |
| Drug_Names: Methyl 2-(chloromethyl)-4-oxo-3,4-dihydroquinazoline-5-carboxylate, CAS: 1140964-67-5, stock 62g, assay 98.8%, MWt 252.65, Formula C11H9ClN2O3, Purity >98%, SMILES O=C(C(C=CC=C1N=C(CCl)N2)=C1C2=O)OC, MDL NA |
| Drug_Names: 6-Bromo-8-ethyl-2-methylsulfinylpyrido[2,3-d]pyrimidin-7-one, CAS: 1286738-62-2, stock 718.8g, assay 98.3%, MWt 316.17, Formula C10H10BrN3O2S, Purity >98%, SMILES CCN1C2=NC(S(C)=O)=NC=C2C=C(Br)C1=O, MDL NA |
| Drug_Names: 5-Bromo-2-chloro-N-ethylpyrimidin-4-amine, CAS: 954221-06-8, stock 269.9g, assay 98.4%, MWt 236.50, Formula C6H7BrClN3, Purity >98%, SMILES ClC1=NC=C(Br)C(NCC)=N1, MDL NA |
| Drug_Names: 8-Ethyl-2-methanethio-8H-pyrido[2,3-d]pyrimidin-7-one, CAS: 211244-82-5, stock 886.6g, assay 98.9%, MWt 221.28, Formula C10H11N3OS, Purity >98%, SMILES O=C1N(CC)C2=NC(SC)=NC=C2C=C1, MDL NA |
| Drug_Names: 6-Bromo-8-ethyl-2-methylsulfanylpyrido[2,3-d]pyrimidin-7-one, CAS: 1232030-55-5, stock 810g, assay 98.5%, MWt 300.17, Formula C10H10BrN3OS, Purity >98%, SMILES O=C1N(CC)C2=NC(SC)=NC=C2C=C1Br, MDL NA |
| Drug_Names: 6-Bromo-8-ethyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one, CAS: 1232030-40-8, stock 649.6g, assay 98.4%, MWt 443.34, Formula C20H23BrN6O, Purity >98%, SMILES CN1CCN(C2=CC=C(NC3=NC=C4C(N(CC)C(C(Br)=C4)=O)=N3)C=C2)CC1, MDL NA |
| Drug_Names: 2-Chloro-4-(thiazol-5-yl)phenol, CAS: 1823423-09-1, stock 595.9g, assay 99%, MWt 211.67, Formula C9H6ClNOS, Purity >98%, SMILES OC1=CC=C(C2=CN=CS2)C=C1Cl, MDL NA |
| Drug_Names: 2-Chloro-4-(thiazol-5-yl)phenyl trifluoromethanesulfonate, CAS: 1823433-21-1, stock 468g, assay 98.3%, MWt 343.73, Formula C10H5ClF3NO3S2, Purity >98%, SMILES ClC1=CC(C2=CN=CS2)=CC=C1OS(C(F)(F)F)(=O)=O, MDL NA |
| Drug_Names: 8-Ethyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one, CAS: 211245-14-6, stock 603.9g, assay 98.2%, MWt 364.44, Formula C20H24N6O, Purity >98%, SMILES CN1CCN(C2=CC=C(NC3=NC=C4C(N(CC)C(C=C4)=O)=N3)C=C2)CC1, MDL NA |
| Drug_Names: N-(1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, CAS: 874638-98-9, stock 495.3g, assay 98.1%, MWt 363.34, Formula C17H18FN3O5, Purity >98%, SMILES O[C@H]1[C@](F)(C)[C@H](N2C=CC(NC(C3=CC=CC=C3)=O)=NC2=O)O[C@@H]1CO, MDL NA |
| Drug_Names: H-D-Ala-OiPr.HCl, CAS: 39613-92-8, stock 49.8g, assay 98.1%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES N[C@H](C)C(OC(C)C)=O.Cl, MDL MFCD17976853 |
| Drug_Names: N-[(2S)-6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-L-norvaline, CAS: 865774-79-4, stock 711.2g, assay 98.7%, MWt 283.31, Formula C15H19F2NO2, Purity >98%, SMILES CCC[C@H](N[C@@H]1CC2=C(C=C(F)C=C2F)CC1)C(O)=O, MDL NA |
| Drug_Names: (S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-nitrophenyl)-1,2-dihydroisoquinolin-3(4H)-one, CAS: 1821463-87-9, stock 338.2g, assay 98.5%, MWt 466.91, Formula C25H23ClN2O5, Purity >98%, SMILES O=C1N(C2=CC=C([N+]([O-])=O)C=C2)[C@@H](C3=CC=C(Cl)C=C3)C4=C(C=C(OC)C(OC(C)C)=C4)C1, MDL NA |
| Drug_Names: 1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4r)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,4-dihydroisoquinolin-3(2H)-one, CAS: 1313363-86-8, stock 15.1g, assay 98.8%, MWt 659.26, Formula C38H47ClN4O4, Purity >98%, SMILES O=C1N(C2=CC=C(N(C)C[C@H]3CC[C@H](N4CC(N(C)CC4)=O)CC3)C=C2)C(C5=CC=C(Cl)C=C5)C6=C(C=C(OC)C(OC(C)C)=C6)C1, MDL NA |
| Drug_Names: Methyl 3-((R)-2-amino-3-(((R)-1-((4-nitrobenzyl)oxy)-1-oxohexan-2-yl)amino)-3-oxopropyl)-1H-indole-1-carboxylate hydrochloride, CAS: 865488-40-0, stock 817.8g, assay 98.4%, MWt 547.00, Formula C26H31ClN4O7, Purity >98%, SMILES N[C@@H](C(N[C@H](CCCC)C(OCC1=CC=C([N+]([O-])=O)C=C1)=O)=O)CC2=CN(C(OC)=O)C3=CC=CC=C32.[H]Cl, MDL NA |
| Drug_Names: tert-Butyl 4-(4-amino-2-fluorophenyl)tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 154590-35-9, stock 311.8g, assay 98.7%, MWt 295.35, Formula C15H22FN3O2, Purity >98%, SMILES FC1=CC(N)=CC=C1N2CCN(C(OC(C)(C)C)=O)CC2, MDL MFCD08443960 |
| Drug_Names: 8-Ethyl-4-methyl-2-(methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one, CAS: 934493-79-5, stock 110.3g, assay 98.9%, MWt 235.31, Formula C11H13N3OS, Purity >98%, SMILES O=C1C=CC2=C(C)N=C(SC)N=C2N1CC, MDL NA |
| Drug_Names: 8-Ethyl-2-methoxy-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one, CAS: 2070015-42-6, stock 361.4g, assay 98.2%, MWt 219.24, Formula C11H13N3O2, Purity >98%, SMILES O=C1C=CC2=C(C)N=C(OC)N=C2N1CC, MDL NA |
| Drug_Names: 1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone, CAS: 1378387-81-5, stock 834.7g, assay 98.9%, MWt 357.58, Formula C15H8BrClF2O, Purity >98%, SMILES ClCC(C1=CC(C(F)(F)C2=C3C=CC(Br)=C2)=C3C=C1)=O, MDL MFCD28400046 |
| Drug_Names: 3-Carboxy-6-methoxy-2,3,4,4a,5,10-hexahydrobenzo[g]quinolin-1-ium chloride, CAS: 288389-25-3, stock 754g, assay 98.5%, MWt 295.76, Formula C15H18ClNO3, Purity >98%, SMILES COC1=C2C(CC3=[NH+]CC(C(O)=O)CC3C2)=CC=C1.[Cl-], MDL NA |
| Drug_Names: O-Allyl-N-[(9-anthracenyl)methyl]cinchonidium bromide, CAS: 200132-54-3, stock 872.7g, assay 98.2%, MWt 525.70, Formula C37H37N2O+, Purity >98%, SMILES [H][C@]1(C[C@H]2[C@@H](C=C)C[N@+]1(CC3=C(C=CC=C4)C4=CC5=C3C=CC=C5)CC2)[C@H](OCC=C)C6=CC=NC7=CC=CC=C76, MDL MFCD01632446 |
| Drug_Names: 3-(((5-Chloro-3-ethylpyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide, CAS: 779353-65-0, stock 421.6g, assay 98%, MWt 303.75, Formula C14H14ClN5O, Purity >98%, SMILES [O-][N+]1=CC=CC(CNC2=CC(Cl)=NC3=C(CC)C=NN23)=C1, MDL NA |
| Drug_Names: 4-(((3,3-Dimethylbutan-2-yl)amino)methyl)benzoic acid, CAS: 1569537-18-3, stock 35.3g, assay 98.1%, MWt 235.32, Formula C14H21NO2, Purity >98%, SMILES OC(C1=CC=C(CNC(C)C(C)(C)C)C=C1)=O, MDL NA |
| Drug_Names: NSC 88911, CAS: 1624-62-0, stock 713.9g, assay 98.8%, MWt 284.39, Formula C19H24O2, Purity >98%, SMILES O=C1CC[C@@]2([H])[C@]3([H])CCC4=C(C=CC(OC)=C4)[C@@]3([H])CC[C@]12C, MDL NA |
| Drug_Names: N1-((8R,9S,13S,14S,17S)-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)hexane-1,6-diamine, CAS: 112646-70-5, stock 199.9g, assay 98.1%, MWt 384.60, Formula C25H40N2O, Purity >98%, SMILES NCCCCCCN[C@H]1CC[C@@]2([H])[C@]3([H])CCC4=C(C=CC(OC)=C4)[C@@]3([H])CC[C@]12C, MDL NA |
| Drug_Names: (S)-(-)-3-(N-Methylamino)-1-(2-thienyl)-1-propanol, CAS: 116539-55-0, stock 866.5g, assay 98%, MWt 171.26, Formula C8H13NOS, Purity >98%, SMILES O[C@H](C1=CC=CS1)CCNC, MDL MFCD07357308 |
| Drug_Names: Methyl 1-(2-chloroacetyl)-2-oxoindoline-6-carboxylate, CAS: 1160293-25-3, stock 879.1g, assay 98.3%, MWt 267.67, Formula C12H10ClNO4, Purity >98%, SMILES O=C(C1=CC2=C(C=C1)CC(N2C(CCl)=O)=O)OC, MDL NA |
| Drug_Names: (E)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate, CAS: 1174335-83-1, stock 516.1g, assay 98.7%, MWt 385.80, Formula C20H16ClNO5, Purity >98%, SMILES O=C(C1=CC(N(C(CCl)=O)C/2=O)=C(C=C1)C2=C(C3=CC=CC=C3)/OC)OC, MDL NA |
| Drug_Names: (2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, CAS: 817204-32-3, stock 185.9g, assay 98%, MWt 571.55, Formula C31H26FN3O7, Purity >98%, SMILES O=C(N=C(C=C1)NC(C2=CC=CC=C2)=O)N1[C@H](O3)[C@](C)(F)[C@H](OC(C4=CC=CC=C4)=O)[C@H]3COC(C5=CC=CC=C5)=O, MDL NA |
| Drug_Names: (S)-6-(2-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-2-oxoethyl) 5-tert-butyl 5-azaspiro[2.4]heptane-5,6-dicarboxylate, CAS: 1499193-61-1, stock 843.8g, assay 98%, MWt 562.40, Formula C27H26BrF2NO5, Purity >98%, SMILES O=C([C@H](C1)N(C(OC(C)(C)C)=O)CC21CC2)OCC(C3=CC(C(F)(F)C4=C5C=CC(Br)=C4)=C5C=C3)=O, MDL NA |
| Drug_Names: 2-Methyl-3-methoxycarbonylindole, CAS: 65417-22-3, stock 309.5g, assay 98.7%, MWt 189.21, Formula C11H11NO2, Purity >98%, SMILES CC1=C(C(OC)=O)C2=CC=CC=C2N1, MDL MFCD00963961 |
| Drug_Names: 3-Fluoro-4-[4-(tert-butoxycarbonyl)piperazin-1-yl]nitrobenzene, CAS: 154590-34-8, stock 358.4g, assay 98.7%, MWt 325.34, Formula C15H20FN3O4, Purity >98%, SMILES FC1=CC([N+]([O-])=O)=CC=C1N2CCN(C(OC(C)(C)C)=O)CC2, MDL MFCD08443959 |
| Drug_Names: Methyl (S)-3-(tert-butoxycarbonyl)-2,2-dimethyl-4-oxazolidinecarboxylate, CAS: 108149-60-6, stock 724.1g, assay 98.8%, MWt 259.30, Formula C12H21NO5, Purity >98%, SMILES O=C([C@@H]1COC(C)(C)N1C(OC(C)(C)C)=O)OC, MDL MFCD00192279 |
| Drug_Names: [(1S,3S,5S)-3-(Tritylamino)-6-oxabicyclo[3.1.0]hexan-1-yl]methanol, CAS: 1113025-23-2, stock 685.6g, assay 99%, MWt 371.47, Formula C25H25NO2, Purity >98%, SMILES OC[C@]1(O2)[C@@H]2C[C@H](NC(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)C1, MDL NA |
| Drug_Names: (1S,3S)-1-(Hydroxymethyl)-3-(tritylamino)cyclopentanol, CAS: 1113025-25-4, stock 727.3g, assay 98.6%, MWt 373.49, Formula C25H27NO2, Purity >98%, SMILES O[C@@]1(CO)CC[C@H](NC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C1, MDL NA |
| Drug_Names: (1S,2S,4R)-4-amino-2-(hydroxymethyl)cyclopentanol hydrochloride, CAS: 1951424-77-3, stock 124g, assay 98.3%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES N[C@H]1C[C@H](O)[C@H](CO)C1.Cl, MDL NA |
| Drug_Names: 4-Amino-N-hydroxy-1,2,5-oxadiazole-3-carbimidoyl chloride, CAS: 147085-13-0, stock 668.5g, assay 98.3%, MWt 162.53, Formula C3H3ClN4O2, Purity >98%, SMILES O/N=C(Cl)/C1=NON=C1N, MDL NA |
| Drug_Names: 3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one, CAS: 914471-43-5, stock 210.3g, assay 98.2%, MWt 342.08, Formula C10H5BrFN5O3, Purity >98%, SMILES NC1=NON=C1C(N2C3=CC(Br)=C(F)C=C3)=NOC2=O, MDL NA |
| Drug_Names: N-[4-[4-(3-Bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-yl]-2,2,2-trifluoroacetamide, CAS: 914471-60-6, stock 3.2g, assay 98.9%, MWt 438.09, Formula C12H4BrF4N5O4, Purity >98%, SMILES FC(C=C1)=C(Br)C=C1N2C(C3=NON=C3NC(C(F)(F)F)=O)=NOC2=O, MDL NA |
| Drug_Names: 3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydrochloride, CAS: 1204669-67-9, stock 808.7g, assay 98.8%, MWt 421.61, Formula C12H11BrClFN6O3, Purity >98%, SMILES FC1=CC=C(N2C(C3=NON=C3NCCN)=NOC2=O)C=C1Br.[H]Cl, MDL NA |
| Drug_Names: 2-(3-Chlorophenyl)-1-(4-chlorophenyl)ethan-1-one, CAS: 68968-12-7, stock 148.6g, assay 98.9%, MWt 265.13, Formula C14H10Cl2O, Purity >98%, SMILES ClC1=CC=C(C(CC2=CC=CC(Cl)=C2)=O)C=C1, MDL NA |
| Drug_Names: 3-Dimethylaminomethylene-4-oxo-pyrrolidine-1-carboxylic acid tert-butyl ester, CAS: 157327-42-9, stock 280.1g, assay 98.9%, MWt 240.30, Formula C12H20N2O3, Purity >98%, SMILES O=C1/C(CN(C(OC(C)(C)C)=O)C1)=C\N(C)C, MDL MFCD11616027 |
| Drug_Names: tert-Butyl 6a-hydroxy-3a,4,6,6a-tetrahydropyrrolo[3,4-c]pyrazole-5(1H)-carboxylate, CAS: 1211594-55-6, stock 156.3g, assay 98.1%, MWt 227.26, Formula C10H17N3O3, Purity >98%, SMILES OC12NN=CC1CN(C(OC(C)(C)C)=O)C2, MDL NA |
| Drug_Names: tert-Butyl 2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate, CAS: 1280210-79-8, stock 307.4g, assay 98.3%, MWt 209.25, Formula C10H15N3O2, Purity >98%, SMILES CC(C)(C)OC(N1CC2=CNN=C2C1)=O, MDL MFCD22565651 |
| Drug_Names: 2-(Methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylic acid tert-butyl ester, CAS: 1226781-82-3, stock 877.3g, assay 98.9%, MWt 287.34, Formula C11H17N3O4S, Purity >98%, SMILES O=S(N1C=C2CN(C(OC(C)(C)C)=O)CC2=N1)(C)=O, MDL NA |
| Drug_Names: Sodium 2-propanesulfinate, CAS: 4160-19-4, stock 890.3g, assay 98.8%, MWt 130.14, Formula C3H7NaO2S, Purity >98%, SMILES CC(C)S([O-])=O.[Na+], MDL NA |
| Drug_Names: Methyl 5-(2-nitrobenzoyl)furan-2-carboxylate, CAS: 353504-65-1, stock 889.7g, assay 98.3%, MWt 275.21, Formula C13H9NO6, Purity >98%, SMILES O=C(C1=CC=C(C(OC)=O)O1)C2=CC=CC=C2[N+]([O-])=O, MDL NA |
| Drug_Names: Methyl 5-(1H-indazol-3-yl)furan-2-carboxylate, CAS: 353504-12-8, stock 553.2g, assay 99%, MWt 242.23, Formula C13H10N2O3, Purity >98%, SMILES O=C(OC)C1=CC=C(O1)C2=NNC3=CC=CC=C32, MDL NA |
| Drug_Names: 1-Benzyl-3-(5-methoxycarbonyl-2-furyl)indazole, CAS: 170632-13-0, stock 602.8g, assay 98.8%, MWt 332.35, Formula C20H16N2O3, Purity >98%, SMILES O=C(OC)C1=CC=C(O1)C2=NN(CC3=CC=CC=C3)C4=CC=CC=C42, MDL NA |
| Drug_Names: (S)-1-(tetrahydro-2H-pyran-4-yl)ethyl methanesulfonate, CAS: 1932098-49-1, stock 399.6g, assay 98.8%, MWt 208.28, Formula C8H16O4S, Purity >98%, SMILES C[C@H](OS(C)(=O)=O)C1CCOCC1, MDL NA |
| Drug_Names: 3-(Aminomethyl)-4-methoxy-6-methylpyridin-2(1H)-one hydrochloride, CAS: 1450662-30-2, stock 139.6g, assay 98.7%, MWt 204.65, Formula C8H13ClN2O2, Purity >98%, SMILES NCC1=C(OC)C=C(C)NC1=O.[H]Cl, MDL NA |
| Drug_Names: (9S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-9-isopropyl-12-methoxy-5,5,10-trimethyl-3,6,8-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid, CAS: 1438851-55-8, stock 143.1g, assay 98.1%, MWt 609.75, Formula C34H47N3O7, Purity >98%, SMILES CC[C@H](C)[C@@H]([C@@H](CC(O)=O)OC)N(C([C@H](C(C)C)NC(C(C)(C)NC(OCC1C2=C(C=CC=C2)C3=C1C=CC=C3)=O)=O)=O)C, MDL NA |
| Drug_Names: 4-Bromopyridine hydrochloride, CAS: 19524-06-2, stock 751.1g, assay 98.1%, MWt 194.46, Formula C5H5BrClN, Purity >98%, SMILES BrC1=CC=NC=C1.[H]Cl, MDL MFCD00012828 |
| Drug_Names: Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate, CAS: 503614-91-3, stock 545.7g, assay 98.3%, MWt 488.54, Formula C27H28N4O5, Purity >98%, SMILES O=C(N(C(C=C1)=CC=C1N(CCCC2)C2=O)CC3)C4=C3C(C(OCC)=O)=NN4C5=CC=C(OC)C=C5, MDL MFCD18072444 |
| Drug_Names: 2,7-Dibromo-9H-fluoren-9-one, CAS: 14348-75-5, stock 43.9g, assay 98.8%, MWt 337.99, Formula C13H6Br2O, Purity >98%, SMILES O=C1C2=C(C3=C1C=C(Br)C=C3)C=CC(Br)=C2, MDL MFCD00010790 |
| Drug_Names: NSC 408493, CAS: 19672-49-2, stock 813g, assay 98.9%, MWt 304.34, Formula C20H16O3, Purity >98%, SMILES OC(C1=CC=C(C(O)=O)C=C1)(C2=CC=CC=C2)C3=CC=CC=C3, MDL NA |
| Drug_Names: (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate, CAS: 122350-59-8, stock 617.2g, assay 98.8%, MWt 367.40, Formula C21H21NO5, Purity >98%, SMILES O=C(OC)[C@@H]1C[C@@H](O)CN1C(OCC2C3=C(C=CC=C3)C4=C2C=CC=C4)=O, MDL MFCD12545917 |
| Drug_Names: tert-Butyl [1-[methoxy(methyl)amino]-1-oxo-4-pentyn-2-yl]carbamate, CAS: 1172623-95-8, stock 898.2g, assay 98%, MWt 256.30, Formula C12H20N2O4, Purity >98%, SMILES C#CCC(NC(OC(C)(C)C)=O)C(N(OC)C)=O, MDL NA |
| Drug_Names: tert-Butyl [1-(2,5-difluorophenyl)-1-oxo-4-pentyn-2-yl]carbamate, CAS: 1172623-96-9, stock 893.1g, assay 98.7%, MWt 309.31, Formula C16H17F2NO3, Purity >98%, SMILES C#CCC(NC(OC(C)(C)C)=O)C(C1=CC(F)=CC=C1F)=O, MDL NA |
| Drug_Names: 5,6-Diphenylpyrazinol, CAS: 18591-57-6, stock 303.8g, assay 98.1%, MWt 248.28, Formula C16H12N2O, Purity >98%, SMILES O=C1NC(C2=CC=CC=C2)=C(N=C1)C3=CC=CC=C3, MDL NA |
| Drug_Names: 5-Chloro-2,3-diphenylpyrazine, CAS: 41270-66-0, stock 243.1g, assay 98.5%, MWt 266.72, Formula C16H11ClN2, Purity >98%, SMILES ClC1=CN=C(C2=CC=CC=C2)C(C3=CC=CC=C3)=N1, MDL MFCD00234892 |
| Drug_Names: 4-(Isopropylamino)butanol, CAS: 42042-71-7, stock 14.2g, assay 99%, MWt 131.22, Formula C7H17NO, Purity >98%, SMILES OCCCCNC(C)C, MDL NA |
| Drug_Names: 4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butan-1-ol, CAS: 475086-75-0, stock 5.5g, assay 98.6%, MWt 361.48, Formula C23H27N3O, Purity >98%, SMILES OCCCCN(C1=NC(C2=CC=CC=C2)=C(C3=CC=CC=C3)N=C1)C(C)C, MDL NA |
| Drug_Names: 2-Methyl-5-chloromethyl-1,3,4-thiadiazole, CAS: 75341-23-0, stock 698.7g, assay 98.1%, MWt 148.61, Formula C4H5ClN2S, Purity >98%, SMILES CC1=NN=C(CCl)S1, MDL MFCD13188552 |
| Drug_Names: (2-Aminoethyl)naphthalimide, CAS: 162265-51-2, stock 63.2g, assay 98.1%, MWt 240.26, Formula C14H12N2O2, Purity >98%, SMILES O=C(C1=C2C(C=CC=C23)=CC=C1)N(CCN)C3=O, MDL NA |
| Drug_Names: N'-acetyl-2-bromoacetohydrazide, CAS: 1342263-70-0, stock 313.5g, assay 98.7%, MWt 195.01, Formula C4H7BrN2O2, Purity >98%, SMILES CC(NNC(CBr)=O)=O, MDL NA |
| Drug_Names: 2-(2-Aminoethyl)-6-(dimethylamino)-1H-benz[de]isoquinoline-1,3(2H)-dione, CAS: 1051373-06-8, stock 684.4g, assay 98.4%, MWt 283.33, Formula C16H17N3O2, Purity >98%, SMILES O=C(C1=C2C(C=CC=C23)=C(N(C)C)C=C1)N(CCN)C3=O, MDL NA |
| Drug_Names: 2-Chloro-N-(methylsulfonyl)acetamide, CAS: 202658-88-6, stock 886.7g, assay 98.7%, MWt 171.60, Formula C3H6ClNO3S, Purity >98%, SMILES CS(NC(CCl)=O)(=O)=O, MDL NA |
| Drug_Names: 1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone, CAS: 1157938-97-0, stock 111.5g, assay 98.7%, MWt 223.18, Formula C10H7F2N3O, Purity >98%, SMILES O=C(CN1N=CN=C1)C2=CC(F)=CC=C2F, MDL MFCD12061657 |
| Drug_Names: 2-Fluoro-5-bromobenzaldehyde, CAS: 93777-26-5, stock 340.6g, assay 98%, MWt 203.01, Formula C7H4BrFO, Purity >98%, SMILES FC1=C(C([H])=O)C=C(Br)C=C1, MDL MFCD00070755 |
| Drug_Names: (4R)-1-(tert-Butoxycarbonyl)-4-hydroxy-L-proline, CAS: 13726-69-7, stock 481.9g, assay 98.9%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES O[C@@H]1C[C@@H](C(O)=O)N(C(OC(C)(C)C)=O)C1, MDL MFCD00053370 |
| Drug_Names: D-Mannitol 1,2:5,6-bis-acetonide, CAS: 1707-77-3, stock 44.3g, assay 98.7%, MWt 262.30, Formula C12H22O6, Purity >98%, SMILES O[C@@H]([C@@H]([C@@H]1OC(C)(C)OC1)O)[C@H]2COC(C)(C)O2, MDL MFCD00003211 |
| Drug_Names: (R)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid, CAS: 1234474-57-7, stock 245.1g, assay 98.5%, MWt 524.63, Formula C29H32O7S, Purity >98%, SMILES CC1=C(C2=CC(COC3=CC=C([C@@H](CC(O)=O)CO4)C4=C3)=CC=C2)C(C)=CC(OCCCS(C)(=O)=O)=C1, MDL NA |
| Drug_Names: N-(2-((S)-3-(((1r,4S)-4-hydroxy-4-(5-(pyrimidin-2-yl)pyridin-2-yl)cyclohexyl)amino)pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide, CAS: 1372407-07-2, stock 813.9g, assay 98.3%, MWt 568.59, Formula C29H31F3N6O3, Purity >98%, SMILES O[C@]1(CC[C@@](CC1)([H])N[C@@H]2CN(CC2)C(CNC(C3=CC=CC(C(F)(F)F)=C3)=O)=O)C4=NC=C(C=C4)C5=NC=CC=N5, MDL NA |
| Drug_Names: (3R,6S)-3-Amino-6-(2,3-difluorophenyl)-1-(2,2,2-trifluoroethyl)azepan-2-one (hydrochloride), CAS: 953077-37-7, stock 774.4g, assay 98.4%, MWt 358.73, Formula C14H16ClF5N2O, Purity >98%, SMILES FC1=C(F)C([C@@H]2CC[C@@H](N)C(N(CC(F)(F)F)C2)=O)=CC=C1.[H]Cl, MDL NA |
| Drug_Names: Dimethylmethylenehydrazine, CAS: 2035-89-4, stock 363.4g, assay 98.3%, MWt 72.11, Formula C3H8N2, Purity >98%, SMILES CN(C)N=C, MDL NA |
| Drug_Names: 3-(4-(2-Chlorophenoxy)piperidine-1-carboxamido)benzoic acid, CAS: 1058702-87-6, stock 1.1g, assay 98.5%, MWt 374.82, Formula C19H19ClN2O4, Purity >98%, SMILES O=C(NC1=CC=CC(C(O)=O)=C1)N(CC2)CCC2OC3=CC=CC=C3Cl, MDL NA |
| Drug_Names: (R)-2-(((Benzyloxy)carbonyl)amino)-3,3-dimethylbutanoic acid, CAS: 70874-05-4, stock 881.7g, assay 98.3%, MWt 265.30, Formula C14H19NO4, Purity >98%, SMILES OC([C@H](NC(OCC1=CC=CC=C1)=O)C(C)(C)C)=O, MDL MFCD07368370 |
| Drug_Names: 4-Iodo-2,6-dimethylaniline, CAS: 4102-53-8, stock 859.3g, assay 98.2%, MWt 247.08, Formula C8H10IN, Purity >98%, SMILES IC1=CC(C)=C(N)C(C)=C1, MDL MFCD08061611 |
| Drug_Names: (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one, CAS: 875444-08-9, stock 640.9g, assay 98.9%, MWt 313.20, Formula C12H9F6NO2, Purity >98%, SMILES C[C@H](NC(O1)=O)[C@H]1C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2, MDL MFCD16294904 |
| Drug_Names: [2-Iodo-5-(trifluoromethyl)phenyl]methanol, CAS: 702641-05-2, stock 730.4g, assay 98.2%, MWt 302.03, Formula C8H6F3IO, Purity >98%, SMILES IC1=C(CO)C=C(C(F)(F)F)C=C1, MDL MFCD11849936 |
| Drug_Names: [4-Fluoro-2-methoxy-5-(propan-2-yl)phenyl]boronic acid, CAS: 875446-29-0, stock 129.9g, assay 98.8%, MWt 212.03, Formula C10H14BFO3, Purity >98%, SMILES COC1=C(B(O)O)C=C(C(C)C)C(F)=C1, MDL MFCD16294183 |
| Drug_Names: 1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride, CAS: 1228879-37-5, stock 264.7g, assay 98.9%, MWt 291.26, Formula C14H24Cl2N2, Purity >98%, SMILES CC1CCN(CC2=CC=CC=C2)CC1NC.Cl[H].Cl[H], MDL NA |
| Drug_Names: (S)-3-benzyl-1-(tert-Butoxycarbonyl)piperidine-3-carboxylic acid, CAS: 170838-87-6, stock 10.8g, assay 98.2%, MWt 319.40, Formula C18H25NO4, Purity >98%, SMILES O=C(N1C[C@@](C(O)=O)(CC2=CC=CC=C2)CCC1)OC(C)(C)C, MDL MFCD02179131 |
| Drug_Names: (R)-tert-Butyl 3-benzyl-3-(1,2,2-trimethylhydrazinecarbonyl)piperidine-1-carboxylate, CAS: 339539-82-1, stock 757.3g, assay 98.7%, MWt 375.51, Formula C21H33N3O3, Purity >98%, SMILES CC(C)(C)OC(N1CCC[C@@](C(N(C)N(C)C)=O)(CC2=CC=CC=C2)C1)=O, MDL NA |
| Drug_Names: (R)-3-benzyl-N,N',N'-trimethylpiperidine-3-carbohydrazide dihydrochloride, CAS: 883572-50-7, stock 763.3g, assay 98.8%, MWt 348.31, Formula C16H27Cl2N3O, Purity >98%, SMILES O=C(N(C)N(C)C)[C@]1(CC2=CC=CC=C2)CNCCC1.Cl[H].Cl[H], MDL NA |
| Drug_Names: (R)-2-(2-((tert-Butoxycarbonyl)amino)-2-methylpropanamido)-3-(1H-indol-3-yl)propanoic acid, CAS: 159634-94-3, stock 797.7g, assay 98.4%, MWt 389.45, Formula C20H27N3O5, Purity >98%, SMILES O=C(O)[C@H](NC(C(C)(NC(OC(C)(C)C)=O)C)=O)CC1=CNC2=C1C=CC=C2, MDL MFCD08704784 |
| Drug_Names: N-[(1,1-Dimethylethoxy)carbonyl]-2-methylalanyl-L-tryptophan, CAS: 210481-85-9, stock 501.4g, assay 98.8%, MWt 389.45, Formula C20H27N3O5, Purity >98%, SMILES O=C(O)[C@@H](NC(C(C)(C)NC(OC(C)(C)C)=O)=O)CC1=CNC2=C1C=CC=C2, MDL NA |
| Drug_Names: tert-Butyl (1-(((S)-1-((R)-3-benzyl-3-(1,2,2-trimethylhydrazinecarbonyl)piperidin-1-yl)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-2-methyl-1-oxopropan-2-yl)carbamate, CAS: 883572-59-6, stock 199.7g, assay 98%, MWt 646.82, Formula C36H50N6O5, Purity >98%, SMILES O=C(N(C)N(C)C)[C@]1(CC2=CC=CC=C2)CN(C([C@@H](NC(C(C)(C)NC(OC(C)(C)C)=O)=O)CC3=CNC4=C3C=CC=C4)=O)CCC1, MDL NA |
| Drug_Names: (S)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetic acid, CAS: 1380792-92-6, stock 186.1g, assay 98.2%, MWt 194.18, Formula C10H10O4, Purity >98%, SMILES O=C(O)C[C@@H]1COC2=CC(O)=CC=C12, MDL NA |
| Drug_Names: (R)-1-phenylethanamine (S)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, CAS: 1394138-46-5, stock 33.3g, assay 98.4%, MWt 315.36, Formula C18H21NO4, Purity >98%, SMILES O=C(O)C[C@@H]1COC2=CC(O)=CC=C12.C[C@@H](N)C3=CC=CC=C3, MDL NA |
| Drug_Names: Ethyl 2-amino-4-fluoro-4-methylpentanoate, CAS: 885498-60-2, stock 784.4g, assay 98.7%, MWt 177.22, Formula C8H16FNO2, Purity >98%, SMILES NC(CC(C)(F)C)C(OCC)=O, MDL NA |
| Drug_Names: Ethyl 2-((diphenylmethylene)amino)-4-methylpent-4-enoate, CAS: 80741-44-2, stock 528.3g, assay 98.9%, MWt 321.41, Formula C21H23NO2, Purity >98%, SMILES CC(CC(C(OCC)=O)/N=C(C1=CC=CC=C1)\C2=CC=CC=C2)=C, MDL NA |
| Drug_Names: (S,S)-(-)-2,2'-Bis[(R)-(N,N-dimethylamino)(phenyl)methyl]-1,1'-bis(diphenylphosphino)ferrocene, CAS: 210842-74-3, stock 620.1g, assay 98%, MWt 820.76, Formula C52H50FeN2P2, Purity >98%, SMILES [][Fe][].CN(C)[C@H](C1=CC=CC=C1)c2c(P(C3=CC=CC#C3)C4=CC=CC=C4)ccc2.CN(C)[C@@H](C5=CC=CC=C5)[C@H]6CCCC6P(C7=CC=CC=C7)C8=CC=CC=C8, MDL NA |
| Drug_Names: tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl)carbamate, CAS: 1172623-98-1, stock 532.1g, assay 98.7%, MWt 311.32, Formula C16H19F2NO3, Purity >98%, SMILES FC1=CC([C@H]2OC=CC[C@@H]2NC(OC(C)(C)C)=O)=C(F)C=C1, MDL MFCD28144045 |
| Drug_Names: tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl)carbamate, CAS: 1172623-99-2, stock 718.5g, assay 98.4%, MWt 329.34, Formula C16H21F2NO4, Purity >98%, SMILES FC1=CC([C@H]2OCC(O)C[C@@H]2NC(OC(C)(C)C)=O)=C(F)C=C1, MDL NA |
| Drug_Names: [tert-Butoxycarbonylimino(piperazin-1-yl)methyl]carbamic acid tert-butyl ester, CAS: 203258-20-2, stock 898.8g, assay 98.9%, MWt 328.41, Formula C15H28N4O4, Purity >98%, SMILES CC(C)(C)OC(/N=C(NC(OC(C)(C)C)=O)/N1CCNCC1)=O, MDL NA |
| Drug_Names: tert-Butyl (tert-butoxycarbonyl)(((tert-butoxycarbonyl)imino)(4-(piperazine-1-carbonyl)phenyl)methyl)carbamate, CAS: 1379574-12-5, stock 584.5g, assay 98.7%, MWt 532.63, Formula C27H40N4O7, Purity >98%, SMILES O=C(N1CCNCC1)C2=CC=C(/C(N(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)=N\C(OC(C)(C)C)=O)C=C2, MDL NA |
| Drug_Names: NSC 157569, CAS: 20099-89-2, stock 18.5g, assay 98.3%, MWt 224.05, Formula C9H6BrNO, Purity >98%, SMILES N#CC1=CC=C(C(CBr)=O)C=C1, MDL MFCD00052931 |
| Drug_Names: 5-Chloro-4-formyl-3-methyl-1-phenylpyrazole, CAS: 947-95-5, stock 860g, assay 98.9%, MWt 220.66, Formula C11H9ClN2O, Purity >98%, SMILES CC1=NN(C2=CC=CC=C2)C(Cl)=C1C=O, MDL MFCD00100755 |
| Drug_Names: (S)-benzyl (1-(4-phenyl-1H-imidazol-2-yl)ethyl)carbamate, CAS: 864825-21-8, stock 61g, assay 98.8%, MWt 321.37, Formula C19H19N3O2, Purity >98%, SMILES C[C@H](NC(OCC1=CC=CC=C1)=O)C2=NC(C3=CC=CC=C3)=CN2, MDL NA |
| Drug_Names: (S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine, CAS: 864825-23-0, stock 353.8g, assay 98.3%, MWt 187.24, Formula C11H13N3, Purity >98%, SMILES C[C@H](N)C1=NC(C2=CC=CC=C2)=CN1, MDL MFCD22689971 |
| Drug_Names: Methyl 5-formyl-2-methoxybenzoate, CAS: 78515-16-9, stock 336.4g, assay 98.1%, MWt 194.18, Formula C10H10O4, Purity >98%, SMILES COC1=CC=C(C=O)C=C1C(OC)=O, MDL MFCD10565654 |
| Drug_Names: Methyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate, CAS: 93267-04-0, stock 457.9g, assay 98.9%, MWt 329.13, Formula C9H16INO4, Purity >98%, SMILES O=C(OC)[C@H](CI)NC(OC(C)(C)C)=O, MDL MFCD00216579 |
| Drug_Names: (S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoate, CAS: 623950-05-0, stock 198.3g, assay 98.9%, MWt 350.41, Formula C18H26N2O5, Purity >98%, SMILES CC1=C(C[C@@H](C(OC)=O)NC(OC(C)(C)C)=O)C(C)=CC(C(N)=O)=C1, MDL NA |
| Drug_Names: (S)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-cyano-2,6-dimethylphenyl)propanoate, CAS: 1227311-10-5, stock 12.9g, assay 98.3%, MWt 332.39, Formula C18H24N2O4, Purity >98%, SMILES CC1=C(C[C@@H](C(OC)=O)NC(OC(C)(C)C)=O)C(C)=CC(C#N)=C1, MDL NA |
| Drug_Names: (S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid, CAS: 623950-02-7, stock 606.7g, assay 98.9%, MWt 336.38, Formula C17H24N2O5, Purity >98%, SMILES CC1=C(C[C@@H](C(O)=O)NC(OC(C)(C)C)=O)C(C)=CC(C(N)=O)=C1, MDL MFCD20528368 |
| Drug_Names: Benzoic acid, 4-[[bis[(1,1-dimethylethoxy)carbonyl]amino][[(1,1- dimethylethoxy)carbonyl]imino]methyl]-, methyl ester, CAS: 135321-85-6, stock 858.3g, assay 98.3%, MWt 478.54, Formula C24H34N2O8, Purity >98%, SMILES O=C(OC)C1=CC=C(/C(N(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O)=N\C(OC(C)(C)C)=O)C=C1, MDL NA |
| Drug_Names: (S)-N-(2-(3-aminopyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide hydrochloride, CAS: 857651-01-5, stock 56.6g, assay 98.9%, MWt 351.75, Formula C14H17ClF3N3O2, Purity >98%, SMILES O=C(NCC(N1C[C@@H](N)CC1)=O)C2=CC=CC(C(F)(F)F)=C2.Cl, MDL NA |
| Drug_Names: (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol, CAS: 875573-67-4, stock 845.9g, assay 98.4%, MWt 477.52, Formula C27H41BrO2, Purity >98%, SMILES C[C@@]12[C@@H](O)CC[C@@]1([H])[C@]3([H])[C@H](CCCCCCCCCBr)CC4=C(C=CC(O)=C4)[C@@]3([H])CC2, MDL MFCD16038540 |
| Drug_Names: (R)-methyl 2-((methoxycarbonyl)amino)-3-methylbutanoate, CAS: 153575-98-5, stock 522.5g, assay 98.4%, MWt 189.21, Formula C8H15NO4, Purity >98%, SMILES CC(C)[C@@H](NC(OC)=O)C(OC)=O, MDL NA |
| Drug_Names: (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol, CAS: 133775-25-4, stock 370.7g, assay 98.5%, MWt 269.25, Formula C12H13F2N3O2, Purity >98%, SMILES C[C@@H](O)[C@@](O)(C1=CC=C(F)C=C1F)CN2N=CN=C2, MDL NA |
| Drug_Names: Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate, CAS: 1533519-85-5, stock 824.6g, assay 98.2%, MWt 339.41, Formula C18H17N3O2S, Purity >98%, SMILES O=C(OC)CSC1=NN=CN1C2=C3C=CC=CC3=C(C4CC4)C=C2, MDL NA |
| Drug_Names: Dihydrobenzopyran, CAS: 493-08-3, stock 62.8g, assay 98.6%, MWt 134.18, Formula C9H10O, Purity >98%, SMILES C12=CC=CC=C1CCCO2, MDL MFCD00138123 |
| Drug_Names: 6-Bromochroman, CAS: 3875-78-3, stock 330.8g, assay 98.3%, MWt 213.07, Formula C9H9BrO, Purity >98%, SMILES BrC1=CC(CCCO2)=C2C=C1, MDL MFCD10698725 |
| Drug_Names: Chroman-6-ylboronic acid, CAS: 279261-84-6, stock 460.9g, assay 98.7%, MWt 177.99, Formula C9H11BO3, Purity >98%, SMILES OB(O)C1=CC(CCCO2)=C2C=C1, MDL MFCD12779349 |
| Drug_Names: 4-(2-Chlorophenoxy)piperidine hydrochloride, CAS: 849107-20-6, stock 644.7g, assay 99%, MWt 248.15, Formula C11H15Cl2NO, Purity >98%, SMILES ClC(C=CC=C1)=C1OC2CCNCC2.Cl, MDL MFCD02684107 |
| Drug_Names: 1-Methyl-4-(6-nitropyridin-3-yl)piperazine, CAS: 657410-79-2, stock 785.4g, assay 98.7%, MWt 222.24, Formula C10H14N4O2, Purity >98%, SMILES O=[N+](C1=NC=C(N2CCN(C)CC2)C=C1)[O-], MDL MFCD11520856 |
| Drug_Names: 1-Methyl-4-(6-aminopyridin-3-yl)piperazine, CAS: 571189-49-6, stock 870.7g, assay 98.9%, MWt 192.26, Formula C10H16N4, Purity >98%, SMILES NC1=NC=C(N2CCN(C)CC2)C=C1, MDL MFCD10009563 |
| Drug_Names: 1-Methyl-3-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)amino)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, CAS: 1242156-62-2, stock 450.9g, assay 98.8%, MWt 425.33, Formula C22H32BN5O3, Purity >98%, SMILES O=C1C(NC2=NC=C(N3CCN(C)CC3)C=C2)=CC(B4OC(C)(C)C(C)(C)O4)=CN1C, MDL NA |
| Drug_Names: 2-Bromo-6-chlorobenzaldehyde, CAS: 64622-16-8, stock 778.8g, assay 98.1%, MWt 219.46, Formula C7H4BrClO, Purity >98%, SMILES BrC1=C(C=O)C(Cl)=CC=C1, MDL NA |
| Drug_Names: 2,6-Dibromobenzaldehyde, CAS: 67713-23-9, stock 347.6g, assay 98.7%, MWt 263.91, Formula C7H4Br2O, Purity >98%, SMILES BrC1=C(C=O)C(Br)=CC=C1, MDL MFCD11040410 |
| Drug_Names: 2,6-Dibromobenzyl alcohol, CAS: 1013031-65-6, stock 686.5g, assay 98.8%, MWt 265.93, Formula C7H6Br2O, Purity >98%, SMILES BrC1=C(CO)C(Br)=CC=C1, MDL NA |
| Drug_Names: 4-Bromo-2-fluoro-6-methylbenzonitrile, CAS: 1427438-75-2, stock 711.2g, assay 98.1%, MWt 214.03, Formula C8H5BrFN, Purity >98%, SMILES FC1=C(C#N)C(C)=CC(Br)=C1, MDL NA |
| Drug_Names: 4-Bromo-2-fluoro-6-methylbenzamide, CAS: 1242156-51-9, stock 467.6g, assay 98.3%, MWt 232.05, Formula C8H7BrFNO, Purity >98%, SMILES FC1=C(C(N)=O)C(C)=CC(Br)=C1, MDL NA |
| Drug_Names: 4-Cyclopropyl-2-fluoro-6-methylbenzamide, CAS: 1242156-52-0, stock 745.4g, assay 98.9%, MWt 193.22, Formula C11H12FNO, Purity >98%, SMILES FC1=C(C(N)=O)C(C)=CC(C2CC2)=C1, MDL NA |
| Drug_Names: 6-Cyclopropyl-8-fluoroisoquinolin-1(2H)-one, CAS: 1242156-53-1, stock 179.1g, assay 98.6%, MWt 203.21, Formula C12H10FNO, Purity >98%, SMILES FC1=C2C(C=CNC2=O)=CC(C3CC3)=C1, MDL NA |
| Drug_Names: NSC 128902, CAS: 74896-24-5, stock 413.1g, assay 98.9%, MWt 146.19, Formula C9H10N2, Purity >98%, SMILES CC1=CC(C#N)=CC(C)=C1N, MDL MFCD07369841 |
| Drug_Names: 2-Oxo-2-phenylethyl ((benzyloxy)carbonyl)-L-alaninate, CAS: 6530-41-2, stock 345.3g, assay 98.1%, MWt 341.36, Formula C19H19NO5, Purity >98%, SMILES O=C(OCC(C1=CC=CC=C1)=O)[C@H](C)NC(OCC2=CC=CC=C2)=O, MDL NA |
| Drug_Names: 4-Iodo-3,5-dimethylbenzonitrile, CAS: 1227311-09-2, stock 533.6g, assay 98.6%, MWt 257.07, Formula C9H8IN, Purity >98%, SMILES CC1=CC(C#N)=CC(C)=C1I, MDL MFCD19441144 |
| Drug_Names: (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-cyano-2,6-dimethylphenyl)propanoic acid, CAS: 1870867-59-6, stock 557.5g, assay 98.2%, MWt 318.37, Formula C17H22N2O4, Purity >98%, SMILES CC1=C(C[C@@H](C(O)=O)NC(OC(C)(C)C)=O)C(C)=CC(C#N)=C1, MDL NA |
| Drug_Names: 1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]piperazine, CAS: 938043-30-2, stock 684.1g, assay 98.1%, MWt 316.25, Formula C18H29BN2O2, Purity >98%, SMILES CN(CC1)CCN1CC2=CC=C(B3OC(C)(C)C(C)(C)O3)C=C2, MDL MFCD09266182 |
| Drug_Names: trans-4-(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol, CAS: 1621619-12-2, stock 413.2g, assay 98.2%, MWt 251.71, Formula C12H14ClN3O, Purity >98%, SMILES O[C@@H](CC1)CC[C@H]1N2C3=NC(Cl)=NC=C3C=C2, MDL NA |
| Drug_Names: rel-7-((1r,4r)-4-((tert-Butyldimethylsilyl)oxy)cyclohexyl)-2-chloro-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1621619-13-3, stock 810.8g, assay 98.2%, MWt 365.97, Formula C18H28ClN3OSi, Purity >98%, SMILES C[Si](O[C@H]1CC[C@H](N2C=CC3=CN=C(Cl)N=C32)CC1)(C(C)(C)C)C, MDL NA |
| Drug_Names: 5-Bromo-7-[trans-4-(tert-butyldimethylsilanyloxy)cyclohexyl]-2-chloro-7H-pyrrolo[2,3-d]pyrimidine, CAS: 1392804-15-7, stock 177.1g, assay 98.7%, MWt 444.87, Formula C18H27BrClN3OSi, Purity >98%, SMILES ClC1=NC=C2C(N([C@@H]3CC[C@@H](O[Si](C)(C)C(C)(C)C)CC3)C=C2Br)=N1, MDL NA |
| Drug_Names: 5-Bromo-N-butyl-7-[trans-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]cyclohexyl]-7H-pyrrolo[2,3-d]pyrimidin-2-amine, CAS: 1429882-29-0, stock 570g, assay 98.9%, MWt 481.54, Formula C22H37BrN4OSi, Purity >98%, SMILES BrC1=CN([C@H]2CC[C@H](O[Si](C)(C)C(C)(C)C)CC2)C3=NC(NCCCC)=NC=C31, MDL NA |
| Drug_Names: Sodium 2-acetamidomalonate, CAS: 117976-12-2, stock 305.3g, assay 98.4%, MWt 205.08, Formula C5H5NNa2O5, Purity >98%, SMILES O=C(O[Na])C(NC(C)=O)C(O[Na])=O, MDL NA |
| Drug_Names: Tributylamine (S,Z)-2-acetamido-5-(2,3-difluorophenyl)-6-nitrohex-2-enoate, CAS: 1254841-06-9, stock 126.6g, assay 98.5%, MWt 513.62, Formula C26H41F2N3O5, Purity >98%, SMILES FC1=C([C@@H](C[N+]([O-])=O)C/C=C(NC(C)=O)/C(O)=O)C=CC=C1F.CCCCN(CCCC)CCCC, MDL NA |
| Drug_Names: (5S)-isopropyl 2-acetamido-6-amino-5-(2,3-difluorophenyl)hexanoate, CAS: 1254841-08-1, stock 449.2g, assay 98.3%, MWt 342.38, Formula C17H24F2N2O3, Purity >98%, SMILES FC1=C([C@@H](CN)CCC(NC(C)=O)C(OC(C)C)=O)C=CC=C1F, MDL NA |
| Drug_Names: 6,8-Dibromoimidazo[1,2-a]pyrazine, CAS: 63744-22-9, stock 414.1g, assay 98.8%, MWt 276.92, Formula C6H3Br2N3, Purity >98%, SMILES BrC1=CN2C(C(Br)=N1)=NC=C2, MDL MFCD08460056 |
| Drug_Names: 6-Bromo-8-methylthioimidazo[1,2-a]pyrazinamine, CAS: 887475-71-0, stock 450.4g, assay 98.3%, MWt 244.11, Formula C7H6BrN3S, Purity >98%, SMILES BrC1=CN2C(C(SC)=N1)=NC=C2, MDL NA |
| Drug_Names: 6-Methyl-8-methylsulfanyl-imidazo[1,2-a]pyrazine, CAS: 1094070-46-8, stock 204.5g, assay 98.7%, MWt 179.24, Formula C8H9N3S, Purity >98%, SMILES CC1=CN2C(C(SC)=N1)=NC=C2, MDL MFCD17215754 |
| Drug_Names: 2-(3-Methylisothiazol-5-yl)isoindole-1,3-dione, CAS: 1258841-00-7, stock 325.1g, assay 98.5%, MWt 244.27, Formula C12H8N2O2S, Purity >98%, SMILES O=C1N(C2=CC(C)=NS2)C(C3=CC=CC=C31)=O, MDL NA |
| Drug_Names: Sulfoxonium, [(5S)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydrozy-6-oxo-6-(phenylmethoxy)-1-hexen-1-yl]dimethyl-, inner salt, CAS: 2002431-79-8, stock 632.8g, assay 98.2%, MWt 411.51, Formula C20H29NO6S, Purity >98%, SMILES O=C([C@@H](NC(OC(C)(C)C)=O)CC/C([O-])=C/[S+](C)(C)=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: (S)-benzyl 5-((benzyloxy)imino)-2-((tert-butoxycarbonyl)amino)-6-chlorohexanoate, CAS: 1133931-73-3, stock 274.1g, assay 98.9%, MWt 474.98, Formula C25H31ClN2O5, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@@H](CC/C(CCl)=N\OCC1=CC=CC=C1)C(OCC2=CC=CC=C2)=O, MDL NA |
| Drug_Names: (2S)-5-(benzyloxyimino)-piperidine-2-carboxylic acid benzyl ester, CAS: 1133931-74-4, stock 854.3g, assay 98.3%, MWt 338.40, Formula C20H22N2O3, Purity >98%, SMILES O=C([C@H]1NC/C(CC1)=N/OCC2=CC=CC=C2)OCC3=CC=CC=C3, MDL NA |
| Drug_Names: (2S,5R)-Benzyl 5-((benzyloxy)amino)piperidine-2-carboxylate oxalate, CAS: 1171080-45-7, stock 154.5g, assay 98.5%, MWt 430.45, Formula C22H26N2O7, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)[C@@H](NC2)CC[C@H]2NOCC3=CC=CC=C3.OC(C(O)=O)=O, MDL NA |
| Drug_Names: 4-Iodo-3,5-dimethylbenzamide, CAS: 1206679-91-5, stock 182.4g, assay 99%, MWt 275.09, Formula C9H10INO, Purity >98%, SMILES IC1=C(C)C=C(C(N)=O)C=C1C, MDL NA |
| Drug_Names: (Z)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)acrylate, CAS: 864825-84-3, stock 196.3g, assay 98.5%, MWt 348.39, Formula C18H24N2O5, Purity >98%, SMILES CC1=C(/C=C(C(OC)=O)\NC(OC(C)(C)C)=O)C(C)=CC(C(N)=O)=C1, MDL NA |
| Drug_Names: 6-Nitroindazole, CAS: 7597-18-4, stock 693.1g, assay 98.7%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES O=[N+](C1=CC2=C(C=C1)C=NN2)[O-], MDL MFCD00005695 |
| Drug_Names: 3'-Hydroxy-3-oxo-6'-[[(trifluoromethyl)sulfonyl]oxy]spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, CAS: 1268491-68-4, stock 275.2g, assay 98.4%, MWt 508.38, Formula C22H11F3O9S, Purity >98%, SMILES O=C1OC2(C3=C(OC4=C2C=CC(OS(C(F)(F)F)(=O)=O)=C4)C=C(O)C=C3)C5=C1C=CC(C(O)=O)=C5, MDL NA |
| Drug_Names: benzyl (tert-Butoxycarbonyl)-L-leucyl-L-phenylalaninate, CAS: 70637-26-2, stock 510.1g, assay 98.4%, MWt 468.59, Formula C27H36N2O5, Purity >98%, SMILES O=C([C@@H](NC([C@H](CC(C)C)NC(OC(C)(C)C)=O)=O)CC1=CC=CC=C1)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: (S)-benzyl 2-((S)-2-amino-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate, CAS: 70637-28-4, stock 304.9g, assay 98.2%, MWt 482.49, Formula C24H29F3N2O5, Purity >98%, SMILES O=C([C@@H](NC([C@H](CC(C)C)N)=O)CC1=CC=CC=C1)OCC2=CC=CC=C2.O=C(O)C(F)(F)F, MDL NA |
| Drug_Names: (6S,9S,12S)-Benzyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate, CAS: 868540-15-2, stock 694.1g, assay 98.8%, MWt 629.79, Formula C37H47N3O6, Purity >98%, SMILES O=C([C@@H](NC([C@H](CC(C)C)NC([C@@H](NC(OC(C)(C)C)=O)CCC1=CC=CC=C1)=O)=O)CC2=CC=CC=C2)OCC3=CC=CC=C3, MDL NA |
| Drug_Names: (S)-benzyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate, CAS: 875309-83-4, stock 24.7g, assay 98.5%, MWt 643.69, Formula C34H40F3N3O6, Purity >98%, SMILES O=C([C@@H](NC([C@H](CC(C)C)NC([C@@H](N)CCC1=CC=CC=C1)=O)=O)CC2=CC=CC=C2)OCC3=CC=CC=C3.O=C(O)C(F)(F)F, MDL NA |
| Drug_Names: 4-Hydroxy-4-(6-methoxypyridin-3-yl)cyclohexanone, CAS: 708273-57-8, stock 382.2g, assay 98.7%, MWt 221.25, Formula C12H15NO3, Purity >98%, SMILES O=C1CCC(C2=CC=C(OC)N=C2)(O)CC1, MDL MFCD13185918 |
| Drug_Names: (R)-N-(2-((1-benzylpyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide, CAS: 226228-88-2, stock 14.2g, assay 98.6%, MWt 405.41, Formula C21H22F3N3O2, Purity >98%, SMILES O=C(NCC(N[C@H]1CN(CC2=CC=CC=C2)CC1)=O)C3=CC=CC(C(F)(F)F)=C3, MDL NA |
| Drug_Names: (R)-N-(2-oxo-2-(pyrrolidin-3-ylamino)ethyl)-3-(trifluoromethyl)benzamide, CAS: 226249-16-7, stock 553.9g, assay 98.4%, MWt 315.29, Formula C14H16F3N3O2, Purity >98%, SMILES O=C(NCC(N[C@H]1CNCC1)=O)C2=CC=CC(C(F)(F)F)=C2, MDL NA |
| Drug_Names: (S)-N-(2-((1-benzylpyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide, CAS: 226228-42-8, stock 766.3g, assay 98.1%, MWt 405.41, Formula C21H22F3N3O2, Purity >98%, SMILES O=C(NCC(N[C@@H]1CN(CC2=CC=CC=C2)CC1)=O)C3=CC=CC(C(F)(F)F)=C3, MDL NA |
| Drug_Names: Boc-Ser(Tos)-OMe, CAS: 56926-94-4, stock 207.7g, assay 98.9%, MWt 373.42, Formula C16H23NO7S, Purity >98%, SMILES O=C(OC)[C@H](COS(C1=CC=C(C)C=C1)(=O)=O)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (S)-3-(Benzyloxycarbonyl)-4-isopropyl-2,5-oxazolidinedione, CAS: 158257-41-1, stock 147.1g, assay 98.6%, MWt 277.27, Formula C14H15NO5, Purity >98%, SMILES O=C(N([C@H]1C(C)C)C(OC1=O)=O)OCC2=CC=CC=C2, MDL MFCD00274015 |
| Drug_Names: 5,6-Dichloro-1H-benzo[d]imidazol-2(3H)-one, CAS: 2033-29-6, stock 158.1g, assay 98.2%, MWt 203.03, Formula C7H4Cl2N2O, Purity >98%, SMILES O=C1NC2=CC(Cl)=C(Cl)C=C2N1, MDL MFCD12963764 |
| Drug_Names: 2-Bromo-5,6-dichloro-1H-benzo[d]imidazole, CAS: 142356-40-9, stock 610.2g, assay 98%, MWt 265.92, Formula C7H3BrCl2N2, Purity >98%, SMILES ClC1=C(Cl)C=C2NC(Br)=NC2=C1, MDL NA |
| Drug_Names: 2-Fluoro-4-bromobenzoic acid, CAS: 112704-79-7, stock 667.1g, assay 98.9%, MWt 219.01, Formula C7H4BrFO2, Purity >98%, SMILES O=C(O)C1=CC=C(Br)C=C1F, MDL MFCD00143263 |
| Drug_Names: 2-Trifluoromethyl-4-aminobenzonitrile, CAS: 654-70-6, stock 320.2g, assay 98.9%, MWt 186.13, Formula C8H5F3N2, Purity >98%, SMILES N#CC1=CC=C(N)C=C1C(F)(F)F, MDL MFCD00042155 |
| Drug_Names: 4-Isopropylthiophenylboronic acid, CAS: 380427-38-3, stock 564.7g, assay 98.1%, MWt 196.07, Formula C9H13BO2S, Purity >98%, SMILES CC(SC1=CC=C(B(O)O)C=C1)C, MDL MFCD03411947 |
| Drug_Names: 4-(Isopropylsulfonyl)phenylboronic acid, CAS: 850567-98-5, stock 495.6g, assay 98.4%, MWt 228.07, Formula C9H13BO4S, Purity >98%, SMILES CC(S(C1=CC=C(B(O)O)C=C1)(=O)=O)C, MDL MFCD06659866 |
| Drug_Names: tert-Butyl 4-((hydroxyimino)methyl)benzyl(methyl)carbamate, CAS: 1349198-30-6, stock 619.7g, assay 98.1%, MWt 264.32, Formula C14H20N2O3, Purity >98%, SMILES CN(C(OC(C)(C)C)=O)CC1=CC=C(/C=N/O)C=C1, MDL NA |
| Drug_Names: tert-Butyl 4-(chloro(hydroxyimino)methyl)benzyl(methyl)carbamate, CAS: 1428935-49-2, stock 572.6g, assay 98.8%, MWt 298.77, Formula C14H19ClN2O3, Purity >98%, SMILES CN(C(OC(C)(C)C)=O)CC1=CC=C(/C(Cl)=N/O)C=C1, MDL NA |
| Drug_Names: 5-bromo-3-(2-(trimethylsilyl)ethynyl)pyrazin-2-amine, CAS: 875781-41-2, stock 181.8g, assay 98.9%, MWt 270.20, Formula C9H12BrN3Si, Purity >98%, SMILES NC1=NC=C(Br)N=C1C#C[Si](C)(C)C, MDL NA |
| Drug_Names: tert-Butyl N-(5-bromo-3-ethynylpyrazin-2-yl)-N-(tert-butoxycarbonyl)carbamate, CAS: 1232423-55-0, stock 855.4g, assay 98.4%, MWt 398.25, Formula C16H20BrN3O4, Purity >98%, SMILES C#CC1=NC(Br)=CN=C1N(C(OC(C)(C)C)=O)C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (2-(Methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate, CAS: 1180002-01-0, stock 640.4g, assay 98.3%, MWt 309.36, Formula C15H23N3O4, Purity >98%, SMILES O=C(OCC1=CC=CN=C1NC)CN(C(OC(C)(C)C)=O)C, MDL NA |
| Drug_Names: 7-Bromo-5-chloro-2,3-dihydropyrano[4,3,2-de]quinoline, CAS: 1155270-71-5, stock 283g, assay 98%, MWt 284.54, Formula C11H7BrClNO, Purity >98%, SMILES BrC1=C(N=C(Cl)C=C2CCO3)C2=C3C=C1, MDL NA |
| Drug_Names: 7-Bromo-2,3-dihydropyrano[4,3,2-de]quinoline, CAS: 1155270-72-6, stock 670.8g, assay 98.6%, MWt 250.09, Formula C11H8BrNO, Purity >98%, SMILES BrC1=C(N=CC=C2CCO3)C2=C3C=C1, MDL NA |
| Drug_Names: 3-Bromo-2-methyl-4-quinolinol, CAS: 65673-88-3, stock 724g, assay 98.6%, MWt 238.08, Formula C10H8BrNO, Purity >98%, SMILES CC1=NC2=CC=CC=C2C(O)=C1Br, MDL NA |
| Drug_Names: 3-Bromo-4-chloro-2-methylquinoline, CAS: 1333256-98-6, stock 469.3g, assay 98.7%, MWt 256.53, Formula C10H7BrClN, Purity >98%, SMILES CC1=NC2=CC=CC=C2C(Cl)=C1Br, MDL NA |
| Drug_Names: (S)-methyl 2-(4-chloro-2-methylquinolin-3-yl)-2-hydroxyacetate, CAS: 1402597-30-1, stock 517.1g, assay 98.9%, MWt 265.69, Formula C13H12ClNO3, Purity >98%, SMILES CC1=NC2=CC=CC=C2C(Cl)=C1[C@@H](C(OC)=O)O, MDL NA |
| Drug_Names: (S)-methyl 2-(tert-butoxy)-2-((R)-4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetate, CAS: 1402714-51-5, stock 767.6g, assay 98.7%, MWt 456.53, Formula C28H28N2O4, Purity >98%, SMILES CC1=C([C@@H](C(OC)=O)OC(C)(C)C)[C@@]([C@@]2=CC=C3C4=C2N=CC=C4CCO3)=C5C(C=CC=C5)=N1, MDL NA |
| Drug_Names: 3-Iodo-2-methylquinolin-4-ol, CAS: 64965-49-7, stock 23.8g, assay 98.2%, MWt 285.08, Formula C10H8INO, Purity >98%, SMILES CC1=NC2=CC=CC=C2C(O)=C1I, MDL NA |
| Drug_Names: (Z)-methyl 2-acetamido-3-(4-acetoxy-2,6-dimethylphenyl)acrylate, CAS: 145235-85-4, stock 828.9g, assay 98.6%, MWt 305.33, Formula C16H19NO5, Purity >98%, SMILES CC1=C(/C=C(C(OC)=O)\NC(C)=O)C(C)=CC(OC(C)=O)=C1, MDL NA |
| Drug_Names: Diiodo(p-cymene)ruthenium(II) dimer, CAS: 90614-07-6, stock 360.2g, assay 98.9%, MWt 978.19, Formula C20H28I4Ru2, Purity >98%, SMILES Cc1ccc(C(C)C)cc1.I[Ru](I2)I[Ru]2I.C[C@@H]3CC[C@H](C(C)C)CC3, MDL MFCD08064027 |
| Drug_Names: MK-3102 intermediate, CAS: 951127-25-6, stock 669.7g, assay 98.7%, MWt 327.32, Formula C16H19F2NO4, Purity >98%, SMILES FC1=CC([C@H]2OCC(C[C@@H]2NC(OC(C)(C)C)=O)=O)=C(F)C=C1, MDL MFCD20926096 |
| Drug_Names: (4S)-4-Benzyl-3-(5,5,5-trifluoropentanoyl)-1,3-oxazolidin-2-one, CAS: 1401065-46-0, stock 644.9g, assay 98%, MWt 315.29, Formula C15H16F3NO3, Purity >98%, SMILES FC(F)(F)CCCC(N1C(OC[C@@H]1CC2=CC=CC=C2)=O)=O, MDL NA |
| Drug_Names: (2R)-2-(2-tert-Butoxy-2-oxoethyl)-5,5,5-trifluoropentanoic acid, CAS: 1401067-08-0, stock 785.8g, assay 98.9%, MWt 270.25, Formula C11H17F3O4, Purity >98%, SMILES O=C(O)[C@@H](CC(OC(C)(C)C)=O)CCC(F)(F)F, MDL NA |
| Drug_Names: (2R,3S)-3-(tert-butoxycarbonyl)-2-(3,3,3-trifluoropropyl)hex-5-enoic acid, CAS: 1581735-07-0, stock 774.6g, assay 98.8%, MWt 310.31, Formula C14H21F3O4, Purity >98%, SMILES OC([C@@H]([C@@H](C(OC(C)(C)C)=O)CC=C)CCC(F)(F)F)=O, MDL NA |
| Drug_Names: (2R,3S)-1-benzyl 4-tert-butyl 3-(cyclopropylmethyl)-2-(3,3,3-trifluoropropyl)succinate, CAS: 1581734-69-1, stock 101.3g, assay 98.5%, MWt 414.46, Formula C22H29F3O4, Purity >98%, SMILES O=C([C@@H]([C@@H](C(OC(C)(C)C)=O)CC1CC1)CCC(F)(F)F)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: (R)-2-((S)-1-(tert-butoxy)-3-cyclopropyl-1-oxopropan-2-yl)-5,5,5-trifluoropentanoic acid, CAS: 1581735-04-7, stock 456g, assay 98.5%, MWt 324.34, Formula C15H23F3O4, Purity >98%, SMILES OC([C@@H]([C@@H](C(OC(C)(C)C)=O)CC1CC1)CCC(F)(F)F)=O, MDL NA |
| Drug_Names: (2S,3R)-3-((benzyloxy)carbonyl)-2-(cyclopropylmethyl)-6,6,6-trifluorohexanoic acid, CAS: 1933524-47-0, stock 205.4g, assay 98.3%, MWt 358.35, Formula C18H21F3O4, Purity >98%, SMILES O=C([C@@H]([C@@H](C(O)=O)CC1CC1)CCC(F)(F)F)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: 7-Fluoro-3-hydroxy-3-phenylindolin-2-one, CAS: 1584139-77-4, stock 149.7g, assay 98.5%, MWt 243.23, Formula C14H10FNO2, Purity >98%, SMILES O=C1NC2=C(C=CC=C2F)C1(O)C3=CC=CC=C3, MDL NA |
| Drug_Names: (2-Amino-3-fluorophenyl)(phenyl)methanone, CAS: 1584139-76-3, stock 784.8g, assay 98.7%, MWt 215.22, Formula C13H10FNO, Purity >98%, SMILES FC1=CC=CC(C(C2=CC=CC=C2)=O)=C1N, MDL NA |
| Drug_Names: (Benzotriazol-1-yl)(benzyloxycarbonylamino)acetic acid, CAS: 124676-19-3, stock 68.4g, assay 98.3%, MWt 326.31, Formula C16H14N4O4, Purity >98%, SMILES O=C(O)C(NC(OCC1=CC=CC=C1)=O)N2N=NC3=CC=CC=C32, MDL MFCD00961511 |
| Drug_Names: 3-Amino-9-fluoro-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one, CAS: 1584714-99-7, stock 226g, assay 98%, MWt 269.27, Formula C15H12FN3O, Purity >98%, SMILES NC1N=C(C2=CC=CC=C2)C3=CC=CC(F)=C3NC1=O, MDL NA |
| Drug_Names: (S)-2-(benzylamino)-4-fluoro-4-methylpentanoic acid, CAS: 2166017-06-5, stock 343.5g, assay 98.8%, MWt 239.29, Formula C13H18FNO2, Purity >98%, SMILES CC(F)(C[C@@H](C(O)=O)NCC1=CC=CC=C1)C, MDL NA |
| Drug_Names: (S)-2-(benzyl(methyl)amino)-4-fluoro-4-methylpentanoic acid, CAS: 2165598-22-9, stock 271.3g, assay 98.9%, MWt 253.31, Formula C14H20FNO2, Purity >98%, SMILES CC(F)(C[C@@H](C(O)=O)N(C)CC1=CC=CC=C1)C, MDL NA |
| Drug_Names: (S)-4-fluoro-4-methyl-2-(methylamino)pentanoic acid, CAS: 2165719-18-4, stock 794.9g, assay 98.8%, MWt 163.19, Formula C7H14FNO2, Purity >98%, SMILES CC(F)(C[C@@H](C(O)=O)NC)C, MDL NA |
| Drug_Names: 5-(Pyridin-4-yl)-1,3,4-thiadiazol-2-amine, CAS: 2002-04-2, stock 69.1g, assay 99%, MWt 178.21, Formula C7H6N4S, Purity >98%, SMILES NC1=NN=C(S1)C2=CC=NC=C2, MDL NA |
| Drug_Names: (S)-N-((1S,2R)-2-(prop-2-yn-1-yloxy)-2,3-dihydro-1H-inden-1-yl)pyrrolidine-2-carboxamide 2,2,2-trifluoroacetate, CAS: 1514922-97-4, stock 302.6g, assay 99%, MWt 398.38, Formula C19H21F3N2O4, Purity >98%, SMILES O=C([C@H]1NCCC1)N[C@@H]2[C@H](OCC#C)CC3=C2C=CC=C3.O=C(O)C(F)(F)F, MDL NA |
| Drug_Names: (2R,3R)-3,4-bis(benzyloxy)butane-1,2-diol, CAS: 960365-70-2, stock 721.7g, assay 98.6%, MWt 302.36, Formula C18H22O4, Purity >98%, SMILES OC[C@@H](O)[C@H](OCC1=CC=CC=C1)COCC2=CC=CC=C2, MDL NA |
| Drug_Names: (3S,6R)-6-((R)-1,2-bis(benzyloxy)ethyl)-3-methoxy-1,4-dioxan-2-one, CAS: 960365-78-0, stock 436.7g, assay 98.5%, MWt 372.41, Formula C21H24O6, Purity >98%, SMILES O=C1O[C@@H]([C@H](OCC2=CC=CC=C2)COCC3=CC=CC=C3)CO[C@@H]1OC, MDL NA |
| Drug_Names: 2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, CAS: 1056039-83-8, stock 272.6g, assay 98.9%, MWt 287.13, Formula C13H18BN5O2, Purity >98%, SMILES CC1(C)C(C)(C)OB(C2=CN=C(C3=NN(C)N=N3)C=C2)O1, MDL NA |
| Drug_Names: (R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one, CAS: 444335-16-4, stock 57.1g, assay 98.7%, MWt 290.09, Formula C10H9BrFNO3, Purity >98%, SMILES O=C1O[C@@H](CO)CN1C2=CC=C(Br)C(F)=C2, MDL MFCD08166353 |
| Drug_Names: Benzyl (2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)carbamate, CAS: 108895-98-3, stock 349.6g, assay 98.8%, MWt 385.42, Formula C23H19N3O3, Purity >98%, SMILES O=C(OCC1=CC=CC=C1)NC2N=C(C3=CC=CC=C3)C4=CC=CC=C4NC2=O, MDL NA |
| Drug_Names: 3-Amino-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one, CAS: 103343-47-1, stock 693.9g, assay 98.4%, MWt 251.28, Formula C15H13N3O, Purity >98%, SMILES NC1N=C(C2=CC=CC=C2)C3=CC=CC=C3NC1=O, MDL MFCD01318260 |
| Drug_Names: 2-(Chloromethyl)-5-methyl-Pyridine hydrochloride, CAS: 71670-70-7, stock 659g, assay 98.3%, MWt 178.06, Formula C7H9Cl2N, Purity >98%, SMILES CC1=CN=C(CCl)C=C1.Cl, MDL MFCD18253390 |
| Drug_Names: (2S)-[[N-(tert-Butoxycarbonyl)-N-methyl-L-alanyl]amino](cyclohexyl)ethanoic acid, CAS: 894789-27-6, stock 152.9g, assay 98.5%, MWt 342.43, Formula C17H30N2O5, Purity >98%, SMILES CN([C@H](C(N[C@@H](C1CCCCC1)C(O)=O)=O)C)C(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (3R)-3-[(1,1-Dimethylethoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic acid, CAS: 486460-00-8, stock 439.3g, assay 98.6%, MWt 333.30, Formula C15H18F3NO4, Purity >98%, SMILES FC1=C(C[C@@H](NC(OC(C)(C)C)=O)CC(O)=O)C=C(F)C(F)=C1, MDL MFCD06659147 |
| Drug_Names: 3-Methyl-6-nitro-1H-indazole, CAS: 6494-19-5, stock 49g, assay 98.4%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES CC1=NNC2=CC([N+]([O-])=O)=CC=C21, MDL MFCD07082704 |
| Drug_Names: 2,3-Dimethyl-6-nitro-2H-indazole, CAS: 444731-73-1, stock 275.4g, assay 98.3%, MWt 191.19, Formula C9H9N3O2, Purity >98%, SMILES CC1=C2C(C=C([N+]([O-])=O)C=C2)=NN1C, MDL MFCD10703326 |
| Drug_Names: N,2,3-trimethyl-2H-indazol-6-amine, CAS: 1376676-65-1, stock 291.3g, assay 98.1%, MWt 175.23, Formula C10H13N3, Purity >98%, SMILES CC1=C2C(C=C(NC)C=C2)=NN1C, MDL NA |
| Drug_Names: Methyl 5-(((S)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoate, CAS: 1137026-67-5, stock 884.3g, assay 98.1%, MWt 683.79, Formula C38H45N5O7, Purity >98%, SMILES O=C(OC)C1=CC(CN(C([C@@H](NC(OC(C)(C)C)=O)CC2=C(C)C=C(C(N)=O)C=C2C)=O)[C@H](C3=NC=C(C4=CC=CC=C4)N3)C)=CC=C1OC, MDL NA |
| Drug_Names: 4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol, CAS: 1533519-84-4, stock 832.4g, assay 98%, MWt 267.35, Formula C15H13N3S, Purity >98%, SMILES SC1=NN=CN1C2=C3C=CC=CC3=C(C4CC4)C=C2, MDL MFCD28404707 |
| Drug_Names: (2S,5R)-5-((Benzyloxy)amino)piperidine-2-carboxamide, CAS: 1416134-49-0, stock 803.8g, assay 98.4%, MWt 249.31, Formula C13H19N3O2, Purity >98%, SMILES O=C(N)[C@@H](NC1)CC[C@H]1NOCC2=CC=CC=C2, MDL NA |
| Drug_Names: (2S,5R)-6-(Benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide, CAS: 1192651-49-2, stock 153.8g, assay 98.7%, MWt 275.30, Formula C14H17N3O3, Purity >98%, SMILES O=C1N(OCC2=CC=CC=C2)[C@@H]3CC[C@@H](C(N)=O)[N@]1C3, MDL NA |
| Drug_Names: Tetrabutylammonium (1R,2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate, CAS: 1192651-80-1, stock 385.2g, assay 99%, MWt 506.70, Formula C23H46N4O6S, Purity >98%, SMILES O=C1N(OS(=O)([O-])=O)[C@@H]2CC[C@@H](C(N)=O)[N@]1C2.CCCC[N+](CCCC)(CCCC)CCCC, MDL NA |
| Drug_Names: 3-Bromo-4-chloropyridine, CAS: 36953-42-1, stock 136.7g, assay 98%, MWt 192.44, Formula C5H3BrClN, Purity >98%, SMILES ClC1=C(Br)C=NC=C1, MDL MFCD00234008 |
| Drug_Names: 3-Bromopyridine-4-thiol, CAS: 82264-72-0, stock 119.3g, assay 98%, MWt 190.06, Formula C5H4BrNS, Purity >98%, SMILES BrC1=C(S)C=CN=C1, MDL NA |
| Drug_Names: Ethyl 2-((3-bromopyridin-4-yl)thio)-2-methylpropanoate, CAS: 1352794-86-5, stock 594.2g, assay 98.6%, MWt 304.20, Formula C11H14BrNO2S, Purity >98%, SMILES BrC1=C(SC(C)(C)C(OCC)=O)C=CN=C1, MDL NA |
| Drug_Names: 1,4-Dibromonaphthalene, CAS: 83-53-4, stock 237.5g, assay 98.4%, MWt 285.96, Formula C10H6Br2, Purity >98%, SMILES BrC1=CC=C(Br)C2=C1C=CC=C2, MDL MFCD00041823 |
| Drug_Names: Cyclopropyl(trimethylsilyl)acetylene, CAS: 81166-84-9, stock 846.1g, assay 98.9%, MWt 138.28, Formula C8H14Si, Purity >98%, SMILES C[Si](C)(C)C#CC1CC1, MDL NA |
| Drug_Names: 1-((Trimethylsilyl)ethynyl)cyclopropane-1-carboxylic acid, CAS: 1268810-07-6, stock 855.3g, assay 98.4%, MWt 182.29, Formula C9H14O2Si, Purity >98%, SMILES O=C(O)C1(C#C[Si](C)(C)C)CC1, MDL NA |
| Drug_Names: tert-Butyl (1-((trimethylsilyl)ethynyl)cyclopropyl)carbamate, CAS: 1268810-08-7, stock 174.2g, assay 98.9%, MWt 253.41, Formula C13H23NO2Si, Purity >98%, SMILES CC(C)(C)OC(NC1(C#C[Si](C)(C)C)CC1)=O, MDL NA |
| Drug_Names: tert-Butyl (1-ethynylcyclopropyl)carbamate, CAS: 1268810-09-8, stock 835g, assay 98.3%, MWt 181.23, Formula C10H15NO2, Purity >98%, SMILES C#CC1(NC(OC(C)(C)C)=O)CC1, MDL NA |
| Drug_Names: 4-Iodo-3,5-dimethylphenol, CAS: 80826-86-4, stock 323g, assay 98%, MWt 248.06, Formula C8H9IO, Purity >98%, SMILES OC1=CC(C)=C(I)C(C)=C1, MDL MFCD00174284 |
| Drug_Names: (3aS,4R,6aS)-2,2-Dimethyl-4-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 865838-13-7, stock 693.8g, assay 98.1%, MWt 428.52, Formula C28H28O4, Purity >98%, SMILES O[C@](C=C1)(COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)[C@@]([C@@]1([H])O5)([H])OC5(C)C, MDL NA |
| Drug_Names: (3AS,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 805245-42-5, stock 573.5g, assay 98.5%, MWt 446.51, Formula C28H27FO4, Purity >98%, SMILES FC([C@@H]1O)=C(COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)[C@]5([H])[C@@]1([H])OC(C)(C)O5, MDL NA |
| Drug_Names: 5,5,5-Trifluorovaleric acid, CAS: 407-62-5, stock 472.5g, assay 98.6%, MWt 156.10, Formula C5H7F3O2, Purity >98%, SMILES O=C(O)CCCC(F)(F)F, MDL MFCD02262192 |
| Drug_Names: Methyl 5-hydroxypyrazine-2-carboxylate, CAS: 13924-95-3, stock 450.7g, assay 98.7%, MWt 154.12, Formula C6H6N2O3, Purity >98%, SMILES O=C(C(N=C1)=CNC1=O)OC, MDL MFCD08273469 |
| Drug_Names: 2-((tert-Butoxycarbonyl)(methyl)amino)-3-methyl-3-phenylbutanoic acid, CAS: 676487-35-7, stock 874.6g, assay 98.2%, MWt 307.38, Formula C17H25NO4, Purity >98%, SMILES OC(C(N(C(OC(C)(C)C)=O)C)C(C)(C)C1=CC=CC=C1)=O, MDL NA |
| Drug_Names: (S)-1-phenylethanamine (S)-2-((tert-butoxycarbonyl)(methyl)amino)-3-methyl-3-phenylbutanoate, CAS: 676487-36-8, stock 825g, assay 98.5%, MWt 428.56, Formula C25H36N2O4, Purity >98%, SMILES OC([C@@H](N(C(OC(C)(C)C)=O)C)C(C)(C)C1=CC=CC=C1)=O.C[C@H](N)C2=CC=CC=C2, MDL NA |
| Drug_Names: (S)-2-((tert-butoxycarbonyl)(methyl)amino)-3-methyl-3-phenylbutanoic acid, CAS: 228266-38-4, stock 421.8g, assay 98.7%, MWt 307.38, Formula C17H25NO4, Purity >98%, SMILES OC([C@@H](N(C(OC(C)(C)C)=O)C)C(C)(C)C1=CC=CC=C1)=O, MDL NA |
| Drug_Names: NSC 135130, CAS: 24164-06-5, stock 773.4g, assay 98.4%, MWt 245.32, Formula C12H23NO4, Purity >98%, SMILES O=C(OC)[C@H](C(C)C)N(C(OC(C)(C)C)=O)C, MDL NA |
| Drug_Names: (S,E)-ethyl 2,5-dimethyl-4-(methylamino)hex-2-enoate hydrochloride, CAS: 610786-69-1, stock 208.6g, assay 99%, MWt 235.75, Formula C11H22ClNO2, Purity >98%, SMILES CC(C)[C@@H](/C=C(C)/C(OCC)=O)NC.Cl, MDL NA |
| Drug_Names: (S,E)-ethyl 4-((S)-2-((tert-butoxycarbonyl)amino)-N,3,3-trimethylbutanamido)-2,5-dimethylhex-2-enoate, CAS: 187345-37-5, stock 557.3g, assay 99%, MWt 412.56, Formula C22H40N2O5, Purity >98%, SMILES CC(C)[C@@H](/C=C(C)/C(OCC)=O)N(C([C@H](C(C)(C)C)NC(OC(C)(C)C)=O)=O)C, MDL NA |
| Drug_Names: (S,E)-ethyl 4-((S)-2-amino-N,3,3-trimethylbutanamido)-2,5-dimethylhex-2-enoate hydrochloride, CAS: 610786-70-4, stock 215.4g, assay 98.5%, MWt 348.91, Formula C17H33ClN2O3, Purity >98%, SMILES CC(C)[C@@H](/C=C(C)/C(OCC)=O)N(C([C@H](C(C)(C)C)N)=O)C.Cl, MDL NA |
| Drug_Names: D-Boc valine methyl ester, CAS: 106391-85-9, stock 145.9g, assay 98.3%, MWt 231.29, Formula C11H21NO4, Purity >98%, SMILES O=C(OC)[C@@H](C(C)C)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (R)-tert-Butyl (1-hydroxy-3-methylbutan-2-yl)(methyl)carbamate, CAS: 2165479-27-4, stock 629.1g, assay 98.4%, MWt 217.31, Formula C11H23NO3, Purity >98%, SMILES CN(C(OC(C)(C)C)=O)[C@H](C(C)C)CO, MDL NA |
| Drug_Names: (R)-tert-Butyl methyl(3-methyl-1-oxobutan-2-yl)carbamate, CAS: 2165540-24-7, stock 231.9g, assay 98.8%, MWt 215.29, Formula C11H21NO3, Purity >98%, SMILES CC(C)[C@@H](N(C(OC(C)(C)C)=O)C)C=O, MDL NA |
| Drug_Names: (1S,2S,4R)-1-methyl-2-morpholino-4-(prop-1-en-2-yl)cyclohexanol oxalate, CAS: 404866-38-2, stock 604.6g, assay 98.1%, MWt 329.39, Formula C16H27NO6, Purity >98%, SMILES C[C@]1(O)CC[C@@H](C(C)=C)C[C@@H]1N2CCOCC2.OC(C(O)=O)=O, MDL NA |
| Drug_Names: 4-((1S,2S,5R)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexyl)morpholine 4-oxide, CAS: 790220-87-0, stock 815.9g, assay 98.7%, MWt 255.35, Formula C14H25NO3, Purity >98%, SMILES CC([C@@H]1CC[C@@](O)(C)[C@@H]([N+]2([O-])CCOCC2)C1)=C, MDL NA |
| Drug_Names: (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol, CAS: 22972-51-6, stock 470.6g, assay 98.6%, MWt 152.23, Formula C10H16O, Purity >98%, SMILES C[C@]1(O)CC[C@@H](C(C)=C)C=C1, MDL NA |
| Drug_Names: 6-Chloro-2-methylthiopyrimidine, CAS: 49844-90-8, stock 563g, assay 98.3%, MWt 160.62, Formula C5H5ClN2S, Purity >98%, SMILES ClC1=NC(SC)=NC=C1, MDL MFCD00006083 |
| Drug_Names: 4-(2-Fluoropyridin-4-yl)-2-(methylthio)pyrimidine, CAS: 1453851-73-4, stock 565.7g, assay 98.2%, MWt 221.25, Formula C10H8FN3S, Purity >98%, SMILES CSC1=NC=CC(C2=CC(F)=NC=C2)=N1, MDL NA |
| Drug_Names: 4-[2-(Methylsulfanyl)pyrimidin-4-yl]-1,2-dihydropyridin-2-one, CAS: 1453851-57-4, stock 335.8g, assay 98.7%, MWt 219.26, Formula C10H9N3OS, Purity >98%, SMILES O=C1C=C(C2=NC(SC)=NC=C2)C=CN1, MDL NA |
| Drug_Names: (R)-1-(4-Chloro-3-fluorophenyl)ethane-1,2-diol, CAS: 1453854-84-6, stock 102.2g, assay 98.8%, MWt 190.60, Formula C8H8ClFO2, Purity >98%, SMILES FC1=CC([C@@H](O)CO)=CC=C1Cl, MDL NA |
| Drug_Names: (R)-2-((tert-butyldimethylsilyl)oxy)-1-(4-chloro-3-fluorophenyl)ethanol, CAS: 1395078-43-9, stock 859.2g, assay 98.3%, MWt 304.86, Formula C14H22ClFO2Si, Purity >98%, SMILES FC1=CC([C@@H](O)CO[Si](C)(C)C(C)(C)C)=CC=C1Cl, MDL NA |
| Drug_Names: 2-Oxo-2-phenylethyl (tert-butoxycarbonyl)-L-alaninate, CAS: 51814-46-1, stock 657.1g, assay 98.6%, MWt 307.34, Formula C16H21NO5, Purity >98%, SMILES O=C(OCC(C1=CC=CC=C1)=O)[C@H](C)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: Methyl 1-((tert-butoxycarbonyl)amino)cyclopropanecarboxylate, CAS: 66494-26-6, stock 258.3g, assay 98.5%, MWt 215.25, Formula C10H17NO4, Purity >98%, SMILES O=C(OC)C1(NC(OC(C)(C)C)=O)CC1, MDL MFCD11520021 |
| Drug_Names: 5-methoxy-2-Pyrazinecarboxylic acid methyl ester, CAS: 38789-75-2, stock 299.9g, assay 98.4%, MWt 168.15, Formula C7H8N2O3, Purity >98%, SMILES O=C(OC)C1=CN=C(OC)C=N1, MDL MFCD18417636 |
| Drug_Names: 7-(Benzyloxy)-5-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one, CAS: 111922-60-2, stock 341.7g, assay 98.5%, MWt 388.41, Formula C24H20O5, Purity >98%, SMILES O=C1C=C(C2=CC=C(OC)C=C2)OC3=CC(OCC4=CC=CC=C4)=CC(OC)=C31, MDL NA |
| Drug_Names: tert-Butyl(((3aR,4S,6aR)-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)diphenylsilane, CAS: 2241016-47-5, stock 356.8g, assay 98.3%, MWt 666.92, Formula C44H46O4Si, Purity >98%, SMILES CC1(C)O[C@H]2[C@H]([C@@H](O[Si](C3=CC=CC=C3)(C(C)(C)C)C4=CC=CC=C4)C=C2COC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)O1, MDL NA |
| Drug_Names: 3-[2-Hydroxy-5-(methylthio)phenyl]propanoic acid, CAS: 1672665-65-4, stock 443.2g, assay 98.2%, MWt 212.27, Formula C10H12O3S, Purity >98%, SMILES OC1=C(CCC(O)=O)C=C(SC)C=C1, MDL NA |
| Drug_Names: 3-Fluoro-5-((7-(methylthio)-1-oxo-2,3-dihydro-1H-inden-4-yl)oxy)benzonitrile, CAS: 1672665-69-8, stock 190.6g, assay 99%, MWt 313.35, Formula C17H12FNO2S, Purity >98%, SMILES CSC1=C(C(CC2)=O)C2=C(OC3=CC(F)=CC(C#N)=C3)C=C1, MDL NA |
| Drug_Names: 1,2,3,4-Tetrahydro-6-isoquinolinol, CAS: 14446-24-3, stock 109.8g, assay 98.2%, MWt 149.19, Formula C9H11NO, Purity >98%, SMILES OC1=CC2=C(CNCC2)C=C1, MDL MFCD01717047 |
| Drug_Names: 1-(2-Methoxy-6-((4-methoxybenzyl)oxy)phenyl)ethanone, CAS: 1234015-61-2, stock 314g, assay 98.8%, MWt 286.32, Formula C17H18O4, Purity >98%, SMILES CC(C1=C(OCC2=CC=C(OC)C=C2)C=CC=C1OC)=O, MDL MFCD21648248 |
| Drug_Names: 1-(2-Methoxy-6-((4-methoxybenzyl)oxy)phenyl)-3,3-bis(methylthio)prop-2-en-1-one, CAS: 1234015-62-3, stock 89.4g, assay 98.2%, MWt 390.52, Formula C20H22O4S2, Purity >98%, SMILES O=C(C1=C(OCC2=CC=C(OC)C=C2)C=CC=C1OC)/C=C(SC)/SC, MDL NA |
| Drug_Names: 5-((5-(2-Hydroxy-6-methoxyphenyl)-1H-pyrazol-3-yl)amino)pyrazine-2-carbonitrile dihydrochloride, CAS: 1234015-70-3, stock 194.2g, assay 98.2%, MWt 381.22, Formula C15H14Cl2N6O2, Purity >98%, SMILES OC1=C(C2=CC(NC3=CN=C(C#N)C=N3)=NN2)C(OC)=CC=C1.Cl.Cl, MDL MFCD29126242 |
| Drug_Names: 6-Hydroxy-1-benzofuran-3(2H)-one, CAS: 6272-26-0, stock 206.8g, assay 98.9%, MWt 150.13, Formula C8H6O3, Purity >98%, SMILES OC1=CC=C2C(COC2=C1)=O, MDL MFCD00068174 |
| Drug_Names: 1-(2-Bromo-5-chlorophenyl)-5-methyl-1H-pyrazole, CAS: 1125828-28-5, stock 857.5g, assay 99%, MWt 271.54, Formula C10H8BrClN2, Purity >98%, SMILES ClC1=CC(N2C(C)=CC=N2)=C(Br)C=C1, MDL NA |
| Drug_Names: Cyclohexylglycine, CAS: 5664-29-9, stock 2.8g, assay 98.6%, MWt 157.21, Formula C8H15NO2, Purity >98%, SMILES NC(C(O)=O)C1CCCCC1, MDL MFCD05662746 |
| Drug_Names: p-Nitrotoluene-o-sulfonic acid, CAS: 121-03-9, stock 774.8g, assay 98.3%, MWt 217.20, Formula C7H7NO5S, Purity >98%, SMILES O=S(C1=CC([N+]([O-])=O)=CC=C1C)(O)=O, MDL MFCD00024914 |
| Drug_Names: (2S,4R)-1-benzyl 2-methyl 4-(((2-((tert-butoxycarbonyl)amino)ethyl)carbamoyl)oxy)pyrrolidine-1,2-dicarboxylate, CAS: 700864-09-1, stock 8.5g, assay 98.2%, MWt 465.50, Formula C22H31N3O8, Purity >98%, SMILES O=C(OC)[C@H]1N(C(OCC2=CC=CC=C2)=O)C[C@H](OC(NCCNC(OC(C)(C)C)=O)=O)C1, MDL NA |
| Drug_Names: 2-((4-Carbamoyl-3-fluorophenyl)amino)-2-methylpropanoic acid, CAS: 1242137-20-7, stock 72g, assay 98.6%, MWt 240.23, Formula C11H13FN2O3, Purity >98%, SMILES FC1=C(C(N)=O)C=CC(NC(C)(C)C(O)=O)=C1, MDL NA |
| Drug_Names: {N-[3-(η6-phenyl)propyl]-[(1R-2R)-1,2-diphenyl-1-4-methylbenzenesulfonylamidato(kN')-ethyl-2-amino-(kN)]}ruthenium(II), CAS: 1192620-83-9, stock 242.3g, assay 98.7%, MWt 620.17, Formula C30H31ClN2O2RuS, Purity >98%, SMILES Cl[Ru]([N@@]1([H])CCCC2=CC=CC=C2)N([C@H](C3=CC=CC=C3)[C@H]1C4=CC=CC=C4)S(C5=CC=C(C)C=C5)(=O)=O, MDL NA |
| Drug_Names: 7,12 Diketolithocholic acid methyl ester, CAS: 10538-66-6, stock 24.7g, assay 98.8%, MWt 418.57, Formula C25H38O5, Purity >98%, SMILES C[C@H](CCC(OC)=O)[C@H]([C@]12C)CC[C@@]1([H])[C@]3([H])C(C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC2=O)=O, MDL NA |
| Drug_Names: 1-(Pyridin-3-yl)cyclopropan-1-amine bis(4-nitrobenzoate), CAS: 1820650-49-4, stock 317.4g, assay 98.7%, MWt 468.42, Formula C22H20N4O8, Purity >98%, SMILES [O-][N+](C(C=C1)=CC=C1C(O)=O)=O.[O-][N+](C(C=C2)=CC=C2C(O)=O)=O.NC3(C4=CC=CN=C4)CC3, MDL NA |
| Drug_Names: 1-Chloroethyl 4-nitrophenyl carbonate, CAS: 101623-69-2, stock 720.1g, assay 98.8%, MWt 245.62, Formula C9H8ClNO5, Purity >98%, SMILES CC(Cl)OC(OC1=CC=C([N+]([O-])=O)C=C1)=O, MDL NA |
| Drug_Names: 1-(Methoxycarbonyl)cyclopropanecarboxylic acid, CAS: 113020-21-6, stock 345g, assay 98.4%, MWt 144.13, Formula C6H8O4, Purity >98%, SMILES O=C(C1(C(O)=O)CC1)OC, MDL MFCD06800496 |
| Drug_Names: Methyl 3-amino-5-bromo-2-methylbenzoate, CAS: 1000342-11-9, stock 578.2g, assay 98.8%, MWt 244.09, Formula C9H10BrNO2, Purity >98%, SMILES O=C(OC)C1=CC(Br)=CC(N)=C1C, MDL MFCD08690071 |
| Drug_Names: (S)-tert-butyl 2-(5-(4-chlorophenyl)-6,7-dimethyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl)acetate, CAS: 1268524-67-9, stock 378.3g, assay 98.1%, MWt 418.94, Formula C21H23ClN2O3S, Purity >98%, SMILES ClC1=CC=C(C(C2=C(NC3=O)SC(C)=C2C)=N[C@H]3CC(OC(C)(C)C)=O)C=C1, MDL NA |
| Drug_Names: (R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethanol, CAS: 1033805-26-3, stock 648.5g, assay 98.1%, MWt 290.67, Formula C12H10ClF3N2O, Purity >98%, SMILES ClC1=CC(N2N=C(C)C=C2)=C([C@@H](O)C(F)(F)F)C=C1, MDL NA |
| Drug_Names: Boc-L-Tyrosine methyl ester, CAS: 4326-36-7, stock 706.2g, assay 98.8%, MWt 295.33, Formula C15H21NO5, Purity >98%, SMILES OC1=CC=C(C[C@H](NC(OC(C)(C)C)=O)C(OC)=O)C=C1, MDL MFCD00191181 |
| Drug_Names: N-tert-Butoxycarbonyl-D-tyrosine methyl ester, CAS: 76757-90-9, stock 341.2g, assay 99%, MWt 295.33, Formula C15H21NO5, Purity >98%, SMILES OC1=CC=C(C[C@@H](NC(OC(C)(C)C)=O)C(OC)=O)C=C1, MDL MFCD00057824 |
| Drug_Names: (R)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-(((trifluoromethyl)sulfonyl)oxy)phenyl)propanoate, CAS: 149709-56-8, stock 628.2g, assay 98.9%, MWt 427.39, Formula C16H20F3NO7S, Purity >98%, SMILES O=C(OC)[C@H](NC(OC(C)(C)C)=O)CC1=CC=C(OS(C(F)(F)F)(=O)=O)C=C1, MDL NA |
| Drug_Names: (S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, CAS: 220587-29-1, stock 336.5g, assay 98.6%, MWt 405.29, Formula C21H32BNO6, Purity >98%, SMILES O=C(OC)[C@H](CC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1)NC(OC(C)(C)C)=O, MDL NA |
| Drug_Names: (R)-2-tert-Butoxycarbonylamino-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionic acid methyl ester, CAS: 335030-24-5, stock 705.6g, assay 98.3%, MWt 405.29, Formula C21H32BNO6, Purity >98%, SMILES O=C(OC)[C@H](NC(OC(C)(C)C)=O)CC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1, MDL NA |
| Drug_Names: (S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid, CAS: 216439-76-8, stock 218.7g, assay 98.3%, MWt 391.27, Formula C20H30BNO6, Purity >98%, SMILES OC([C@H](CC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1)NC(OC(C)(C)C)=O)=O, MDL NA |
| Drug_Names: 2-Amino-4,6-dichloropyrimidine, CAS: 56-05-3, stock 480.3g, assay 98.3%, MWt 163.99, Formula C4H3Cl2N3, Purity >98%, SMILES ClC1=CC(Cl)=NC(N)=N1, MDL NA |
| Drug_Names: (S)-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid, CAS: 1033805-27-4, stock 314.6g, assay 98.4%, MWt 647.04, Formula C30H30ClF3N6O5, Purity >98%, SMILES O=C(O)[C@@H](NC(OC(C)(C)C)=O)CC1=CC=C(C2=NC(N)=NC(O[C@H](C3=CC=C(Cl)C=C3N4N=C(C)C=C4)C(F)(F)F)=C2)C=C1, MDL NA |
| Drug_Names: (S)-ethyl 3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)-2-((tert-butoxycarbonyl)amino)propanoate, CAS: 1125828-44-5, stock 716.7g, assay 98.2%, MWt 675.10, Formula C32H34ClF3N6O5, Purity >98%, SMILES O=C(OCC)[C@@H](NC(OC(C)(C)C)=O)CC1=CC=C(C2=NC(N)=NC(O[C@H](C3=CC=C(Cl)C=C3N4N=C(C)C=C4)C(F)(F)F)=C2)C=C1, MDL NA |
| Drug_Names: 1-(1-(2-Methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine, CAS: 1254058-33-7, stock 891g, assay 98.8%, MWt 334.41, Formula C17H26N4O3, Purity >98%, SMILES COC1=C(N2CCC(N3CCN(C)CC3)CC2)C=CC([N+]([O-])=O)=C1, MDL NA |
| Drug_Names: tert-Butyl (2S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate, CAS: 1007882-59-8, stock 471.1g, assay 98.7%, MWt 316.19, Formula C12H18BrN3O2, Purity >98%, SMILES BrC1=CN=C([C@H]2N(C(OC(C)(C)C)=O)CCC2)N1, MDL MFCD16620748 |
| Drug_Names: tert-Butyl (2S)-2-(1H-imidazol-2-yl)pyrrolidine-1-carboxylate, CAS: 1007882-58-7, stock 350.9g, assay 99%, MWt 237.30, Formula C12H19N3O2, Purity >98%, SMILES CC(C)(C)OC(N1[C@H](C2=NC=CN2)CCC1)=O, MDL MFCD16660093 |
| Drug_Names: (S)-tert-butyl 2-(4,5-dibromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate, CAS: 1240893-76-8, stock 774.8g, assay 98.2%, MWt 395.09, Formula C12H17Br2N3O2, Purity >98%, SMILES BrC1=C(Br)N=C([C@H]2N(C(OC(C)(C)C)=O)CCC2)N1, MDL NA |
| Drug_Names: Ethyl 3,3-dimethyl-4-nitrobutanoate, CAS: 130912-54-8, stock 394.1g, assay 98.1%, MWt 189.21, Formula C8H15NO4, Purity >98%, SMILES O=C(OCC)CC(C)(C)C[N+]([O-])=O, MDL NA |
| Drug_Names: 4,4-Dimethyl-2-pyrrolidone, CAS: 66899-02-3, stock 345.5g, assay 98.3%, MWt 113.16, Formula C6H11NO, Purity >98%, SMILES O=C1CC(C)(C)CN1, MDL MFCD09864496 |
| Drug_Names: 4-Amino-3,3-dimethylbutanoic acid hydrochloride, CAS: 89584-21-4, stock 819g, assay 98.1%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES O=C(O)CC(C)(C)CN.Cl, MDL NA |
| Drug_Names: (R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate, CAS: 143322-56-9, stock 187.8g, assay 99%, MWt 427.29, Formula C21H19BrN2O3, Purity >98%, SMILES BrC1=CC=C(NC=C2C([C@@H]3N(C(OCC4=CC=CC=C4)=O)CCC3)=O)C2=C1, MDL MFCD09835149 |
| Drug_Names: (S)-2-((tert-Butoxycarbonyl)amino)-4-fluoro-4-methylpentanoic acid, CAS: 857026-03-0, stock 51.4g, assay 98.5%, MWt 249.28, Formula C11H20FNO4, Purity >98%, SMILES CC(C)(F)C[C@H](NC(OC(C)(C)C)=O)C(O)=O, MDL NA |
| Drug_Names: 4-Chloro-5H-pyrrolo[3,2-d]pyrimidine, CAS: 84905-80-6, stock 876g, assay 98.7%, MWt 153.57, Formula C6H4ClN3, Purity >98%, SMILES ClC1=NC=NC2=C1NC=C2, MDL MFCD06658411 |
| Drug_Names: 7-Bromo-4-methoxy-5-[(phenylmethoxy)methyl]-5H-pyrrolo[3,2-d]pyrimidine, CAS: 299916-62-4, stock 154.9g, assay 98.8%, MWt 348.19, Formula C15H14BrN3O2, Purity >98%, SMILES COC1=NC=NC2=C1N(COCC3=CC=CC=C3)C=C2Br, MDL NA |
| Drug_Names: (3aR,4R,6aS)-5-benzyl-4-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyrrole, CAS: 153172-30-6, stock 222g, assay 98.1%, MWt 377.59, Formula C21H35NO3Si, Purity >98%, SMILES CC1(C)O[C@@H]2[C@@H](CO[Si](C)(C)C(C)(C)C)N(CC3=CC=CC=C3)C[C@@H]2O1, MDL NA |
| Drug_Names: 4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-N,N-diisobutyl-2-nitroaniline, CAS: 1629125-73-0, stock 448.6g, assay 98.7%, MWt 362.27, Formula C19H31BN2O4, Purity >98%, SMILES CC(C)CN(CC(C)C)C1=CC=C(B2OCC(C)(C)CO2)C=C1[N+]([O-])=O, MDL NA |
| Drug_Names: cis-2-Iodocyclopropanecarboxylic acid, CAS: 122676-92-0, stock 215.6g, assay 98.7%, MWt 211.99, Formula C4H5IO2, Purity >98%, SMILES O=C([C@@H]1[C@H](I)C1)O, MDL MFCD27501034 |
| Drug_Names: (1R,2S)-ethyl 2-(3-amino-4-(diisobutylamino)phenyl)cyclopropanecarboxylate, CAS: 1629126-20-0, stock 790g, assay 98.6%, MWt 332.48, Formula C20H32N2O2, Purity >98%, SMILES NC1=CC([C@@H](C2)[C@@H]2C(OCC)=O)=CC=C1N(CC(C)C)CC(C)C, MDL NA |
| Drug_Names: tert-Butyl 4-oxooctahydro-1H-indole-1-carboxylate, CAS: 1332584-12-9, stock 384g, assay 98.3%, MWt 239.31, Formula C13H21NO3, Purity >98%, SMILES O=C1C(CCN2C(OC(C)(C)C)=O)C2CCC1, MDL NA |
| Drug_Names: (3aR,7aR)-tert-butyl 4-oxooctahydro-1H-indole-1-carboxylate, CAS: 543910-34-5, stock 420.2g, assay 98.6%, MWt 239.31, Formula C13H21NO3, Purity >98%, SMILES O=C1[C@H](CCN2C(OC(C)(C)C)=O)[C@H]2CCC1, MDL NA |
| Drug_Names: (3aR,4S,7aR)-4-(m-tolylethynyl)octahydro-1H-indol-4-ol hydrochloride, CAS: 1636881-76-9, stock 673.6g, assay 98.7%, MWt 291.82, Formula C17H22ClNO, Purity >98%, SMILES O[C@]1(C#CC2=CC(C)=CC=C2)[C@H]3[C@H](NCC3)CCC1.Cl, MDL NA |
| Drug_Names: tert-Butyl 4-oxo-4,5,6,7-tetrahydro-1H-indole-1-carboxylate, CAS: 877170-76-8, stock 283.6g, assay 98.7%, MWt 235.28, Formula C13H17NO3, Purity >98%, SMILES O=C1C(C=CN2C(OC(C)(C)C)=O)=C2CCC1, MDL MFCD19440919 |
| Drug_Names: tert-Butyl 4-hydroxyoctahydro-1H-indole-1-carboxylate, CAS: 1821237-04-0, stock 784.2g, assay 98.4%, MWt 241.33, Formula C13H23NO3, Purity >98%, SMILES OC1C(CCN2C(OC(C)(C)C)=O)C2CCC1, MDL NA |
| Drug_Names: tert-Butyl (3aR,4S,7aR)-4-hydroxyoctahydro-1H-indole-1-carboxylate, CAS: 543910-49-2, stock 663.7g, assay 98.4%, MWt 241.33, Formula C13H23NO3, Purity >98%, SMILES O[C@@H]1[C@H](CCN2C(OC(C)(C)C)=O)[C@H]2CCC1, MDL MFCD13248566 |
| Drug_Names: (3aS,4R,7aS)-tert-butyl 4-acetoxyoctahydro-1H-indole-1-carboxylate, CAS: 543910-44-7, stock 860.4g, assay 98.2%, MWt 283.36, Formula C15H25NO4, Purity >98%, SMILES O=C(C)O[C@H]1[C@@H](CCN2C(OC(C)(C)C)=O)[C@@H]2CCC1, MDL NA |
| Drug_Names: (R)-benzyl 4-isopropyl-2,5-dioxooxazolidine-3-carboxylate, CAS: 178614-85-2, stock 426.3g, assay 98.6%, MWt 277.27, Formula C14H15NO5, Purity >98%, SMILES O=C(OC([C@H]1C(C)C)=O)N1C(OCC2=CC=CC=C2)=O, MDL NA |
| Drug_Names: Fmoc-Hyp(Bom)-OH, CAS: 187223-15-0, stock 792.9g, assay 98.3%, MWt 539.58, Formula C28H33N3O8, Purity >98%, SMILES O=C(O)[C@@H]1C[C@@H](OC(NCCNC(OC(C)(C)C)=O)=O)CN1C(OCC2C3=C(C=CC=C3)C4=C2C=CC=C4)=O, MDL MFCD07366898 |
| Drug_Names: 3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methylpropan-1-one hydrochloride, CAS: 37951-53-4, stock 403.4g, assay 98.8%, MWt 257.76, Formula C13H20ClNO2, Purity >98%, SMILES CC(CN(C)C)C(C1=CC=CC(OC)=C1)=O.Cl, MDL NA |
| Drug_Names: 3-(2-Thienyl)-L-alanine, CAS: 22951-96-8, stock 64.2g, assay 98.1%, MWt 171.22, Formula C7H9NO2S, Purity >98%, SMILES N[C@H](C(O)=O)CC1=CC=CS1, MDL MFCD00064335 |
| Drug_Names: 3-Ethoxy-4-methoxybenzonitrile, CAS: 60758-86-3, stock 295g, assay 98.2%, MWt 177.20, Formula C10H11NO2, Purity >98%, SMILES N#CC1=CC=C(OC)C(OCC)=C1, MDL MFCD02256160 |
| Drug_Names: (2S,3R)-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride, CAS: 809282-45-9, stock 346.6g, assay 98.5%, MWt 287.83, Formula C15H26ClNO2, Purity >98%, SMILES O[C@](C1=CC(OC)=CC=C1)(CC)[C@@H](C)CN(C)C.Cl[H], MDL NA |
| Drug_Names: 1,2,3,4-Tetrahydroisoquinolin-6-ol hydrobrimide, CAS: 59839-23-5, stock 209.7g, assay 99%, MWt 230.10, Formula C9H12BrNO, Purity >98%, SMILES OC1=CC2=C(CNCC2)C=C1.Br, MDL MFCD08437641 |
| Drug_Names: 3-Methoxyphenylethylamine, CAS: 2039-67-0, stock 260g, assay 98.8%, MWt 151.21, Formula C9H13NO, Purity >98%, SMILES NCCC1=CC(OC)=CC=C1, MDL MFCD00008187 |
| Drug_Names: Bis(6-methoxy-3,4-dihydroisoquinolin-2(1H)-yl)methane, CAS: 942150-85-8, stock 325.8g, assay 98%, MWt 338.44, Formula C21H26N2O2, Purity >98%, SMILES COC1=CC2=C(CN(CN3CC4=C(C=C(OC)C=C4)CC3)CC2)C=C1, MDL NA |
| Drug_Names: Methyl 2-(2,5-dibromophenyl)-2-oxoacetate, CAS: 1032231-15-4, stock 824.7g, assay 98.9%, MWt 321.95, Formula C9H6Br2O3, Purity >98%, SMILES BrC1=C(C(C(OC)=O)=O)C=C(Br)C=C1, MDL NA |
| Drug_Names: 2-(2,5-Dibromophenyl)-2-oxoacetic acid, CAS: 1094428-27-9, stock 873.3g, assay 98.9%, MWt 307.92, Formula C8H4Br2O3, Purity >98%, SMILES BrC1=C(C(C(O)=O)=O)C=C(Br)C=C1, MDL NA |
| Drug_Names: (2,5-Dibromophenyl)acetic acid, CAS: 203314-28-7, stock 1.6g, assay 98.4%, MWt 293.94, Formula C8H6Br2O2, Purity >98%, SMILES BrC1=C(CC(O)=O)C=C(Br)C=C1, MDL MFCD02664691 |
| Drug_Names: 2,5-Dibromophenylacetic acid 3-bromophenyl ester, CAS: 1403991-82-1, stock 367.5g, assay 98.5%, MWt 448.93, Formula C14H9Br3O2, Purity >98%, SMILES BrC1=CC=C(Br)C(CC(OC2=CC(Br)=CC=C2)=O)=C1, MDL NA |
| Drug_Names: 1-(4-Bromo-2-hydroxyphenyl)-2-(2,5-dibromophenyl)ethanone, CAS: 1403991-85-4, stock 661.9g, assay 98.9%, MWt 448.93, Formula C14H9Br3O2, Purity >98%, SMILES BrC1=CC=C(Br)C(CC(C2=C(O)C=C(Br)C=C2)=O)=C1, MDL NA |
| Drug_Names: 5-Bromo-2-(2-(2,5-dibromophenyl)-1-iminoethyl)phenol, CAS: 1585969-22-7, stock 74.4g, assay 99%, MWt 447.95, Formula C14H10Br3NO, Purity >98%, SMILES BrC1=CC=C(Br)C(CC(C2=C(O)C=C(Br)C=C2)=N)=C1, MDL NA |
| Drug_Names: (R)-2-(1-amino-2-(2,5-dibromophenyl)ethyl)-5-bromophenol, CAS: 1585969-24-9, stock 156.4g, assay 98.3%, MWt 449.96, Formula C14H12Br3NO, Purity >98%, SMILES BrC1=CC=C(Br)C(C[C@@H](N)C2=C(O)C=C(Br)C=C2)=C1, MDL NA |
| Drug_Names: (R)-5-bromo-2-(5-bromoindolin-2-yl)phenol, CAS: 1585969-17-0, stock 437.1g, assay 98.5%, MWt 369.05, Formula C14H11Br2NO, Purity >98%, SMILES BrC1=CC=C2C(C[C@H](C3=C(O)C=C(Br)C=C3)N2)=C1, MDL NA |
| Drug_Names: (6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydro-6H-benzo[5,6][1,3]oxazino[3,4-a]indole, CAS: 1585969-16-9, stock 465g, assay 98.2%, MWt 457.16, Formula C21H15Br2NO, Purity >98%, SMILES BrC1=CC=C2C(C[C@H]3N2[C@H](C4=CC=CC=C4)OC5=C3C=CC(Br)=C5)=C1, MDL NA |
| Drug_Names: (S)-3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole, CAS: 1392102-38-3, stock 374.3g, assay 98.3%, MWt 455.14, Formula C21H13Br2NO, Purity >98%, SMILES BrC1=CC=C2C(C=C3N2[C@H](C4=CC=CC=C4)OC5=C3C=CC(Br)=C5)=C1, MDL NA |
| Drug_Names: di-tert-Butyl 2,2'-(((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))(2S,2'S)-bis(pyrrolidine-1-carboxylate) 4-nitrobenzoate, CAS: 1585969-26-1, stock 206.8g, assay 98.5%, MWt 1102.15, Formula C59H59N9O13, Purity >98%, SMILES CC(C)(C)OC(N(CCC1)[C@@H]1C2=NC=C(N2)C(C=C3)=CC4=C3C5=CC6=C(N5[C@H](C7=CC=CC=C7)O4)C=CC(C8=CN=C([C@H]9N(C(OC(C)(C)C)=O)CCC9)N8)=C6)=O.O=C(O)C%10=CC=C([N+]([O-])=O)C=C%10.O=C(O)C%11=CC=C([N+]([O-])=O)C=C%11, MDL NA |
| Drug_Names: (S)-6-phenyl-3,10-bis(2-((S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)-6H-benzo[5,6][1,3]oxazino[3,4-a]indole dihydrochloride, CAS: 1585969-27-2, stock 326g, assay 98.1%, MWt 640.60, Formula C35H35Cl2N7O, Purity >98%, SMILES C1(C2=CN=C([C@H]3NCCC3)N2)=CC4=C(N5C(C6=C(O[C@H]5C7=CC=CC=C7)C=C(C8=CN=C([C@H]9NCCC9)N8)C=C6)=C4)C=C1.Cl.Cl, MDL NA |
| Drug_Names: 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-acetoxy-1-propanol, CAS: 88110-89-8, stock 527.5g, assay 98.3%, MWt 297.27, Formula C11H15N5O5, Purity >98%, SMILES O=C1N=C(N)NC2=C1N=CN2COC(COC(C)=O)CO, MDL NA |
| Drug_Names: 1-(2,2,2-Trifluoroethyl)-4-piperidone, CAS: 81363-14-6, stock 748.9g, assay 98.4%, MWt 181.16, Formula C7H10F3NO, Purity >98%, SMILES O=C1CCN(CC(F)(F)F)CC1, MDL NA |
| Drug_Names: 4-Bromomethyl-2(1H)-quinolinone, CAS: 4876-10-2, stock 217.8g, assay 98.4%, MWt 238.08, Formula C10H8BrNO, Purity >98%, SMILES O=C1NC2=C(C=CC=C2)C(CBr)=C1, MDL NA |
| Drug_Names: tert-Butyl 4-((1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate, CAS: 1174020-63-3, stock 267.8g, assay 98.1%, MWt 458.55, Formula C24H34N4O5, Purity >98%, SMILES O=C([C@H](CC[C@@]1([H])N2OCC3=CC=CC=C3)[N@@](C1)C2=O)NC4CCN(C(OC(C)(C)C)=O)CC4, MDL NA |
| Drug_Names: tert-Butyl ((2-phenyl-5-pivalamido-3-pivaloyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)methyl)carbamate, CAS: 781675-01-2, stock 9.3g, assay 98.1%, MWt 476.63, Formula C24H36N4O4S, Purity >98%, SMILES O=C(C(C)(C)C)N1C(C2=CC=CC=C2)(CNC(OC(C)(C)C)=O)SC(NC(C(C)(C)C)=O)=N1, MDL NA |
| Drug_Names: (R)-tert-butyl ((2-phenyl-5-pivalamido-3-pivaloyl-2,3-dihydro-1,3,4-thiadiazol-2-yl)methyl)carbamate, CAS: 910634-47-8, stock 329.3g, assay 98.1%, MWt 476.63, Formula C24H36N4O4S, Purity >98%, SMILES O=C(C(C)(C)C)N1[C@@](C2=CC=CC=C2)(CNC(OC(C)(C)C)=O)SC(NC(C(C)(C)C)=O)=N1, MDL NA |
| Drug_Names: N-(5-(aminomethyl)-5-phenyl-4-pivaloyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)pivalamide hydrochloride, CAS: 781675-10-3, stock 426.1g, assay 98.8%, MWt 412.98, Formula C19H29ClN4O2S, Purity >98%, SMILES O=C(C(C)(C)C)N1C(C2=CC=CC=C2)(CN)SC(NC(C(C)(C)C)=O)=N1.Cl, MDL NA |
| Drug_Names: N-(5-phenyl-4-pivaloyl-5-(vinylsulfonamidomethyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)pivalamide, CAS: 546111-92-6, stock 781.9g, assay 98.1%, MWt 466.62, Formula C21H30N4O4S2, Purity >98%, SMILES O=C(C(C)(C)C)N1C(C2=CC=CC=C2)(CNS(C=C)(=O)=O)SC(NC(C(C)(C)C)=O)=N1, MDL NA |
| Drug_Names: 1-Acetylnaphthalene oxime, CAS: 1956-40-7, stock 338.8g, assay 98.9%, MWt 185.22, Formula C12H11NO, Purity >98%, SMILES C/C(C1=CC=CC2=CC=CC=C21)=N/O, MDL NA |
| Drug_Names: Ethyl 4-(butylamino)benzoate, CAS: 94-32-6, stock 555.6g, assay 98.3%, MWt 221.30, Formula C13H19NO2, Purity >98%, SMILES O=C(OCC)C1=CC=C(NCCCC)C=C1, MDL MFCD00017283 |
| Drug_Names: 2-Amino-9-(((2-ethoxy-2-methyl-1,3-dioxan-5-yl)oxy)methyl)-3H-purin-6(9H)-one, CAS: 194159-14-3, stock 248.2g, assay 98.6%, MWt 325.32, Formula C13H19N5O5, Purity >98%, SMILES O=C1N=C(N)NC2=C1N=CN2COC3COC(C)(OCC)OC3, MDL NA |
| Drug_Names: 3-(2,3-Dihydrobenzofuran-5-yl)-2-propenoic acid, CAS: 198707-57-2, stock 764g, assay 98.6%, MWt 190.20, Formula C11H10O3, Purity >98%, SMILES O=C(O)/C=C\C1=CC=C2C(CCO2)=C1, MDL NA |
| Drug_Names: Ethyl 3-(7-bromo-2,3-dihydrobenzofuran-5-yl)propanoate, CAS: 196597-67-8, stock 50.6g, assay 98.6%, MWt 299.16, Formula C13H15BrO3, Purity >98%, SMILES O=C(OCC)CCC1=CC(Br)=C2C(CCO2)=C1, MDL NA |
| Drug_Names: 3-(7-Bromo-2,3-dihydrobenzofuran-5-yl)propanoic acid, CAS: 196597-68-9, stock 11.6g, assay 98.4%, MWt 271.11, Formula C11H11BrO3, Purity >98%, SMILES O=C(O)CCC1=CC(Br)=C2C(CCO2)=C1, MDL NA |
| Drug_Names: Ethyl 3-(6,7-dibromo-2,3-dihydrobenzofuran-5-yl)propanoate, CAS: 196597-75-8, stock 462.7g, assay 98.4%, MWt 378.06, Formula C13H14Br2O3, Purity >98%, SMILES O=C(OCC)CCC1=C(Br)C(Br)=C2C(CCO2)=C1, MDL NA |
| Drug_Names: 1-(5-Fluoro-2-hydroxyphenyl)-2-(3-fluorophenyl)ethanone, CAS: 1300582-07-3, stock 452.4g, assay 98.4%, MWt 248.22, Formula C14H10F2O2, Purity >98%, SMILES FC1=CC(CC(C2=CC(F)=CC=C2O)=O)=CC=C1, MDL NA |
| Drug_Names: (R)-methyl 2-(benzyloxy)propanoate, CAS: 115458-99-6, stock 636.2g, assay 98.4%, MWt 194.23, Formula C11H14O3, Purity >98%, SMILES C[C@@H](OCC1=CC=CC=C1)C(OC)=O, MDL NA |
| Drug_Names: (R)-2-(1-(benzyloxy)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one, CAS: 1479107-53-3, stock 350.5g, assay 98.2%, MWt 392.39, Formula C24H18F2O3, Purity >98%, SMILES O=C1C(C2=CC=CC(F)=C2)=C([C@H](OCC3=CC=CC=C3)C)OC4=C1C=C(F)C=C4, MDL NA |
| Drug_Names: (R)-6-fluoro-3-(3-fluorophenyl)-2-(1-hydroxyethyl)-4H-chromen-4-one, CAS: 1479107-10-2, stock 467g, assay 98.7%, MWt 302.27, Formula C17H12F2O3, Purity >98%, SMILES O=C1C(C2=CC=CC(F)=C2)=C([C@H](O)C)OC3=C1C=C(F)C=C3, MDL NA |
| Drug_Names: (S)-benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate, CAS: 199659-03-5, stock 628.2g, assay 98.9%, MWt 427.29, Formula C21H19BrN2O3, Purity >98%, SMILES BrC1=CC=C(NC=C2C([C@H]3N(C(OCC4=CC=CC=C4)=O)CCC3)=O)C2=C1, MDL NA |
| Drug_Names: (R)-1-(naphthalen-1-yl)ethanamine (R)-2-hydroxy-2-phenylacetate, CAS: 1073144-62-3, stock 71.6g, assay 98.5%, MWt 323.39, Formula C20H21NO3, Purity >98%, SMILES C[C@@H](N)C1=CC=CC2=CC=CC=C21.OC([C@H](O)C3=CC=CC=C3)=O, MDL NA |
| Drug_Names: 2-Methyl-5-nitrophenol, CAS: 5428-54-6, stock 694g, assay 98.8%, MWt 153.14, Formula C7H7NO3, Purity >98%, SMILES OC1=C(C)C=CC([N+]([O-])=O)=C1, MDL MFCD00043909 |
| Drug_Names: 2-Methyl-5-nitrobenzenamine, CAS: 99-55-8, stock 796.5g, assay 98.6%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES NC1=C(C)C=CC([N+]([O-])=O)=C1, MDL MFCD00007741 |
| Drug_Names: (R)-(+)-2-Benzyloxypropionic acid, CAS: 100836-85-9, stock 204.2g, assay 98.3%, MWt 180.20, Formula C10H12O3, Purity >98%, SMILES O=C(O)[C@@H](C)OCC1=CC=CC=C1, MDL MFCD06799065 |
| Drug_Names: 5-(((S)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic acid, CAS: 864825-69-4, stock 457.2g, assay 98.2%, MWt 669.77, Formula C37H43N5O7, Purity >98%, SMILES O=C(O)C1=CC(CN(C([C@@H](NC(OC(C)(C)C)=O)CC2=C(C)C=C(C(N)=O)C=C2C)=O)[C@H](C3=NC=C(C4=CC=CC=C4)N3)C)=CC=C1OC, MDL NA |
| Drug_Names: 2,5-dioxopyrrolidin-1-yl 2-cyanoacetate, CAS: 56657-76-2, stock 755.1g, assay 98%, MWt 182.13, Formula C7H6N2O4, Purity >98%, SMILES O=C(ON1C(CCC1=O)=O)CC#N, MDL MFCD00798802 |
| Drug_Names: 2-(5-Iodo-2-Methylbenzoyl)-5-(4-fluorophenyl)thiophene, CAS: 1071929-08-2, stock 601g, assay 98.8%, MWt 422.26, Formula C18H12FIOS, Purity >98%, SMILES CC1=C(C(C2=CC=C(C3=CC=C(F)C=C3)S2)=O)C=C(I)C=C1, MDL MFCD12405594 |
| Drug_Names: 2,3-Dihydrobenzofuran-5-propanoic acid, CAS: 215057-28-6, stock 744.4g, assay 98.4%, MWt 192.21, Formula C11H12O3, Purity >98%, SMILES OC(CCC1=CC2=C(OCC2)C=C1)=O, MDL MFCD03102298 |
| Drug_Names: tert-Butyl[(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate, CAS: 1210348-34-7, stock 290.2g, assay 98.2%, MWt 375.42, Formula C16H29N3O7, Purity >98%, SMILES O=C(OC(C)(C)C)N[C@H]1[C@@H](N)CC[C@H](C(N(C)C)=O)C1.O=C(O)C(O)=O, MDL NA |
| Drug_Names: 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride, CAS: 720720-96-7, stock 407.1g, assay 98.2%, MWt 234.70, Formula C8H11ClN2O2S, Purity >98%, SMILES O=C(C(S1)=NC2=C1CN(C)CC2)O.[H]Cl, MDL MFCD25542379 |
| Drug_Names: 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetate ethyl ester monohydrochloride, CAS: 1243308-37-3, stock 52.8g, assay 98.9%, MWt 265.09, Formula C9H10Cl2N2O3, Purity >98%, SMILES O=C(OCC)C(NC1=NC=C(Cl)C=C1)=O.[H]Cl, MDL MFCD02625495 |
| Drug_Names: 6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, CAS: 57196-62-0, stock 629.7g, assay 98.1%, MWt 199.68, Formula C10H14ClNO, Purity >98%, SMILES COC1=CC2=C(CNCC2)C=C1.Cl, MDL MFCD01717328 |
| Drug_Names: 5-Bromo-2-methoxypyrimidine, CAS: 14001-66-2, stock 788.4g, assay 98.2%, MWt 189.01, Formula C5H5BrN2O, Purity >98%, SMILES BrC1=CN=C(OC)N=C1, MDL MFCD04973351 |
| Drug_Names: 7-Oxa-1-azaspiro[4.4]nonane hydrochloride, CAS: 1620569-18-7, stock 599.3g, assay 98.5%, MWt 163.65, Formula C7H14ClNO, Purity >98%, SMILES [H]Cl.N1CCCC12COCC2, MDL NA |
| Drug_Names: (R)-2-Methylpyrrolidine-2-carboxylic acid hydrochloride, CAS: 123053-48-5, stock 152.5g, assay 98.7%, MWt 165.62, Formula C6H12ClNO2, Purity >98%, SMILES O=C(O)[C@]1(C)NCCC1.[H]Cl, MDL MFCD20487714 |
| Drug_Names: (R)-2-Ethylpiperazine dihydrochloride, CAS: 438050-07-8, stock 383g, assay 98.7%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES CC[C@@H]1CNCCN1.Cl.Cl, MDL MFCD12756012 |
| Drug_Names: 1-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole, CAS: 761446-44-0, stock 614.5g, assay 98.7%, MWt 208.07, Formula C10H17BN2O2, Purity >98%, SMILES CC1(C)C(C)(C)OB(C2=CN(C)N=C2)O1, MDL MFCD03789259 |
| Drug_Names: 4-Methyl-1,3-benzodioxole-5-carboxylic acid, CAS: 162506-58-3, stock 370.6g, assay 98.1%, MWt 180.16, Formula C9H8O4, Purity >98%, SMILES OC(C1=CC=C(OCO2)C2=C1C)=O, MDL NA |
| Drug_Names: 2,3-Dimethoxytoluene, CAS: 4463-33-6, stock 229.5g, assay 98.2%, MWt 152.19, Formula C9H12O2, Purity >98%, SMILES CC1=CC=CC(OC)=C1OC, MDL MFCD00008379 |
| Drug_Names: (R)-1-(benzylamino)-3-chloropropan-2-ol, CAS: 278788-93-5, stock 359.4g, assay 98.4%, MWt 199.68, Formula C10H14ClNO, Purity >98%, SMILES O[C@@H](CCl)CNCC1=CC=CC=C1, MDL NA |
| Drug_Names: (S)-1-(benzylamino)-3-chloropropan-2-ol, CAS: 198755-87-2, stock 473.7g, assay 98.7%, MWt 199.68, Formula C10H14ClNO, Purity >98%, SMILES O[C@H](CCl)CNCC1=CC=CC=C1, MDL NA |
| Drug_Names: (R)-4-benzyl-6-(chloromethyl)morpholin-3-one, CAS: 278788-94-6, stock 64.9g, assay 98.1%, MWt 239.70, Formula C12H14ClNO2, Purity >98%, SMILES ClC[C@@H](CN1CC2=CC=CC=C2)OCC1=O, MDL NA |
| Drug_Names: (2R)-2-(Chloromethyl)-4-(phenylmethyl)morpholine, CAS: 186293-54-9, stock 136g, assay 98.6%, MWt 225.71, Formula C12H16ClNO, Purity >98%, SMILES ClC[C@@H]1OCCN(CC2=CC=CC=C2)C1, MDL MFCD11847011 |
| Drug_Names: (2S)-2-(Chloromethyl)-4-(phenylmethyl)morpholine, CAS: 1222556-84-4, stock 592.3g, assay 98.5%, MWt 225.71, Formula C12H16ClNO, Purity >98%, SMILES ClC[C@H]1OCCN(CC2=CC=CC=C2)C1, MDL MFCD11847012 |
| Drug_Names: (R)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]morpholine-4-carboxylic acid tert-butyl ester, CAS: 1308849-93-5, stock 40.2g, assay 98.5%, MWt 346.38, Formula C18H22N2O5, Purity >98%, SMILES O=C1N(C[C@H]2OCCN(C(OC(C)(C)C)=O)C2)C(C3=CC=CC=C31)=O, MDL NA |
| Drug_Names: tert-Butyl (2R)-2-(aminomethyl)morpholine-4-carboxylate, CAS: 1174913-80-4, stock 792.8g, assay 98.6%, MWt 216.28, Formula C10H20N2O3, Purity >98%, SMILES NC[C@H]1OCCN(C(OC(C)(C)C)=O)C1, MDL MFCD13189480 |
| Drug_Names: (E)-1-(4-(trifluoromethoxy)phenyl)ethanone oxime, CAS: 1265612-59-6, stock 658.3g, assay 98.9%, MWt 219.16, Formula C9H8F3NO2, Purity >98%, SMILES C/C(C1=CC=C(OC(F)(F)F)C=C1)=N\O, MDL NA |
| Drug_Names: 2-Chloro-6-methylbenzoic acid, CAS: 21327-86-6, stock 323.8g, assay 98.8%, MWt 170.59, Formula C8H7ClO2, Purity >98%, SMILES ClC1=C(C(O)=O)C(C)=CC=C1, MDL MFCD00045799 |
| Drug_Names: tert-Butyl methyl[2-(methylamino)ethyl]carbamate, CAS: 112257-19-9, stock 392.1g, assay 98.8%, MWt 188.27, Formula C9H20N2O2, Purity >98%, SMILES O=C(OC(C)(C)C)N(C)CCNC, MDL NA |
| Drug_Names: 3-Iodopyrazole-4-carboxylic acid ethyl ester, CAS: 827316-43-8, stock 694.5g, assay 98.7%, MWt 266.04, Formula C6H7IN2O2, Purity >98%, SMILES O=C(C1=CNN=C1I)OCC, MDL NA |
| Drug_Names: Ethyl 3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole-4-carboxylate, CAS: 1190060-37-7, stock 319.3g, assay 98.7%, MWt 350.15, Formula C11H15IN2O3, Purity >98%, SMILES O=C(OCC)C1=CN(C2OCCCC2)N=C1I, MDL NA |
| Drug_Names: 3-Iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole-4-carbaldehyde, CAS: 1627924-19-9, stock 523.3g, assay 98.3%, MWt 306.10, Formula C9H11IN2O2, Purity >98%, SMILES O=CC1=CN(C2OCCCC2)N=C1I, MDL NA |
| Drug_Names: 4-(2-Bromoethyl)tetrahydropyran, CAS: 4677-20-7, stock 795.3g, assay 98%, MWt 193.08, Formula C7H13BrO, Purity >98%, SMILES BrCCC1CCOCC1, MDL MFCD09800414 |
| Drug_Names: (((1,3-Dibromopropan-2-yl)oxy)methyl)benzene, CAS: 35995-55-2, stock 707.8g, assay 98.9%, MWt 308.01, Formula C10H12Br2O, Purity >98%, SMILES BrCC(CBr)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: Toluene-4-sulfonic acid cis-3-benzyloxycyclobutyl ester, CAS: 1262278-62-5, stock 588.8g, assay 98.3%, MWt 332.41, Formula C18H20O4S, Purity >98%, SMILES CC1=CC=C(S(O[C@@H]2C[C@H](OCC3=CC=CC=C3)C2)(=O)=O)C=C1, MDL NA |
| Drug_Names: (3S,4R)-Methyl 3-(4-chlorobenzoyl)-6-(4-chlorophenyl)-3,4,5-trihydroxy-6-oxohexanoate, CAS: 99886-53-0, stock 593.6g, assay 98.8%, MWt 425.26, Formula C20H18Cl2O6, Purity >98%, SMILES COC1C[C@H](OC(C2=CC=C(Cl)C=C2)=O)[C@@H](COC(C3=CC=C(Cl)C=C3)=O)O1, MDL MFCD11974936 |
| Drug_Names: N-(1H-Imidazol-2-ylmethyl)-4-chloroaniline, CAS: 166096-16-8, stock 183.9g, assay 98%, MWt 207.66, Formula C10H10ClN3, Purity >98%, SMILES ClC(C=C1)=CC=C1NCC2=NC=CN2, MDL NA |
| Drug_Names: 6-Cyano-2,2-dimethyl-2H-chromene, CAS: 33143-29-2, stock 580.9g, assay 98.9%, MWt 185.22, Formula C12H11NO, Purity >98%, SMILES CC1(C)OC2=CC=C(C#N)C=C2C=C1, MDL MFCD00084978 |
| Drug_Names: 2-(2-(2-(2-(4-Nitrophenoxy)ethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, CAS: 168784-48-3, stock 852.2g, assay 98.4%, MWt 469.51, Formula C21H27NO9S, Purity >98%, SMILES O=[N+](C1=CC=C(OCCOCCOCCOCCOS(C2=CC=C(C)C=C2)(=O)=O)C=C1)[O-], MDL NA |
| Drug_Names: 2-(2-(2-(2-(4-Nitrophenoxy)ethoxy)ethoxy)ethoxy)ethanamine, CAS: 1818885-57-2, stock 216.2g, assay 98.9%, MWt 314.33, Formula C14H22N2O6, Purity >98%, SMILES O=[N+](C1=CC=C(OCCOCCOCCOCCN)C=C1)[O-], MDL NA |
| Drug_Names: 5-Chloro-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol hydrochloride, CAS: 1562343-70-7, stock 277.9g, assay 98.5%, MWt 398.33, Formula C19H25Cl2N3O2, Purity >98%, SMILES OC1=CC(Cl)=CC=C1C2=NN=C(OC3CC(C)(C)NC(C)(C)C3)C=C2.Cl, MDL NA |
| Drug_Names: 2-Fluoro-5-formylbenzoic acid, CAS: 550363-85-4, stock 133.4g, assay 98.1%, MWt 168.12, Formula C8H5FO3, Purity >98%, SMILES FC1=C(C(O)=O)C=C(C=O)C=C1, MDL MFCD04972875 |
| Drug_Names: (S)-3-(1-aminoethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one, CAS: 1350643-72-9, stock 865.8g, assay 98.5%, MWt 298.77, Formula C17H15ClN2O, Purity >98%, SMILES ClC1=C(C2=O)C(C=C([C@@H](N)C)N2C3=CC=CC=C3)=CC=C1, MDL NA |
| Drug_Names: (R)-3-(1-aminoethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one, CAS: 2199389-46-1, stock 151.5g, assay 98.6%, MWt 298.77, Formula C17H15ClN2O, Purity >98%, SMILES ClC1=C(C2=O)C(C=C([C@H](N)C)N2C3=CC=CC=C3)=CC=C1, MDL NA |
| Drug_Names: 1-Methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrazole, CAS: 1607838-14-1, stock 551.6g, assay 98.5%, MWt 284.16, Formula C16H21BN2O2, Purity >98%, SMILES CC1(C)C(C)(C)OB(C2=CC=C(C3=CN(C)N=C3)C=C2)O1, MDL NA |
| Drug_Names: 3-Bromo-4,5-dichloropyridine, CAS: 1001056-83-2, stock 596.9g, assay 98.8%, MWt 226.89, Formula C5H2BrCl2N, Purity >98%, SMILES ClC1=CN=CC(Br)=C1Cl, MDL MFCD17014545 |
| Drug_Names: (R)-N-(pyrrolidin-3-yl)cyclopropanecarboxamide hydrochloride, CAS: 1884705-03-6, stock 353.1g, assay 98.4%, MWt 190.67, Formula C8H15ClN2O, Purity >98%, SMILES O=C(C1CC1)N[C@H]2CNCC2.Cl, MDL NA |
| Drug_Names: Peracetylated D-glucose, CAS: 83-87-4, stock 232.3g, assay 98.2%, MWt 390.34, Formula C16H22O11, Purity >98%, SMILES CC(OC[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)C(OC(C)=O)O1)=O, MDL MFCD00080787 |
| Drug_Names: 2,3,4,6-Tetra-O-acetyl-D-glucopyranose, CAS: 10343-06-3, stock 44.8g, assay 98.7%, MWt 348.30, Formula C14H20O10, Purity >98%, SMILES OC1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O, MDL NA |
| Drug_Names: (2S,3R,4S,5R,6R)-6-((pivaloyloxy)methyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetrakis(2,2-dimethylpropanoate), CAS: 81058-26-6, stock 264.6g, assay 98.8%, MWt 600.74, Formula C31H52O11, Purity >98%, SMILES O=C(C(C)(C)C)OC[C@@H]1[C@@H](OC(C(C)(C)C)=O)[C@H](OC(C(C)(C)C)=O)[C@@H](OC(C(C)(C)C)=O)[C@H](OC(C(C)(C)C)=O)O1, MDL NA |
| Drug_Names: 3-Nitro-6-phenylpyridin-2-amine, CAS: 102266-15-9, stock 305.6g, assay 98.8%, MWt 215.21, Formula C11H9N3O2, Purity >98%, SMILES NC1=C([N+]([O-])=O)C=CC(C2=CC=CC=C2)=N1, MDL MFCD16556297 |
| Drug_Names: Benzyl 3-oxocyclobutanecarboxylate, CAS: 198995-91-4, stock 181.6g, assay 98.2%, MWt 204.22, Formula C12H12O3, Purity >98%, SMILES O=C(C1CC(C1)=O)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: N-(3,3-difluorocyclobutyl)formamide, CAS: 1355328-30-1, stock 378.3g, assay 98%, MWt 135.11, Formula C5H7F2NO, Purity >98%, SMILES O=CNC1CC(F)(F)C1, MDL NA |
| Drug_Names: 2-Chloro-6-methyl-N-phenylbenzamide, CAS: 1386861-46-6, stock 683.6g, assay 98.8%, MWt 245.70, Formula C14H12ClNO, Purity >98%, SMILES ClC1=C(C(NC2=CC=CC=C2)=O)C(C)=CC=C1, MDL MFCD25459278 |
| Drug_Names: Boc-Ala-NMe(OMe), CAS: 87694-49-3, stock 394.4g, assay 98.4%, MWt 232.28, Formula C10H20N2O4, Purity >98%, SMILES CN(C([C@@](C)([H])NC(OC(C)(C)C)=O)=O)OC, MDL MFCD00151859 |
| Drug_Names: 6-Chloro-9-(2-tetrahydropyranyl)purine, CAS: 7306-68-5, stock 255.6g, assay 98.7%, MWt 238.67, Formula C10H11ClN4O, Purity >98%, SMILES ClC1=NC=NC2=C1N=CN2C3OCCCC3, MDL MFCD00022821 |
| Drug_Names: 1-(4-Methylthiophenyl)-3-(3,5-dimethyl-4-hydroxyphenyl)prop-2-en-1-one, CAS: 824932-89-0, stock 14.5g, assay 98%, MWt 298.40, Formula C18H18O2S, Purity >98%, SMILES O=C(C1=CC=C(SC)C=C1)/C=C/C2=CC(C)=C(O)C(C)=C2, MDL NA |
| Drug_Names: 1-(Cyclopropylcarbonyl)piperazine hydrochloride, CAS: 1021298-67-8, stock 877.4g, assay 98.4%, MWt 190.67, Formula C8H15ClN2O, Purity >98%, SMILES O=C(C1CC1)N2CCNCC2.Cl[H], MDL NA |
| Drug_Names: (S)-N-(2-benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide hydrochloride, CAS: 147959-98-6, stock 789g, assay 98.2%, MWt 420.93, Formula C25H25ClN2O2, Purity >98%, SMILES O=C(C1=CC=CC=C1)C2=CC=CC=C2NC([C@H]3N(CC4=CC=CC=C4)CCC3)=O.[H]Cl, MDL NA |
| Drug_Names: (R)-2-tert-Butoxycarbonylamino-4,4-dimethylpentanoic acid, CAS: 112695-98-4, stock 716.2g, assay 98.3%, MWt 245.32, Formula C12H23NO4, Purity >98%, SMILES CC(C)(C)C[C@@H](NC(OC(C)(C)C)=O)C(O)=O, MDL MFCD00798621 |
| Drug_Names: (R)-3-Fluoropyrrolidine hydrochloride, CAS: 136725-55-8, stock 475.8g, assay 98.8%, MWt 125.57, Formula C4H9ClFN, Purity >98%, SMILES F[C@@H]1CCNC1.Cl, MDL MFCD04038717 |
| Drug_Names: 3-Hydrazino-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine, CAS: 802598-74-9, stock 888.3g, assay 98.5%, MWt 226.28, Formula C13H14N4, Purity >98%, SMILES N/N=C1C=C2CCCC3=CC=CC=C3C2=NN\1, MDL NA |
| Drug_Names: N-((1R,2R)-2-((3-(cyclohexa-1,4-dien-1-yl)propyl)amino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide, CAS: 851051-41-7, stock 771.7g, assay 98.7%, MWt 486.67, Formula C30H34N2O2S, Purity >98%, SMILES CC1=CC=C(S(=O)(N[C@H](C2=CC=CC=C2)[C@@H](C3=CC=CC=C3)NCCCC4=CCC=CC4)=O)C=C1, MDL NA |
| Drug_Names: (S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)-N-((S)-1-phenylethyl)ethanamine hydrochloride, CAS: 1450759-47-3, stock 721.5g, assay 98.5%, MWt 413.96, Formula C20H28ClNO4S, Purity >98%, SMILES O=S(C[C@H](C1=CC=C(OC)C(OCC)=C1)N[C@@H](C)C2=CC=CC=C2)(C)=O.Cl, MDL NA |
| Drug_Names: 2-Amino-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid dihydrochloride dihydrate, CAS: 914769-50-9, stock 610g, assay 98%, MWt 341.19, Formula C12H18Cl2N2O5, Purity >98%, SMILES O=C1NC2=CC=CC=C2C(CC(N)C(O)=O)=C1.[H]Cl.[H]Cl.O.O, MDL NA |
| Drug_Names: (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide, CAS: 368421-58-3, stock 686.4g, assay 98.5%, MWt 312.34, Formula C13H14F2N4OS, Purity >98%, SMILES NC([C@H](C)[C@@](O)(C1=CC(F)=CC=C1F)CN2N=CN=C2)=S, MDL MFCD28404611 |
| Drug_Names: 5-Aminoimidazole-4-carboxamide hydrochloride, CAS: 72-40-2, stock 370.8g, assay 98.4%, MWt 162.58, Formula C4H7ClN4O, Purity >98%, SMILES O=C(C1=C(N)NC=N1)N.[H]Cl, MDL MFCD00012704 |
| Drug_Names: 1-(3-Carboxy-4-methoxybenzyl)-1,3,5,7-tetraazaadamantan-1-ium chloride, CAS: 748134-95-4, stock 861g, assay 98.1%, MWt 340.81, Formula C15H21ClN4O3, Purity >98%, SMILES COC1=CC=C(C[N+]2(C3)C[N@@]4C[N@@](C[N@]3C4)C2)C=C1C(O)=O.[Cl-], MDL NA |
